<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy. May 2011</title>
				<funder>
					<orgName type="full">DHHS</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institute on Drug Abuse</orgName>
					<orgName type="abbreviated">NIDA</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
				</funder>
				<funder>
					<orgName type="full">Understanding Drug Abuse and Addiction. Researc DHHS</orgName>
				</funder>
				<funder ref="#_f2ssv8C #_pxgk8Zd">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder>
					<orgName type="full">Author, Rockville, MD. ional Institute on Drug Ab (Ecstasy)</orgName>
				</funder>
				<funder>
					<orgName type="full">NIDA</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Washington</forename><surname>University</surname></persName>
						</author>
						<author>
							<persName><roleName>Chair</roleName><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Parks</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lee</forename><forename type="middle">K</forename><surname>Benham</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Linda</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Steven</forename><forename type="middle">M</forename><surname>Fazzari</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">C</forename><surname>Heath</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Edward</forename><forename type="middle">L</forename><surname>Spitznagel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Murray</forename><forename type="middle">L</forename><surname>Weidenbaum</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Arbi</forename><forename type="middle">Ben</forename><surname>Abdallah</surname></persName>
						</author>
						<author>
							<persName><roleName>Missouri</roleName><forename type="first">St</forename><surname>Louis</surname></persName>
						</author>
						<author>
							<persName><roleName>Agocha, V. B</roleName><forename type="first">M</forename><forename type="middle">L</forename><surname>Cooper</surname></persName>
						</author>
						<author>
							<persName><roleName>M. S.</roleName><surname>Sheldon</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Economics Dissertation Examination Committee</orgName>
								<address>
									<settlement>Shillington</settlement>
									<region>A</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Drug of Dependence. Drug and Alcohol Dependence</orgName>
								<address>
									<addrLine>107, 1-10</addrLine>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy. May 2011</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.1" ident="GROBID" when="2025-10-21T19:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Co chology</term>
					<term>13</term>
					<term>251-262. late</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The DSM-IV field trial for substance use disorders results. Drug Alcohol Depend, 38, 59-69. 234 users. rug use disorder instruments. Drug Co Co sy adults: applicability and Co SMxymethamphetamine (MDMA) abuse Co ., ns: From Cox l of 7, 168-180. Cu , SSI Scientific Software International, DeF ological Review, 40, 88-103.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The consumption of mind-altering drugs is well recognized as a complex behavior entailing many different etiological precursors. To understand its complexity, drug use has to be considered from multiple perspectives. Over time, numerous theories have been advanced to explain drug use, the pattern of its use, and its related consequences. Because they approach such a behavior from slightly different vantage points, these theories offer unique explanations with different take on its genetic, physiological, psychological, and environment risk factors. A substantial body of research suggests that there exist multiple perspectives on psychological precursors to drug abuse; however, the same literature also implicates economic measures that can explain drug etiology. Economic models of consumption suggest that "market forces" adequately explain the use of drugs. Market forces alone are however necessary but not sufficient to account for drug consumption. Other iii factors that appear involved include psychological motivation and other intraindividual characteristics (i.e., depression and risk-taking) that also explain use and problems arising from drug use. Until now, the confluence of both economic and psychological theories has not been tested empirically. The present study used latentvariable Structural equation modeling to examine the influence of both economic (social anomie, monetary price, opportunity cost) and psychological risk factors (motivation, depression, and risk-taking) on self-reported Ecstasy use and its related consequences, referred to as dependence. Data used in this research were obtained from 640 recreational Ecstasy users between 2002 and 2005 in three sites in the United States and Australia participating in a NIDA-funded nosological study examining trends in club drug use. The sample was mainly Caucasian (62%), male (58%), and young [mean age =23years (SD=5.01)]. All the hypothesized latent constructs were statistically reliable and correlated in the expected direction. A Full "saturated" model indicated that, among the three key economic measures, monetary and opportunity cost, but not income, significantly predicted Ecstasy consumption.</p><p>On the other hand, among the psychological measures, motivational cues were the strongest predictors of both consumption and dependence. Dependence was also impacted by depression and sex-risk. Inclusion of demographic measures (gender, age, race, and education) and site location did not appreciably alter the final model parameters. Findings are discussed with regard to incorporating the role of economic and psychological factors in shaping a more refined understanding of Ecstasy consumption and its consequences.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>iv</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DEDICATION</head><p>In loving memory of my mother and father, whose inspiration and love taught me that the greatest value of life is determined by your own resolve and commitment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>v</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p>There are several advantages one gains from working fastidiously on a doctoral degree at a later point in life. The most important of these advantages is the research experience one gains from years of earnestly hard work and empirical inquiry. Added to this devotion, the long road one travels in a graduate school is peppered with incredible support of collaborators, colleagues, and friends. Given the road I traveled, a road paved with tremendous insight and mentorship, I am indebted to many people to whom I would like to express my sincere appreciation.</p><p>First, I am truly grateful to each and every one of my dissertation committee members for their involvement and support.</p><p>Second, I want to especially thank Dr. Linda B. Cottler for her tremendous guidance, vision, and support over the years. The data used for this dissertation was obtained from a NIDA-funded study spearheaded by Dr. Cottler and I do appreciate the opportunity to use this information with her permission. Most importantly, I am grateful for her friendship that has served us both well over the years; it has made the workplace both a vital intellectual and richly spiritual haven. Without her encouragement and valuable feedback I would not have been able to complete this journey.</p><p>Third, I am also deeply grateful to Dr. Robert P. Parks, Chair of my dissertation committee. He was a prescient light during my graduate education; he stuck by my side and made sure that I remained focused on the end product. Here too, vi we are really talking about a deep and mutual respect mixed with friendship. Dr.</p><p>Parks, or dear Bob, thank you! Fourth, I would like to thank Dr. Lawrence M. Scheier, for being a "ghost mentor" and for always being positive, encouraging, and supportive. We co-authored several papers applying advanced statistical techniques. Dr. Scheier, I owe everything I know about Structural Equation Modeling and more to you, thank you! Fifth, I also wish to thank all of my colleagues and friends at the       </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">CHAPTER I: INTRODUCTION</head><p>Throughout history, mankind has sought ways to alter its consciousness with the use of natural herbal products and derivatives of native plants. The most common parts of plants used to create medicinal potions and concoctions have been leaves, roots, and seeds. Even without knowing their medicinal properties or their pharmacological action, many ancient societies used a variety of plants for their soothing effects, inducing relaxation, and even their psychotropic effects. Some of the more popular forms of native plants that possess mind-altering properties include cannabis, coca, datura, ergot, khat, mescal, opium, and peyote.</p><p>With time, and advances made primarily through pharmacology, chemists were able to figure out the structural properties corresponding to the "active ingredients" of native plants that cause altered states of consciousness. Within a short period of time, laboratory advances provided a means to synthesize the active ingredients that conveyed psychoactive properties from plant derivatives. Common examples encountered in the literature include the coca leaf, which can be ground into a milky white paste or refined into a more pure form of powdered cocaine. Likewise, scoring the opium poppy produces the discharge of a thick viscous, pasty, tar-like resin that can eventually be processed as street grade heroin. In 1804 the opiate analgesic morphine was first of several plant alkaloids extracted from the opium plant; it was eventually marketed by the pharmaceutical company Merck (1827) as a major pain reliever. As scientists have become more familiar with the behavioral and psychological effects of numerous plant alkaloids, and particularly their narcotic and analgesic effects, emphasis has been placed on delineating whether they cause addiction.</p><p>One of the first steps in the process of understanding the psychoactive properties for all mind altering substances (i.e., all kind of drugs, including native plants, known to alter mood, perception, and behavior) was to classify them according to their addictive potential. In 1970, the United States (U.S.) Congress enacted the Controlled Substance Act, part of the "Comprehensive Drug Abuse</p><p>Prevention and Control Act of 1970," to provide the Drug Enforcement Administration (DEA) a mechanism to classify all chemical substances into categories, also known as drug schedules or classes. <ref type="foot" target="#foot_0">1</ref> Today, the scheduling (or classification) of drugs encompasses a wide range of illicit drugs including marijuana, cocaine (both powder and crack that can be manufactured in crystalline form), opioids (morphine, heroin, and any derivatives of plant alkaloids in chemical form such as Hydrocodone, Oxycontin, or codeine), and methamphetamines. The classification system has also been extended to include legal substances, such as nicotine, alcohol, and prescription medications. 2 When consumed for recreational purposes to achieve a certain altered state of consciousness [e.g., to promote instant rush (euphoria), induce hallucinations, or to get "high"], these psychoactive drugs have a great potential for abuse and can lead to addiction and are responsible for causing a wide range of adverse medical (physical and/or mental health) and other consequences <ref type="bibr" target="#b32">(Chen &amp; Lin, 2009;</ref><ref type="bibr">Rehm et al., 2006)</ref>.</p><p>The consumption of mind-altering substances by individuals of all socioeconomic strata and age groups, including adolescents and young adults, continues to be a matter of public health concern and represents a tremendous social problem. This is because continued use of these drugs can lead to serious physical as well as mental health problems, including death by overdose <ref type="bibr">(CDC, 2010)</ref>. The costs (monetary and otherwise) of drug use and addiction are enormous to society, including financial outlays for treatment, loss of economic productivity, disruption to the family, and legal incarceration for manufacturing, distribution, possession, and/or consumption. There is yet an ongoing debate as to whether other legal natural-substances, such as sugar, coffee, and chocolate; as well as activities, such as binge eating, gambling, TV viewing, internet surfing, playing video games and even having sex, can be addictive.</p><p>For additional discussion on this continuing debate, see for example, <ref type="bibr" target="#b16">Black (1996)</ref>, <ref type="bibr" target="#b20">Brown (1993)</ref>, <ref type="bibr">Clark (2006)</ref>, <ref type="bibr">Harpaz &amp; Snir (2003)</ref>, <ref type="bibr">Mule (1981)</ref>, and Song, Larose, <ref type="bibr">Eastin &amp; Lin (2004)</ref>.</p><p>among some segments of our nation's secondary school students <ref type="bibr" target="#b93">(Johnston et al., 2010a</ref><ref type="bibr">(Johnston et al., &amp; 2010b) )</ref> underscore an urgent need for improving efforts at prevention and treatment. Developing effective programs for both drug prevention and drug treatment requires, however, a deeper understanding of the various developmental risk processes underlying drug etiology and likewise involves obtaining a more refined understanding of individual differences in susceptibility to drug use and the processes leading to addiction.</p><p>Clinical and epidemiological research on the causes of drug use and abuse have helped scientists gain a better understanding of the genetic, physiological, psychosocial, and environmental dimensions of both the beginning stages of drug use and the more protracted abuse, and even addiction. Lately, economic theories of rational choice and consumer behavior have also been used to account for drug etiology and the various pathways to addiction <ref type="bibr" target="#b30">(Chaloupka &amp; Grossman, 1996;</ref><ref type="bibr" target="#b59">Godfrey &amp; Maynard, 1989;</ref><ref type="bibr">Marvel &amp; Hartmann, 1986;</ref><ref type="bibr">Stigler &amp; Becker, 1977)</ref>.</p><p>Economic theories, however, have not been considered mainstream with regard to the dominant psychological explanations of drug use and thus are less widely accepted <ref type="bibr">(Bridges, 1999;</ref><ref type="bibr" target="#b152">Rachlin, 2003)</ref>. Nonetheless, the economic explanation of behavior has become markedly more prominent, especially as consumerism in the U.S. and abroad has risen and more companies compete worldwide for scarce resources and market share. Understanding the decision-making rationale that leads to product selection has received increasing interest not only for its commercial implications but also for its application in other fields such as drug use and addiction. In the case of drug abuse, consumer behavior emphasizes the acquisition and consumption of psychoactive products, which are associated with an array of medical, psychological, and social problems.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Statement of the Problem</head><p>The concept of addiction is difficult to pin down. There is also some theoretical confusion when discussing "addiction" because of its diverse etiology, multiple outcomes, and numerous ways to discuss the activity that underlies drug taking and drug seeking behaviors. Even the process of becoming addicted is complex with many pathways and courses. Individual addicts each have their own story, painting a detailed picture describing the myriad of ways their life became entangled with an overwhelming sense of urgency, craving, and desire for drug consumption. Added to this, there are developmental considerations that come into play. It is unquestionable that individuals do not become addicted overnight but that addiction results from a prolonged involvement with a drug, and even this basic understanding must consider a wide range of environmental, social, physical, and economic cues that stimulate drug taking. At its earliest stages, addiction begins with experimental or recreational drug use, where an individual smokes a joint, sips a drink of alcohol, takes a pill, or ingests some plant derivative (psilocybin or mescaline) for the first time. Most cigarette smokers state their first cigarette made them cough, and they felt nauseous and sickly. Many say cocaine makes them feel "racy" and their heart beat uncontrollably. Others smoke marijuana and feel their head "buzz" and they quickly crave food. However, within a short period of time, drug users wish to relive the euphoric "high" they experienced, seeking to consume more of the drug in question, in larger quantities and more frequently, inevitably leading to abuse or addiction.</p><p>During the past few decades, a large number of competing theories have been advanced to explain drug-taking as well as individual susceptibility to addiction.</p><p>Focusing on somewhat different aspects of the problem, these various psychological, sociological, economic, and more recently neurological theories offer unique explanations of the drug addiction process. Because they approach drug consumption and addiction from slightly different vantage points, these theories suggest different social policies and interventions. While each theoretical approach provides some empirical support attesting to its validity, the different explanatory models proposed also possess certain limitations in their ability to account for the diverse facets of use, abuse, and addictive behavior.</p><p>One limitation, in particular, has been the failure to integrate across diverse theoretical views producing a "myopic" focus within each theory; each one struggling to develop a satisfactory explanatory model of drug consumption. This has created diffuse and often contradictory explanations of drug use and abuse. Psychological theories of addiction, for instance, because of their emphasis on individual differences, fail to integrate larger macro or structural forces, including the role of environmental and community influences. Sociological explanations, on the other hand, attend to the dynamics of larger institutions including the family, but fail to include micro-forces that may involve genetic explanations. To explain drug use and the addiction process, economists focus on familiar economic factors, assuming that psychological and sociological factors can be held "constant." This narrowness in perspective is particularly startling given that most current models of drug use and addiction agree that the use, misuse, and addiction to drugs is the result of a complex interaction of many contributing factors at multiple levels of influence. Recognizing that drug addiction is etiologically complex and multi-faceted is generally regarded as a more realistic view of the behavior. Support for a multi-factorial approach comes also from the observation that no single theory can sufficiently account for the full spectrum of drug addiction and even more so from the fact that no intervention program based on a single theoretical model has ever been shown to be consistently effective, especially in the long run <ref type="bibr">(Burke, 2002;</ref><ref type="bibr">West &amp; O'Neal., 2004)</ref>. The complexity of human behavior, in general, and addiction, more specifically, requires a more encompassing and theoretically rich model that incorporates a multidisciplinary and more "ecologically" sound approach <ref type="bibr">(Brewer, 2000;</ref><ref type="bibr">Scheier et al., 2010)</ref>.</p><p>In recent years, two models of drug use and addiction, one derived from psychology and the other from economics, have generated considerable debate and empirical research. Although models based on economic theory have focused attention on external or market-based factors, such as income, market prices, and opportunity costs; psychological models of human behavior have emphasized internal cues, such as emotional self-regulation, cognitive functioning, and motivation, all of which regulate an individual's intention to consume psychoactive drugs. Each theory offers important insights into the complexity of drug use and addiction. However, very few empirical studies have fully integrated these competing explanations. 3 The integration of economic and psychological factors into a comprehensive model of addiction is not only essential for a better understanding of addictive behavior, but also represents an important step towards developing scientifically rational and more effective prevention efforts and treatment strategies <ref type="bibr" target="#b136">(Montoya et al., 2000)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Purpose of the Study</head><p>The purpose of this dissertation is to develop, for the first time, a "hybrid" model that effectively combines select components of both economic and psychological theories to predict drug consumption and its related consequences. The model is not designed to test the utility of these theoretical frameworks; rather, it aims essentially to: (1) assess the theoretical importance of combining economic 3 An earlier example of such confluence between economic theory and psychology can be found in Edwards <ref type="bibr">' (1954)</ref>, who provides a scholarly dissection of the particular components of individual decision-making that overlaps quite nicely with some of the main tenets of economic rationality [see also <ref type="bibr" target="#b25">, Camerer (1995)</ref>, for a excellent discussion of decision making from an economic perspective]. Also, <ref type="bibr" target="#b151">Rabin (2002)</ref> presents an excellent discourse on the potential cross-fertilization (i.e., a merger) between psychology and economics, which he terms "behavioral economics." A good deal of Rabin's writing highlights the need for psychological realism in economic theory, lest we forget that people do not always act "sanely," i.e., rationally.</p><p>models of consumption with existing psychosocial theories of addiction; and (2) estimate the unique influence of economic factors on drug consumption in the presence of psychological constructs. The methodology used also advances previous attempts in this direction by using latent-variable Structural Equation Modeling (SEM), a multivariate statistical technique appropriate for theory testing <ref type="bibr">(Bentler, 1978;</ref><ref type="bibr">Nachtigall et al., 2003)</ref>.</p><p>More specifically, this dissertation proposes a novel "psycho-economic" model of addiction, simultaneously combining and testing the unique influence of key economic indicators along with psychosocial risk factors on a specific type of substance that has become popular among youth and young adults. 4 The proposed model represents an outgrowth and further refinement of an earlier, preliminary study published in Substance Use &amp; Misuse <ref type="bibr">(Ben Abdallah et al., 2007)</ref>. In the current dissertation study, the main research questions address: 1) whether specific economic indicators remain statistically and significantly associated with substance use behaviors in the presence of psychosocial influences and more importantly 2) whether a combined "psycho-economic" model is "ecologically" valid. The question of ecological validity has been neglected in the literature despite its inherent 4 Actually, <ref type="bibr">Cameron's (2000)</ref> "psycho-economic" model of cigarette consumption was first to suggest the confluence of psychological and economic factors to account for drug behaviors. However, while the author did not completely dismiss the role of economic factors, such as drug prices and income, his work emphasized how "the psychopharmacological addictive properties of cigarette smoking influences demand" (p. 212).</p><p>relevance to the design, implementation, and evaluation of drug prevention and treatment programs <ref type="bibr">(Brewer, 2000)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Significance of the Study</head><p>There are several other unique features worth noting to the present study.</p><p>First, the study weaves together competing behavioral science disciplines to explain human behavior. Additionally, the study offers a number of significant contributions to the field of behavioral economics in general and drug abuse in particular, emphasizing several theoretical and methodological concerns that have yet to be addressed in the literature. One of the more striking concerns is that prior empirical studies have focused on at most one or two domains of influence as putative risk factors for drug use and abuse. The exclusion of important domains of influence that could explain drug use and even the more harmful course of addiction is likely to increase the risk of spuriousness and foster erroneous inferences. To address this concern, the present study models a wider array of economic indicators, including measures of income, opportunity and monetary cost along with measures of psychological functioning, health risks, and behaviors related to drug abuse. Inclusion of these diverse sets of economic and psychosocial influences in a single comprehensive model should help advance the field of behavioral economics, in particular, toward constructing an ecologically sound and valid model of drug use.</p><p>Second, numerous studies of drug use are characterized by the absence of reliable measures assessing different putative domains of risk. The use of at most one or two items to characterize a broad range of inter-or intra-personal functioning runs the risk of model misspecification and introduces some degree of unreliability into the model. To address this concern, the present study relies on a state-of-the-art diagnostic and risk factor assessment, including measures with excellent psychometric properties; measures that were designed and repeatedly tested in diverse settings by investigators at Washington University with a world-wide reputation for developing diagnostic assessments with clinical and research significance <ref type="bibr">(Cottler et al., 2010)</ref>.</p><p>Related to this point, the analyses used in this study incorporate latentvariable Confirmatory Factor Analysis (CFA) to adjust for unreliability in the putative risk factors. This approach is ideal for assessments that contain multiple indicators of an underlying behavior or risk factor <ref type="bibr" target="#b18">(Bollen, 2002)</ref>. Briefly, with a CFA or measurement model, the moderate association among several observed manifest indicators is hypothesized to be statistically caused by some underlying latent or unobserved "factor." This is a common approach used when modeling psychological processes, many of which are latent or unobserved behavioral tendencies. Estimation of latent-variable constructs is based on classic psychometric theory, which disaggregates error variance from the true variance component of an observed measure. The more reliable, common or shared variation between multiple measures tapping a single construct is then modeled to reflect predictive variance in the model or as an endogenous factor influenced by other model terms. With the CFA model in hand, a second step in the theory development involves testing predictive or structural relations among hypothesized constructs and other exogenous covariates.</p><p>This multivariate approach, known as structural equation modeling (SEM), provides a more rigorous and parsimonious analytic framework to address simultaneous influences within a single specified model <ref type="bibr">(Nachtigall et al., 2003)</ref>.</p><p>A third concern rests with the homogeneous nature of data collection used in past studies. Sampling drug users from at most one or two geographic locales runs the risk of creating a limited view of drug use cultures or drug markets specific to a region or country of interest. In the present study, drug users were recruited simultaneously from three racially and culturally heterogeneous sites located in St.</p><p>Louis, Missouri; Miami, Florida; and Sydney, Australia. Significant cultural and geographic variation should help furnish new information on patterns and trends in drug use as well as open doors to testing differences in economic factors as they may vary across sites and therefore have different influences on drug user's behavior.</p><p>The large cross-site community samples also provided a unique chance to examine patterns of consumption among Ecstasy users and investigate a drug surging in popularity among various age groups particularly during the time of the present study was conducted.</p><p>A fourth concern is that the economic model, which has been advanced in the literature, has primarily been tested with licit drugs. Thus, relatively little is known Ecstasy/MDMA and its effects ---Ecstasy, 6 otherwise identified by its pharmacological name as 3,4 methylenedioxymethamphetamine (or MDMA for short), is a Schedule I drug (i.e., an illegal, controlled substance, in the same drug category that includes heroin, cocaine, and LSD), with no substantiated therapeutic value, and extreme potential for abuse. It is one of several drugs belonging to a group called "club drugs." 7 Although the emergence of MDMA was first reported in the U.S. in the late 1980's by NIDA's Community Epidemiology Work Group (CEWG), information on its consumption and its effects (both short-term side effects and the possible long-term consequences) are still quite limited <ref type="bibr">(NIDA, 2006b</ref>). 8 In fact, "each of these <ref type="bibr">[club]</ref> drugs has very different pharmacological, psychological, and physiological properties" and the literature documents profound differences in the patterns of use, risk profiles and characteristics of users <ref type="bibr">(Maxwell, 2004, p. 1)</ref>.</p><p>MDMA is a synthetic hallucinogenic, psychoactive stimulant, which is usually consumed in a pill (tablet or capsule) form <ref type="bibr">(NIDA, 2006a)</ref>. During the time period <ref type="bibr">(2002)</ref><ref type="bibr">(2003)</ref><ref type="bibr">(2004)</ref><ref type="bibr">(2005)</ref> coinciding with the parent study (CDSLAM), street buy-back and ethnographic information yielded estimates of a market prices ranging from $20 to $40 per tablet.<ref type="foot" target="#foot_5">foot_5</ref> Early studies of club drug users also created the impression that this "designer drug", MDMA (again, commonly known on the street as Ecstasy), was a "safe drug" with few and minor negative health effects <ref type="bibr">(Beck &amp; Rosenbaum, 1994;</ref><ref type="bibr">Moore, 1993;</ref><ref type="bibr">Peroutka et al., 1988;</ref><ref type="bibr">Solowij et al. 1992)</ref>. Additionally, sporadic reports and clinical vignettes confirm that psychotherapists in the U.S. have used Ecstasy to facilitate psychotherapy sessions with patients suffering from psychiatric disorders, including post-traumatic stress disorder (PTSD) (Greer &amp; Tolbert, 1998;   8 MDMA was first synthesized and patented as "diet aid" in 1914 by a German pharmaceutical company that eventually became Merck &amp; Co. (see <ref type="bibr" target="#b66">Grinspoon &amp; Bakalar, 1986</ref>, for details on the history of MDMA before its criminalization in the U.S.). MDMA was not, however, marketed at that time nor utilized for any purpose till the 1950's when it was used in animal studies supported by the U.S. Army to investigate new approaches to "brainwashing, espionage and mind-control" in the 1950s during the Cold War (for more details on these studies, see <ref type="bibr" target="#b72">Hardman et al., 1973)</ref>. In the early 1980's, MDMA began to be used for non-medical purpose (as a recreational drug) in the U.S. under its street name Ecstasy <ref type="bibr">(Rosenbaum, 2002</ref><ref type="bibr">(Rosenbaum, ). berg, 2006;;</ref><ref type="bibr">Parrott, 2001)</ref>. <ref type="bibr" target="#b169">Ruse et al., 2010)</ref>. However, the criminalization of MDMA use in 1985 eliminated physicians' ability to prescribe or even use it for any medical purpose.<ref type="foot" target="#foot_6">foot_6</ref> </p><p>Nevertheless, users describe Ecstasy as being a popular recreational drug used in nightclubs or all-night dance parties, called also "raves" or "trance events,"<ref type="foot" target="#foot_7">foot_7</ref> especially for its ability to produce the "feelings of increasing energy" and to promote "euphoric sensations of well-being," "heightened sensory awareness", and "interpersonal feeling of closeness" to others (Baylen &amp; Rosen</p><p>As clinical data became available from controlled laboratory trials and epidemiological information was obtained from survey research, it has become clear that Ecstasy consumption induces both stimulant and hallucinogen-like effects with deleterious consequences.<ref type="foot" target="#foot_8">foot_8</ref> Several reports have described numerous medical complications and fatalities associated with Ecstasy use <ref type="bibr" target="#b78">(Henry et al., 1992;</ref><ref type="bibr">Lee, hardt et al., 2010;</ref><ref type="bibr"></ref> Leung the use of MDMA 1994; <ref type="bibr" target="#b126">Maxwell et al., 1993;</ref><ref type="bibr">CDC, 2010)</ref>, owing perhaps to extreme hyperthermia, dehydration, high blood pressure, cardiac and even renal failure <ref type="bibr">(Mathias, 1999)</ref>.</p><p>Frequent use can also cause long-lasting damage to areas of the brain underlying memory <ref type="bibr" target="#b26">(Casco et al., 2005;</ref><ref type="bibr">Ricaurte et al., 2002)</ref>. After the reported "high" subsides, Ecstasy users often feel depressed, irritable, and experience drug craving, leading them to take more drugs to extend the high and/or offset withdrawal <ref type="bibr" target="#b4">(Baggott et al., 2001;</ref><ref type="bibr" target="#b89">Jerome 2005;</ref><ref type="bibr" target="#b146">Parrott, 2007;</ref><ref type="bibr">Scholey et al., 2004)</ref>. Ecstasy users also report using, at the same time, other substances such as alcohol, marijuana, cocaine and opiates to relieve the post-stimulant effects, which may even put them at a higher risk for adverse health issues <ref type="bibr" target="#b83">(Cottler et al., 2001</ref><ref type="bibr">(Cottler et al., , 2009;;</ref><ref type="bibr">Degen &amp; Cottler, 2008;</ref><ref type="bibr">Parrott &amp; Lasky, 1998;</ref><ref type="bibr" target="#b201">Topp et al., 1999)</ref>.</p><p>Recent studies suggest that Ecstasy use is no longer limited to "party goers" his drug <ref type="bibr" target="#b83">(Cottler et al., 2001;</ref><ref type="bibr">Degenhardt et al., 2009</ref><ref type="bibr">Degenhardt et al., , 2010;;</ref><ref type="bibr" target="#b111">Leung &amp; Cottler, 2008)</ref>.</p><p>(reaching 1.2 million in 2002), followed by a three-year period of decline, which was then followed by a period of significant increase from 2006 onwards (reaching 1.1 million in 2009; SAMHSA, 2010b). At the same time, between 2005 and 2009, pastyear use of Ecstasy increased among 12 th -graders from 3.0% to 4.3%; and among 10 th -graders from 2.6% to 3.7%; while past-year use among 8 th -graders showed a modest decline from 1.7% to 1.3% <ref type="bibr">(Johnston et al., 2010b)</ref>. Despite these differences in rates, the prevalence of self-reported Ecstasy use among 8 th , 10 th , and 12 th graders surveyed in schools across America is determined to be comparatively higher than that for cocaine, heroin, and LSD; almost making it seem as if Ecstasy has repl older" illicit drugs as the drug of popular choice <ref type="bibr" target="#b93">(Johnston et al., 2010a)</ref>.</p><p>Adding to these compelling statistics, emergency department (ED) statistics</p><p>show that Ecstasy mentions for critical and/or traumatic care have steadily increased At different times in history the reasons for drug use have included the "devil," a "rotten society," and even "dormant intra-psychic conflict" <ref type="bibr" target="#b91">(Johnson, 1999)</ref>. Although a significant focus of empirical research has emphasized the "causes" of drug use, studies of the consequences of drug use and abuse have been just as varied with numerous outcomes used to justify policy initiatives to deter use.</p><p>For instance, public concern with drug use has emphasized cognitive and physical impairment, loss of productivity in the workforce, and negative social consequences stemming from continued use of drugs <ref type="bibr">(NIDA, 2007)</ref>. Overall, the effects of drug use can have ruinous effects on the family, community and even society as a whole.</p><p>Despite continued use during adolescence and sometimes even continuing into young adulthood, most people eventually "mature out" and relinquish their drugusing behaviors <ref type="bibr" target="#b90">(Jochman &amp; Fromme, 2009;</ref><ref type="bibr" target="#b163">Robins et al., 1974;</ref><ref type="bibr">Robins, 1980</ref><ref type="bibr" target="#b164">Robins, , 1993))</ref>. However, for some individuals continued drug use eventually propels them into a downward spiral of addiction. Clinical case studies indicate that for every person who becomes addicted there is a unique story that captures the slow drift into his/her compulsive drug-taking. As a result, there has been a proliferation of theories to account not only for early and more problematic drug use but also for addiction, linking different stages of etiology, maintenance, and even relapse. 13   This chapter provides a brief overview of the literature examining drug use and abuse in order to provide a more complete picture of the different prevailing etiological theories. Etiology concerns root causes and in this respect details the myriad of reasons why people engage in drug use, the processes resulting in abuse, and the manifest ways this can lead to addiction <ref type="bibr">(Scheier et al., 2010)</ref>. The overview presented here provides a theoretical backdrop for the psycho-economic model proposed in this study. The chapter begins with a brief historical perspective of what are generally considered to be relevant models of addiction. 14 The materials 13 For a review of the most relevant drug addiction theories, see Addiction, <ref type="bibr">Supplement-2, 2000;</ref><ref type="bibr">Addiction, Supplement-1, 2001;</ref><ref type="bibr">and Addiction, no. 4, 2002.</ref> 14 Although a model can present a more detailed description or explanation of why and how something happens, it is usually based on a theory with specified axioms, postulates and syntax. Absent specific details, both a model and theory can be framed as means to account for reality. For the present purpose, both theory and model will be used interchangeably throughout this chapter.</p><p>presented clarify how the addiction field has changed conceptually over time, marking the transition from the "moral" view to the traditional medical model, and more recently introducing the biopsychosocial and behavioral-disorder perspective.</p><p>Following this brief introduction the chapter introduces the two theoretical models currently used in the field to account for drug addiction: one clarifying the role of psychological factors and the other highlighting economic measures that presage consumption. A substantial body of research suggests that there exist multiple perspectives on psychological precursors to drug abuse; however, the same rich literature also implicates economic measures that can explain drug etiology. This review is by no means exhaustive, but rather meant to evaluate the strengths of each perspective and provide a means to acquire a more refined picture regarding the unique contributions that each theory provides regarding the processes leading to drug use, abuse, and even addiction. In this respect, this review focuses on causal factors in each theory that are thought to play a role in shaping a person's decisions to use drugs and their eventual course to addiction. Next, the psycho-economic model is discussed in terms of other pertinent literature reviews. Finally, a conceptual model and the hypotheses of this research study are outlined as a prelude to the empirical models that are presented in the subsequent chapter.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">A Historical Perspective of Addiction Theories</head><p>From the earliest recorded history of antiquity and even stretching into the early 20 th century, drunkenness and intoxication from alcoholic beverages and "getting high" on drugs was regarded as largely a voluntary behavior and therefore the result of personal misconducts, bad and even "sinful decisions" <ref type="bibr" target="#b99">(Keller, 1972)</ref>.</p><p>Society regarded the inability to control one's temptations as a character flaw providing a basis for the "moral" view of addiction. Adherents of this position relied on the philosophical position of "free will," postulating that people are in control of their own actions and thus free to behave in any way they choose. Accordingly, consumption of addictive substances results from choosing a shameful lifestyle for which those consumed by addiction are to blame because it is a matter of choice; they control their own destiny and are in charge of their own actions. Only people with "poor moral standards" and "low willpower" or "self-control" would therefore choose to indulge in "demon's behaviors" <ref type="bibr" target="#b17">(Bobgan &amp; Bobgan, 1990;</ref><ref type="bibr" target="#b112">Levine, 1978;</ref><ref type="bibr" target="#b166">Room, 1983)</ref>. As a consequence, addiction was depicted as "punishment for sinful habits" that can only be overcome through complete abstinence. The process of ridding oneself of the demons of alcohol requires a "spiritual awakening" and a devout "commitment to religious beliefs." Despite the popularity of this view and its foothold in the treatment community during the 18 th and 19 th centuries, the "moral" or "puritanical" view of drug use and addiction contributed very little to our understanding of why people initiate and continue to use psychoactive substances.</p><p>Within a short period of time, scholars and influential public leaders realized that the moral view offered no credible scientific evidence that could help fuel the development of effective prevention strategies or contribute to viable treatment options. Although this position was plagued by limited utility, adoption of the moral view was responsible for many of the anti-drug legislative activities that took place in the early 20 th century. For instance, pointing the finger at a moral deficiency in the addict's personality or a character flaw renders the use of addictive substances strictly a sin and/or led to legislation criminalizing drug consumption. This view eventually acted as stimulus for the prohibition policy era in the U.S. <ref type="bibr">(1920)</ref><ref type="bibr">(1921)</ref><ref type="bibr">(1922)</ref><ref type="bibr">(1923)</ref><ref type="bibr">(1924)</ref><ref type="bibr">(1925)</ref><ref type="bibr">(1926)</ref><ref type="bibr">(1927)</ref><ref type="bibr">(1928)</ref><ref type="bibr">(1929)</ref><ref type="bibr">(1930)</ref><ref type="bibr">(1931)</ref><ref type="bibr">(1932)</ref><ref type="bibr">(1933)</ref>, a constitutional "faux pas" that inevitably increased alcohol consumption, stimulated corruption, and increased crime <ref type="bibr" target="#b73">(Health, Education &amp; Welfare, 1968)</ref>. Although certain aspects reminiscent of the moral approach continue to be invoked,<ref type="foot" target="#foot_9">foot_9</ref> scientific research has long challenged this philosophical position by showing that addiction is not the result of a character defect or a moral weakness.</p><p>Introduction of the Disease Model ---Shortly after the repeal of Prohibition, a new approach to drug addiction became popular and grew rapidly, based on advances that took place in medicine and a growing body of scientific knowledge <ref type="bibr">(McMurran, 1994)</ref>. According to this perspective, alcoholism and addiction, in general, are defined as "chronic and progressive conditions" or "diseases" (like other medical conditions including, for example, asthma, hypertension or diabetes) caused by the prolonged effects of the substance used. Moreover, other factors, some often ascribed as common sense, helped derail the moral view. For instance, although many people use alcohol and/or drugs, not all individuals lose control over their use. Furthermore, the moral view was not encompassing and its adherents regarded as myopic and somewhat reluctant to consider alternative views to account for addiction. Within the new approach, however, drug addiction became rooted in a medical condition like any other common physical malady or disease. Many in the scientific community also argued that the undesirable behaviors associated with addiction are only the symptoms of the substance user's ailment. The user shows progressive worsening in terms of loss of control over the drug taken, as his/her body physiologically adapts to the presence or absence of the drug of choice <ref type="bibr">(Leshner, 1997)</ref>.</p><p>The addiction disease-theory as it became known was introduced formally in the late 1940's and early 1950's by E. M. <ref type="bibr">Jellinek (1946</ref><ref type="bibr">Jellinek ( , 1952))</ref>. His view entailed essentially five considerations: (1) addiction reflects an illness and should not be characterized as "the demon's act," (2) denial is usually a common feature of this disease, (3) addiction is a progressive, irreversible condition characterized mostly by the "loss of control" or compulsion over the intake of a substance, (4) addiction cannot be cured, but can be controlled through abstinence and some form of medical intervention or treatment that extends over the rest of the drug user's lifetime, and (5) addiction to alcohol and other drugs can lead to other problems in the user's life such as health problems, mental illnesses, and relationship problems. <ref type="foot" target="#foot_10">16</ref>The "conventional" disease concept of addiction was quickly embraced for both its personal as well as social utility. Many viewed it as a superior approach to the moral model because it removed blame and stigma from the addicts and offered them new hope <ref type="bibr">(White, 2001a;</ref><ref type="bibr">2001b)</ref>. Wrapped up inside this hope is the possibility for treatment instead of punishment <ref type="bibr">(Spicer, 1993)</ref>. The disease concept also provided "an organizing construct, which makes it easier for society as a whole to understand, accept and deal with" <ref type="bibr">(White, 2001a, p. 43)</ref>.</p><p>Over the years, numerous social sciences and medical studies provided credible support for the addiction disease concept. Perhaps some of the strongest evidence for the disease model thus far has come from the biological studies of geneenvironment (GE) interactions. According to the biological view, addiction is caused by physical characteristics that can lead certain individuals to abuse drugs to the point that they lose control. In fact, there is now convincing evidence that factors related to genetic, prenatal and early childhood experiences predispose individuals to develop alcohol and/or drug addiction. Numerous proband and twin studies drawing from the strengths of biologically related individuals have investigated the full extent of genetic influences. The biological closeness between twins raised separately or together as well as parent-offspring combinations enables researchers to provide estimates of the relative contributions of genes and environmental influences to alcoholism and drug addiction <ref type="bibr" target="#b36">(Cloninger et al., 1981;</ref><ref type="bibr" target="#b37">Cloninger, 1987;</ref><ref type="bibr">Heath, 1989)</ref>.</p><p>In particular, behavioral transmission studies have shown an increased propensity among children of addicted parents to become addicted themselves. These family history studies have confirmed that to some degree "addiction runs in families" and have been able to identify familial components associated with addiction.<ref type="foot" target="#foot_11">foot_11</ref> </p><p>Additionally, genetic heritability studies using twins and adopted children have also confirmed that the risk for addiction is greater for twins with addicted than with non-addicted biological parents even when the twins have been separated at birth or adopted and were unaware of their natural parent's condition <ref type="bibr" target="#b24">(Cadoret et al., 1995;</ref><ref type="bibr">Goodwin et al., 1977;</ref><ref type="bibr">Heath et al., 1998;</ref><ref type="bibr" target="#b100">Kendler et al., 2000;</ref><ref type="bibr">Tsuang et al., 2001)</ref>. Estimates from these studies suggest that the genetic makeup explains about 40% to 60% of people's overall vulnerability to alcoholism and, to a lesser extent, drug addiction <ref type="bibr" target="#b100">(Kendler et al., 2000;</ref><ref type="bibr">Prescott &amp; Kendler, 1999;</ref><ref type="bibr">Tsuang et al., 2001)</ref>. 18   Scientists engaged in research on biological marker have argued that genetic and bio-physiological factors play an essential role in drug abuse. Most experts in the field initially believed that reward or pleasure centers of the brain [part of the central nervous system (CNS)] may be genetically predisposed, in certain individuals, to be especially sensitive to alcohol and other psychoactive drugs, making substance use particularly pleasant and more rewarding. In contrast, for others lacking a genetic vulnerability, the effects of drugs might not be as pleasant; such individuals are not likely to become addicted to or even seek drugs. In other words, biologists have emphasized that CNS sensitivity at a cellular or molecular level determines the brain's sensitivity to psychoactive substances and this "susceptibility" has been offered as the reason why some people are particularly prone to addiction more than others <ref type="bibr">(Mathias, 1995)</ref>.</p><p>The strength of genetic arguments is highlighted by the tremendous emphasis in the scientific community to identify gene "markers." With all of the supporting genetic and neurobiological evidence, the "brain disease" approach to substance use and addiction (also referred to as the "biological," "medical" or simply "biomedical"</p><p>18 Some still argue however, that, although genetic predisposition or biological markers are associated with alcoholism and drug addiction, current research has not been yet helpful in discovering direct gene effects, i.e., people's inheritance vulnerability to addictive substances <ref type="bibr" target="#b158">(Reich et al., 1998)</ref>. In other words, researchers have yet to explain how genetic factors inevitably cause drinking or lead to the consumption of drugs (Uhl &amp; <ref type="bibr" target="#b203">Grow, 2004)</ref>.</p><p>model" <ref type="bibr" target="#b63">(Gordis, 2001;</ref><ref type="bibr">White, 2002)</ref> has increasingly gained professional as well as public acceptance and support over time in the U.S. as well as by the larger international drug abuse scientific community. The 1990s was, in fact, proclaimed as the "Brain Decade," a period highly regarded for its numerous advances in brainimaging technologies. Three advances in particular that have had an indelible impact on the field include the discovery of Positron Emission Tomography (PET), Magnetic</p><p>Resonance Imaging (MRI), and then later on Functional Magnetic Resonance Imaging (fMRI) techniques. Since the inception of these neuro-imaging techniques, researchers and clinicians have been able to gain a more acute picture of the brain activity as it parallels the actual physical craving and consumption of psychoactive substances. The visual interface and close analysis of the underlying anatomical structure of the brain helped provide a more accurate picture supporting biological theories of drug addiction <ref type="bibr" target="#b62">(Goldstein &amp; Volkow, 2002)</ref>.</p><p>In particular, neuroimaging studies of the "brain on drugs" have demonstrated that psychoactive substances have, without doubt, physiological effects on the brain "reward circuits," a mechanism through which "electrical impulses" (i.e., signals in the form of action potentials) are transported from one area of the brain to another.</p><p>These signals are the basis for information flow in the brain and connected to the underlying capacity for thought, memory, perception and sensation. Specifically, brain imaging studies suggest that psychoactive drugs enhance the pleasure centers of the brain by causing a massive and rapid release of the neurotransmitter, dopamine (DA). 19,20 The pleasurable feelings created, referred to as rewards, have been construed as "positive-reinforcers" that induce the individual to continue using the drugs responsible for initiating the central DA release <ref type="bibr">(Robinson &amp; Berridge, 1993)</ref>.</p><p>Another advanced reason for the self-motivation view of drug use was that the brain cells become sensitized to the presence of neurotransmitters such as DA and this may be responsible for the underlying "craving" when brain levels return to their normal state and are no longer elevated <ref type="bibr">(Robinson &amp; Berridge, 1993)</ref>. This "negativereinforcer" role has been implicated as important in maintaining drug use and the development of addiction. As a result, positive (achieving a "pleasurable high" or euphoric state) as well as negative (avoiding the unpleasant feelings of withdrawal and craving) reinforcement contingencies have been suggested as the main reason for continued and even compulsive use of psychoactive substances. 21 This explanation 19 The brain reward circuits, known anatomically as the "mesolimbic dopamine system" (MDS), involve important parts of the midbrain regions, primarily the "ventral tegmental area" (VTA) and the "nucleus accumbens" (NAc) among other forebrain areas (such as amygdala and hippocampus). These two central neuroanatomical regions are heavily implicated in the reward process: The VTA responds to the presence of drugs by releasing DA into the NAc, inducing a pleasurable experience <ref type="bibr" target="#b14">(Bespalov et al. 1999)</ref>. 20 Although there are many neurotransmitters involved in the brain reward circuits, such as opioid peptides (endorphins), glutamate, serotonin, and gamma-aminobutyric acid (GABA), dopamine is the neurochemical transmitter most directly implicated in the reinforcement effects of all addictive substances <ref type="bibr">(Tomkins &amp; Sellers, 2001)</ref>. 21 It has also been suggested that this same brain DA system is also involved in mediating reward behavior and motivational aspects of "natural" activities such as feeding and sexual interaction, among others <ref type="bibr" target="#b12">(Berridge &amp; Robinson, 1998)</ref>.</p><p>(referred to as the "dopamine-reward hypothesis") led to the development of a number of "reinforcement models" of drug use and addiction <ref type="bibr">(Wise, 1996</ref><ref type="bibr" target="#b214">(Wise, , 2002))</ref>.</p><p>Starting in the early 1950s, several organizations, including the World Health Organization (WHO) and the American Psychiatric Association (APA), began to formally acknowledge that addiction is a disease of the brain and these influential scientific bodies endorsed the medical model of addiction <ref type="bibr" target="#b166">(Room, 1983)</ref>. Both of these highly respected professional organizations have also made important contributions to the disease model by (1) providing operational definitions and therefore "modernizing" the addiction disease concept and (2) providing standardized diagnostic criteria (a "nomenclature") for the different disorders that result from the use and misuse of drugs.</p><p>The APA, in particular, started this process by establishing a workgroup, referred to as the "Work Force on Nomenclature and Statistics," to analyze and synthesize major addiction research findings. Since 1980, the APA Work Force has also developed and continued to revise and publish a manual called "Diagnostic and Statistical Manual of Mental Disorders" (DSM) that is widely used as a guide by clinicians and researchers for the diagnosis of various forms of addiction and other mental health disorders <ref type="bibr">(APA, 1994)</ref>. <ref type="foot" target="#foot_12">22</ref> The APA began formulating the criteria with the DSM-I and II early on; although those initial compendia were works in progress and not considered complete. The DSM-III became widely used in 1980; it was later revised in 1987 with the DSM-III-R criteria, and again in 1994, with DSM-IV.</p><p>The current DSM-IV defines addiction as a "maladaptive pattern of substance use" <ref type="bibr">(APA, 1994, p. 181</ref>) that can best be conceptualized as existing on a "behavioral continuum" ranging from "normal to pathological." When diagnosed clinically, any alcohol or drug user may fall anywhere along this continuum of severity. The generic DSM diagnosis of "substance-use related disorders" was however categorized into no diagnosis (negative), abuse, and dependence, based on a specific set of criteria <ref type="foot" target="#foot_13">23</ref>(each criterion defined by a specific aggregation or cluster of symptoms).</p><p>In this "hierarchical diagnostic classification scheme," drug dependence, a term often used interchangeably with the term addiction, indicates an advanced stage of drug-consumption; characterized mainly by "impaired control" over the consumption of a "drug-of-choice," craving, increased tolerance and/or withdrawal,</p><p>The WHO ICD is currently in its 10 th version <ref type="bibr">(WHO, 2004)</ref>, while the Current DSM manual is in its fourth edition (referred to as DSM-IV), published in 1994. There is also a recent text-revised version of the DSM (DSM-IV-TR), published in 2000.</p><p>Both the WHO and APA are currently in the process of developing newer revised and updated versions of their respective manuals. More likely, these manuals will be referred to as ICD-11 and DSM-V, respectively <ref type="bibr">(Saunders &amp; Cottler, 2007)</ref>.</p><p>and continued use despite the physical, emotional and social consequences. 24 When conceived of in this manner and as a "disorder syndrome," this problematic state of drug use (defined as drug dependence or addiction) is usually specified as being with or without specific psychological and/or physiological aspects of dependence, the latter evidenced by the presence or absence of tolerance and/or withdrawal symptoms <ref type="bibr">(APA, 1994)</ref>. Drug dependence can therefore manifest itself with features of either psychological and/or physical symptoms or neither <ref type="bibr" target="#b50">(Edwards &amp; Gross, 1976)</ref>.</p><p>Drug abuse, on the other hand, is essentially regarded as a level of drug use causing persistent or recurrent personal problems, such as role impairment or multiple legal problems. 25 Overall, the detailed classification of abuse and dependence provided by the DSM nomenclature added great value to the field of addiction research and gave researchers as well as clinicians useful and practical information in their attempt to understand and treat alcoholism and drug addiction. The diagnostic or nosological view is referred to as the "Symptomatic Theory of Addiction" <ref type="bibr">(Lindstrom, 1992)</ref>. 24 The DSM-IV defines seven possible criteria for the diagnosis of drug dependence <ref type="bibr">(APA, 1994, pp. 176-181)</ref>. The threshold to make a positive drug dependence diagnosis requires that three or more dependence criteria must be endorsed and that those criteria must occur within the same 12-months period. 25 There are four possible DSM-IV criteria for the diagnosis of drug abuse <ref type="bibr">(APA, 1994, pp. 176-181)</ref>. Abuse has a simple threshold: At least one of the four criteria must be endorsed in order to make a positive diagnosis. A drug abusing person may report, however, all four criteria.</p><p>In spite of its benefits and widespread acceptance, the brain disease (or biological) model of addiction has experienced numerous challenges over the years <ref type="bibr">(White, 2001a;</ref><ref type="bibr">2001b)</ref>. One challenge in particular tests that the disease model created more of the same problems it allegedly tried to resolve <ref type="bibr">(Peele, 2003;</ref><ref type="bibr" target="#b181">Schaler, 2002)</ref>. The "no-fault disease" approach, while stripping addicts from any personal responsibility, discourages them from seeking help. Furthermore, the disease model does not in fact provide an adequate framework for prevention <ref type="bibr">(Peele, 1990)</ref>.</p><p>Addiction, according to this view, is primarily a "voluntary choice" or specifically a behavioral problem that is influenced in part by the user's biological constitution. As such, opponents of the medical model argue that addictive behavior can best be justified by the psychological, social, situational or environmental factors contributing to the drug addicted person's decision to use drugs <ref type="bibr" target="#b181">(Schaler, 2002;</ref><ref type="bibr" target="#b206">Vuchinich &amp; Heather, 2003)</ref>.</p><p>Other opponents to the unavoidable disease concept debate whether the medical model is able to adequately account for the full spectrum of behaviors that are symptomatic of drug abuse and even addiction <ref type="bibr">(Milkman &amp; Shaffer, 1985)</ref>.</p><p>Epidemiological data lends some support for this view, suggesting, for instance, that not everyone who is a long-term "chipper," "weekend" or recreational drinker and/or drug user (also referred to as a "weekender") becomes necessarily addicted <ref type="bibr">[Satel and</ref><ref type="bibr">colleagues (1998, 2001)</ref>, citing national prevalence rates from the Epidemiologic Catchment Area study]. Chippers, in fact, stymie many drug abuse researchers because they are chronic in their consumption patterns, but still able to function at high levels in society, in essence, staving off many of the negative problems that are frequently hallmark characteristics of addiction. Others cite cases of "natural recovery" from drug addiction or "maturing out" without treatment <ref type="bibr" target="#b57">[Fingarette (1989)</ref>, citing the study findings from <ref type="bibr">Schuckit (1984)</ref> and <ref type="bibr">Fillmore (1988)</ref>; and <ref type="bibr" target="#b80">Heyman (1996)</ref>, citing <ref type="bibr" target="#b163">Robins et al. (1974</ref><ref type="bibr">Robins et al. ( &amp; 1980) )</ref> well-known seminal findings regarding Vietnam veterans returning stateside and naturally relinquishing their addiction to heroin]. The disease model, despite all these challenges, continues to be regarded as the "conventional wisdom" in most present day addiction treatment programs <ref type="bibr">(White, 2002)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Contemporary Addiction Theories</head><p>While the brain disease model gained a significant foothold in the academic community, there has been a substantial amount of research to refine this position and provide a more detailed causal explanation of addiction in terms of brain mechanisms. This effort has managed to shift the focus away from the conventional "biological disease" (or purely medical) explanation, towards a more elaborate view of addiction, depicting it as a complex "neuro-behavioral" disorder. In these terms, addiction is not just a chronic medical disease but more importantly a neurological disorder that involves higher brain functions; including "cognitive processes," such as attention and memory as well as deficits in learning and motivation; which are essential to the addictive decision-making processes <ref type="bibr">(Mauron, 2003;</ref><ref type="bibr">Nestler &amp; Malenka, 2004)</ref>.</p><p>Proponents of this view cast some doubt on dopamine's (DA) causal role in reward mechanisms. <ref type="foot" target="#foot_14">26</ref> As stated earlier, the projection of dopaminergic neurons in the nucleus accumbens (NAc) has been thought for many years to be implicated in the hedonic (feeling of pleasure) and motivational (rewarding) characteristic of drugs <ref type="bibr">(Wise, 1996)</ref>. Again, the "hedonia hypothesis" was originally presented as strong evidence that addiction is a "reward-motivated" disorder characterized by numerous symptoms including the compulsive urge or need (craving) to consume the drug. In other words, the "liking" of a drug, caused by mimicking the brain's "natural reward system," was thought to promote the motivation (intrinsic reasons) for its use, which, in turn, was thought to promote addiction with its concomitant harmful consequences.</p><p>Thus, the DA reward mechanism was thought to encourage the addict's vigorous drug-seeking and drug-taking behaviors. Support for this "pleasure" theory of addiction has been challenged within the past 10 to 15 years based on evidence from sophisticated "in vivo" laboratory animal studies <ref type="bibr">(Shippenberg &amp; Koob, 2002)</ref>.</p><p>Although this challenge does not discount the hedonic effects of drugs, the findings of several studies have been used as evidence that the brain DA activity is not necessarily sufficient, as a reward motivation per se, to account for the persistent and compulsive pattern in the drug addict's behavior <ref type="bibr">(Garris et al, 1999)</ref>. This point of departure opens the door to consider alternative hypotheses explaining the DA functional role in the drug addiction process. Among these at least three competing theories have evolved.</p><p>One such theory holds that addiction is a "dopamine-dependent associative learning disorder" <ref type="bibr">(Di Chiara, 1999)</ref>. According to this theory, psychoactive drugs activate the brain motivational systems by continually "tricking" it into responding as if the drugs are biologically needed. In addition to their reinforcing or rewarding properties, addictive drugs alter the brain learning and memory processes by forming an association between the drug-rewards value ("the high") and the drug-related environmental cues [environment where drugs were taken previously, places and people associated with drugs, and sight of objects such as drug paraphernalia (e.g. syringes or smoking devices)]. This is caused by the sustained increase of DA induced by drugs and the brain's lack of "habituation" to external stimuli <ref type="bibr" target="#b45">(Di Chiara, 2002;</ref><ref type="bibr" target="#b214">Wise 2002)</ref>. Through this reward "associative conditioning" process, the motivation for drugs is strengthened with each repeated exposure; causing the overwhelming desire or craving that can evolve into compulsive patterns of drug acquisition and consumption habits. In light of these neural and behavioral mechanisms, addiction is hypothesized as a "disease of learning and memory" <ref type="bibr">(Hyman, 2005)</ref>, resulting from the impact on the addict's behavior by the midbrain DA "stimulant role" acquired by the "conditioned stimuli" or reinforcing properties.</p><p>Schultz and colleagues <ref type="bibr" target="#b185">(Schultz et al., 1997;</ref><ref type="bibr" target="#b186">Schultz, 1998)</ref> advanced another theory for the DA neuron function, conceptualizing addiction as the outcome of a compulsive "trial and error" process to obtain the best future reward. <ref type="foot" target="#foot_15">27</ref> In this "reward-dependent" learning theory, the drug-induced midbrain-DA activity is hypothesized to reflect the anticipation ("prediction error") of drug rewards and not its actual "euphorogenic" or hedonic effects (experience of pleasure). According to this "reward-prediction-error" hypothesis, the computational role of DA firing is driven by the unpredictability of the drug reward value (i.e. "high"): The burst of neurons signals a surprising reward (positive prediction error), while the pause signals an expected reward (no difference between received and anticipated rewards).</p><p>Consequently, these phasic bursts and pauses of electrical activity, which are naturally used to maximize future rewards, play a motivational role in the pathological reward-seeking behaviors typical of long-term drug users' behavior <ref type="bibr" target="#b11">(Berke &amp; Hyman, 2000;</ref><ref type="bibr" target="#b46">Di Chiara &amp; Bassareo, 2007;</ref><ref type="bibr">Schultz, 2002)</ref>.</p><p>Finally, an alternative theory of the dopaminergic function proposes that the primary role of the DA released into the mesocorticolimbic dopamine system (MCDS) is to mediate the "incentive salience" (or "noticeableness") of rewards, that reflects different motivational value for drugs than the traditional hedonic "liking" <ref type="bibr">(Robinson &amp; Berridge, 1993</ref><ref type="bibr">, 2000</ref><ref type="bibr">, 2003)</ref>. Incentive salience is a characteristic of a stimulus that makes the drug rewards associated with it more noticeable or important (i.e., attention grabbing), and, therefore, desirable <ref type="bibr">(Berridge, 2003</ref><ref type="bibr">(Berridge, , 2006))</ref>. This hypothesis emphasizes that extended or excessive use of psychoactive drugs can act directly as well as indirectly on the DA receptors, which may have long-lasting (and possibly permanent) effects on the brain's anatomical substrate and cellular molecular biology responsible for attributing significance to environmental stimuli (i.e., memory).</p><p>Specifically, the neurological actions of drugs on the brain's biochemistry and neuronal activity have been shown to deplete the DA from the reward pathways (the NAc, in particular), which may cause "natural rewards" (like food and water) to lose their motivational importance (referred to as motivational toxicity). At the same time, the chronic exposure to drugs is hypothesized to "sensitize" the MCDS to environmental cues or stimuli, so that the incentive salience of the perceived drugrewards becomes pathologically exaggerated, causing the external stimulus to trigger a strong psychological motivational state of "wanting" for the drug rewards and thus the typical addict's compulsive habits <ref type="bibr">(Robinson &amp; Berridge, 2003;</ref><ref type="bibr">Ranaldi &amp; Wise, 2002)</ref>. In other words, the "incentive-sensitization" theory posits that the midbrain DA activity interferes with the "normal" decision making process by falsely enhancing the incentive-motivational properties of the drug rewards and therefore influencing the drug-user' behavior. This view suggests that the DA may be involved in the "wanting" (desire) rather than in the "liking" (pleasure) of drugs. The psychological distinction between the concept of "wanting" and "liking" was advanced as a better explanation of why addicts continue to seek and consume drugs aggressively despite the continued threat of enormous adverse consequences <ref type="bibr" target="#b81">(Hobbs et al., 2004)</ref>.</p><p>Although the debate continues over the precise causal contribution made by the midbrain DA activity to the addiction process <ref type="bibr" target="#b13">(Berridge, 2007)</ref>, two common themes have already emerged from the three advanced "neurochemical" models or theories of addiction. First, the experimental evidence behind these theories has strengthened the view that the neurotransmitter DA is more involved in the behavioral motivation and decision of procuring and consuming drugs than just mediating their euphoric feelings. While its specific involvement is much less clear;</p><p>DA activity has been found to play a key role in explaining drug addiction from the initiation of use to the end-stage of addiction, including craving and relapse even after a long period of abstinence <ref type="bibr">(WHO, 2004)</ref>. It is therefore quite possible that all the above theories about the role of DA are correct, they may however explain different stages in the addiction process <ref type="bibr" target="#b205">(Volkow et al., 2003)</ref>.</p><p>The second common theme to surface across the three theories of DA neuron function is their shared conceptual view of addiction. For all three theories, drug addiction is not just a "disease," but rather a complex neuro-behavioral disorder that occurs in some individuals from their chronic use of psychoactive substances. These addictive drugs have been shown to affect, one way or the other, the "normal" brain functions, including emotions and motivations, which directly influence thought and behavior. According to this perspective, drug addiction is viewed as "an extension of normal behavioral processes" that results from the ability of psychoactive substances to influence the brain mechanism involved in decision making and behavior.</p><p>Addiction manifests itself as an excessive pattern of "reward-seeking" that continues over time at the expense of most other functional activities. In other words, all three DA theories agree that addiction can best be viewed as an extreme case of drug-use habits with a behavioral control problem caused by a neurobiological alteration of the brain motivational systems.</p><p>Based on these new complex brain-behavioral models of addiction, diverse risk factors have been advanced to account for the causes of drug addiction and their variation among users. Clearly, the reinforcement properties of the psychoactive drug involved, together with the user's own genetic predispositions and other biological factors play some role in this process. There is, however, consensus that neither the drug itself nor the genes alone can generally initiate the cycle of addiction. Addicts have to decide voluntarily to initiate taking drugs and continue acquiring them.</p><p>Moreover, most addiction theories agree that the desire to use psychoactive drugs and the process of addiction depend a great deal on the individual's emotional make-up as well as other contextual or environmental factors, such as the availability of the drug and its cost. These arguments come from addiction models based on two dominant social science theories: psychology and economics. Thus, in the next section, these two approaches are presented and discussion ensues as to how each perspective informs the other.</p><p>Economic Models ---Economists have always considered behavior to be the result of an individual-based, cognitive, decision process based on an informed choice between options that are subject to specific budget constraints (or limitations).</p><p>Within this framework, rationality is defined as the pursuit of happiness. Any individual "economic actor" is assumed, therefore, to behave rationally if he/she does things expecting maximum personal benefits (or utility, i.e., satisfaction derived) and he/she is aware and willing to accept any adverse consequences of such a behavior.</p><p>In the past, economists generally downplayed the study of drug use and addiction or treated it specifically as an impulsive and irrational behavior, therefore not suitable for conventional economic analysis <ref type="bibr">(Schelling, 1984)</ref>. Over time, however, several economic models have been proposed that offer a unique view depicting drug users as "rational," guided by his/her own self-interest. <ref type="bibr">Chaloupka, Tauras, and Grossman (2000)</ref> identified three types of economic models that define addiction as myopic, imperfectly rational, or a fully rational process. <ref type="foot" target="#foot_16">28</ref> Within the group of rational choice models <ref type="bibr" target="#b206">(Vuchinich &amp; Heather, 2003</ref>), Becker's Rational Addiction Model (RAM) is often regarded as the gold standard with respect to microeconomic theories. <ref type="foot" target="#foot_17">29</ref> It is frequently used to explain addictive behavior as an "intertemporal, rational process" compelling the pursuit of the best self-interest or happiness <ref type="bibr">(Becker, 1962</ref><ref type="bibr">(Becker, , 1993;;</ref><ref type="bibr">Becker &amp; Murphy, 1988;</ref><ref type="bibr">Stigler &amp; Becker, 1977)</ref>. <ref type="foot" target="#foot_18">30</ref>Based on Rational Choice Theory (RCT), the RAM asserts that drug use, like other rational choices, is part of a solution to the consumer's expected lifetime "utility" (satisfaction) maximization. Accordingly, drug users are motivated, like all consumers who purchase a wide variety of goods, by the satisfaction or long-term happiness caused by the induced pleasure from drug consumption. In this respect, "satisfaction" (i.e., utility) is controlled or dependent on market-based economic criteria. To date, successful applications of the RAM have largely included prediction of cigarette smoking <ref type="bibr">(Becker, Grossman, &amp; Murphy, 1991</ref><ref type="bibr">, 1994;</ref><ref type="bibr">Cameron, 2000;</ref><ref type="bibr">Chaloupka, 1991;</ref><ref type="bibr">Suranovic, Goldfarb, &amp; Leonard, 1999)</ref> and consumption of alcoholic beverages <ref type="bibr">(Grossman et al., 1995;</ref><ref type="bibr">Waters &amp; Sloan, 1995)</ref>. Further extensions have included models to account for drug initiation (e.g., <ref type="bibr">Saffer &amp; Chaloupka, 1999)</ref> and for patterns as well as levels of consumption of marijuana, cocaine, and/or heroin (e.g., <ref type="bibr">Bretteville-Jensen &amp; Birn, 2003;</ref><ref type="bibr">Grossman &amp; Chaloupka, 1998;</ref><ref type="bibr">Jofre-Bonet &amp; Petry 2004;</ref><ref type="bibr">Pacula, et al., 2000)</ref>. <ref type="foot" target="#foot_19">31</ref>The RAM is clearly distinguished from other economic models because it regards addictive behavior as forward-looking<ref type="foot" target="#foot_20">foot_20</ref> and consistent over time. What this means is that the rational component of Becker's model derives from consumer awareness of future implications of continued product selection and the weight of this awareness on current consumption decisions (i.e., rational behavior conveys forward thinking and is based on salient market information). As informed decision-makers, drug users are assumed to recognize that their addictive behavior has negative longterm consequences; however, weighing both the present and future into their consumption decision, they judge that the benefits outweigh the costs. According to Becker's model, drug users who think only in terms of present consumption (i.e., current satisfaction) are 'myopic' (or impulsive) because they do not consider the future or reflect on the potential adverse consequences of their current behavior.</p><p>Discounting future implications of current consumption also underscores the fact that drug users are risk-takers, as they are willing to consume psychoactive drugs in spite of the detrimental consequences, and they do so because they expect the "highs"</p><p>(satisfaction) to outweigh the "lows" (harm). Elaborating further on the rational process of addiction in Becker's model, <ref type="bibr">Orphanides and Zervos (1995)</ref> argued that drug users do not wish to become addicts; that would in fact be entirely irrational.</p><p>Drug users might not even recognize their implicit susceptibility to addiction or they simply choose to ignore it. In either case, addicts are regarded as consumers who lost a "rational gamble."</p><p>Another important feature of the economic approach to drug addiction concerns the core idea supporting the mainstream economic concept of a "rational economic man." In economic RCT, everyone is assumed to have a given set of personal tastes and preferences, referred to as a utility function (a measure of satisfaction derived from the consumption of commodities and based on the individual tastes and preferences). The model also assumes that everyone's choices are limited by the level of income or wealth accumulated, referred to as budget constraints (a measure of purchasing power). To act rationally, the "economic man" has to choose a course of action that maximizes his/her own utility function subject to whatever monetary constraints he/she faces; i.e., the "economic man" makes the best of his/her situation. Becker's RAM postulates that drug users are also rational (or competitive) as they are forward-looking people who constantly maximize their satisfaction within the limitations of their personal preferences, given their lifetime budget, and being fully aware of the future implications of their decision <ref type="bibr">(Becker &amp; Murphy, 1988</ref>).</p><p>Yet another essential feature of the rational economic-approach to drug addiction involves the formulation of certain constructs, such as the concept of "stock of addictive capital." In the RAM, Becker assumed that, in order to become addicted, a drug user must have consumed the drug and thus reached a certain "critical level" of past drug habits or "stock of consumption capital" (i.e., addictive level based on past drug use). This concept of addictive stock is introduced in the RAM in terms of an investment function form. As a "human capital," this construct of stock of past drug use plays a critical role in the drug user's rational decision-making process.</p><p>Indeed, addiction is assumed in this model to involve reinforcement and tolerance, which are mediated via the stock effect of past consumption. An increase in past addiction stock fuels the craving for present consumption because of the adjacent complementarily nature of psychoactive drugs [i.e., the marginal utility of drug use increases with experience due to its reinforcing effects <ref type="bibr">(Becker &amp; Murphy, 1988, p. 677)</ref>]. At the same time, the satisfaction from present consumption is lower when past consumption is greater due to the harmful addictive effects of drugs [i.e., negative marginal utility <ref type="bibr">(Becker &amp; Murphy, 1988, p. 682)</ref>]. Under the RAM assumptions, drug users seek to maximize their own satisfaction and, therefore, constantly compare the negative (future harm) with the positive (current satisfaction)</p><p>effects of an increase in their addictive stock due to an increase in current use. The rational decision to consume drugs requires that the marginal increase in pleasure from an increase in current consumption exceeds future harmful effects from a higher stock. In other words, the reinforcement effect must outweigh the tolerance effect <ref type="bibr">(Becker, Grossman, &amp; Murphy, 1991)</ref>.</p><p>Another key concept built into Becker's model of rational behavior is the discounting of the monetary utility of drug consumption based on the idea of stable or consistent rational preferences. The RAM parameterization is based on the assumptions of perfect information regarding the potential dangerous effects of drugs and time consistency in the drug user's preferences. Taken together, these two assumptions lead to the formulation of an additive discounted value (utility) function over the lifetime stream of drug consumption with a higher weight on immediate use of drugs and a lower weight on future consumption. The assumptions behind the formulation of this exponential discount function in the RAM have recently been called into question <ref type="bibr">[West, 2006 (Chapter 7)</ref>]. The end result is an alternative option to improve the model allowing for flexible preferences (e.g., <ref type="bibr">Winston, 1980)</ref>, hyperbolic discounting <ref type="bibr">(Skog, 1999)</ref>, and imperfect information to take into account the possible future regret and learning from past choices (e.g., <ref type="bibr">Orphanides &amp; Zervos, 1995)</ref>. Although the more recent refinements have provided useful insights into explaining some aspects of addictive behavior, they ultimately represent "simple" modifications and/or extensions of Becker's original model (i.e., the RAM). As such these refinements maintain the assumption that drug users are forward-looking consumers who make rational choices based on the constrained maximization of their utility function.</p><p>Through this constrained maximization, economic theory suggests that drug users pay attention to the price of drugs (as a cost measure) and that income (a measure of "purchasing power" introduced via the "budget constraints") weighs heavily in their individual decision to acquire and to use drugs. Depending on the magnitude of reinforcement and the strength of a drug's addictive properties, the actual market fluctuations in costs determine consumption patterns as a downwardsloping demand schedule <ref type="bibr">(Becker, Grossman, &amp; Murphy, 1991;</ref><ref type="bibr">Chaloupka, Emery, &amp; Liang, 2003)</ref>. This framework suggests that if the price of a drug increases, while holding income constant, demand for the drug will fall. Economists call the relationship between market fluctuations in unit price and consumption patterns 'price elasticity' (a measure of responsiveness of consumption to changes in price). In their empirical studies of smoking initiation and cessation, Chaloupka and colleagues showed that young smoking initiates, for example, attend to current market fluctuations in price (i.e., they are price sensitive), whereas older smokers decide to quit based on future cigarette prices <ref type="bibr" target="#b30">(Chaloupka &amp; Grossman, 1996;</ref><ref type="bibr">Chaloupka &amp; Wechsler, 1997)</ref>. Overall, economists suggest that young people and individuals with less income pay less attention to the future and heavily discount or ignore future events (including health). As a result, their economic reality is heavily based on current price <ref type="bibr">(Becker, 1990)</ref>. Price sensitivity among young people may be tied to their lack of disposable income. On the other hand, older adults, especially those contemplating (or attempting) to quit smoking, may find resolve and support for quitting based on future pricing for cigarettes (i.e., they justify quitting based on the share of their income allotted to cigarette purchases).</p><p>Economists use a broad definition of price that covers not only monetary value of a product (or market unit price), but also the value of time and other costs associated with acquiring and consuming a product. Rich or poor, people must spend time to procure a product and consume it. Such time is therefore considered as an investment in 'human capital.' Given this broad definition of price, neo-classical economists suggest that 'opportunity cost,' as measured by the amount of time spent searching for goods or services and their consumption, is a reflection of market transactions related to price. In the case of drugs, time spent searching and consuming them must therefore be considered as part of the total cost of substance use given that it takes time away from other activities including work, family, or other leisure activities. It is also easy to see how 'rationality' requires a measure of opportunity cost to be incorporated into the economic explanation of drug use, even when drugs are easily accessible.</p><p>This complex economic model of addiction, involving opportunity cost and its manifest influence on behavior, can easily be illustrated. Consider that it is lunchtime on a Friday and an individual decides to purchase a drug to "enhance" their weekend activities (i.e., getting high). Also consider that the dealer is located far from the buyer's place of employment. The buyer, needing the drug for the weekend, has to make a decision whether or not it is worth traveling across town and perhaps running the risk of returning late to work. The individual becomes torn, so to speak, by the choice of being late to work and getting chastised by their boss as opposed to procuring the drug so they can get high and party with friends over the weekend.</p><p>Rationality, in this case, captures the intricate decision tree used to evaluate the various 'costs' associated with drug use and juxtaposes these anticipated costs against the perceived benefits (i.e., the high) from acquiring and consuming the drug.</p><p>In sum, the RAM is the "gold standard" of behavioral-economic model of addiction, treating drug consumption as a perfectly rational behavior, positing that drug users are assumed to be fully aware of their options and make their decision based uniquely on the maximization of their personal utility function that discounts their future pay-offs and consequences from their current drug consumption. As a result, economists believe that drug addiction responds to economic factors (e.g., monetary price, opportunity cost, and income) like any other commercial product.</p><p>While many regard the RAM as a mathematically elegant economic explanation of human behavior, it has been criticized by social scientists because it fails to consider other important factors that affect drug users' decision-making processes and the context in which they make their decisions (e.g., <ref type="bibr" target="#b2">Archer &amp; Tritter, 2000;</ref><ref type="bibr">Elster, 1993;</ref><ref type="bibr">Rogeberg, 2003)</ref>. A number of economists also argue that a rational choice does not necessarily have to be economically rational <ref type="bibr" target="#b219">(Zafirovski, 2003)</ref>. To these economists, rational choice theory does not explain adequately how drug users actually behave in the real world or how they justify their actions <ref type="bibr">(Legrenzi, Girotto, &amp; Johnson-Laird, 1993, p. 38)</ref>. In fact, an individual's decision-making process is often influenced by a range of factors that are not "utility driven" <ref type="bibr" target="#b152">(Rachlin, 2007)</ref>. Psychologists, in particular, believe that people maintain inner motivations (other than maximizing welfare) like attitudes and beliefs that influence behavior. Proponents of this view argue that motives are usually needed as incentives or reasons to carry out a desired course of action or behavior, including drug use <ref type="bibr" target="#b133">(Miller &amp; Rollnick, 1991)</ref>.</p><p>Psychological Models ---Psychologists have had a profound influence on addiction research and treatment. Their influence began to take shape in the early 1950s around the time the American Psychological Association endorsed the disease concept of addiction <ref type="bibr" target="#b166">(Room, 1983)</ref>. Historically, numerous schools of thought in psychology proposed different theories to account for substance use problems, focusing mainly on the individual mental process that leads to behavior. Prevalent themes emphasized: (1) Personality processes, involving certain individual pre-drug use traits or characteristics such as novelty seeking, harm avoidance, and reward dependence <ref type="bibr">(Conway et al., 2003)</ref>; (2) Associative-learning theories, focusing on the idea that all behaviors are acquired mainly through operant conditioning <ref type="bibr">(Schwartz &amp; Lacy, 1982)</ref>; and (3) Intrinsic-motivation theories, taking into account the internal states (or cognitive aspects) of the drug user such as feelings, emotions, motivations and their influence on the decision-making process to explain behavior <ref type="bibr" target="#b3">(Arnkoff &amp; Glass, 1992)</ref>.</p><p>Most of the psychological theories assumed people are goal-oriented and their individual behavior is seen as the pursuit and enjoyment of their goals <ref type="bibr" target="#b105">(Klinger &amp; Cox, 2004</ref>). Based on this common assumption, psychologists offered numerous models to address the wide range of attentional, emotional, expectance and other cognitive processes involved in choosing and pursuing personal goals.</p><p>In the case of drug addiction, it is conceivable that economists and psychologists examine the same behavior merely from different viewpoints. For instance, marginal utility, satisfaction, discounting, stock of addictive capital are all economic terms used to characterize the many factors used by an individual as they weigh or evaluate whether they will consume a product (behavioral motivation).</p><p>Likewise, psychological theories use value expectancy models in which the individual weighs or evaluates the pros and cons of whether to engage in behavior.</p><p>The Theory of Reasoned Action (TRA) suggests that the determining factor in behavioral choice and action is intention <ref type="bibr" target="#b0">(Ajzen &amp; Fishbein, 1980)</ref>. Intention is assumed to be based on the combined effects of personal attitudes (subjective evaluations of importance and pleasantness), beliefs (or behavioral expectations) an individual holds about the consequences of the behavior as well as the perception of its social acceptance (i.e., normative climate). According to the TRA, the intention to act is formed when a person weighs the pros and cons (values) about the outcome (expectancy) associated with the behavior. The attitude toward a behavior is determined by the overall expectancy-value of the behavior <ref type="bibr">(Fishbein &amp; Ajzen, 1974)</ref>.</p><p>Furthermore, psychologists argue that although behavior can reliably be predicted by intention, it may not be performed unless the person is motivated to act <ref type="bibr">(Coon, 2006)</ref>. Motivation influences and directs behavior toward achieving the intended goal. According to <ref type="bibr" target="#b133">Miller and Rollnick (1991)</ref>, "motivation is not <ref type="bibr">[however]</ref> a stable trait that exists within the person." For drug users, motivation can take two forms: a personal enjoyment or an escape from negative feelings (e.g., selfmedication hypothesis <ref type="bibr" target="#b39">(Cohen &amp; Baum, 1995;</ref><ref type="bibr">Khantzian, 1985)</ref>. Either way, the nature of drug users' motivation makes their preferences endogenous to their internal states <ref type="bibr">(Bickel &amp; Marsch, 2001)</ref>. Thus, although psychologists and economists agree that drug use is a personal "choice" based on "self-interest," they approach crafting the factors that influence the drug user's choice quite differently <ref type="bibr" target="#b206">(Vuchinich &amp; Heather, 2003)</ref>. While economists posit that drug consumption is a rational choice based on external factors such as prices and income, psychologists put forth the notion that such a choice is based on internal motivations and could be irrational or at least not completely under individual rational control <ref type="bibr">[West, 2006 (Chapter 7)</ref>].</p><p>Rather than price, utility, and other market factors, psychologists propose that individuals make decisions whether to engage in behavior based on perceived behavioral sanctions from "referent others" (norms regarding what other important people regard as acceptable) and "behavioral expectancies" (perceived benefits of behavior). In this respect, addictive behavior needs to be understood in terms of the constraints and limitations of the drug user's cognitions. According to psychologists, only those "inner limitations" can explain why drug addicts frequently behave in certain ways that might not be rational <ref type="bibr">(Baron, 2000)</ref>.</p><p>Bandura's Social Learning Theory <ref type="bibr" target="#b7">(Bandura, 1977;</ref><ref type="bibr">1997;</ref><ref type="bibr">1999)</ref> goes one step further and offers a more complete social-cognitive framework describing human behavior. According to Bandura, intention or behavioral belief is not enough to explain behavior; in fact, intention alone cannot differentiate performance. Rather, an individual's decision to engage in a behavior, his/her relative level of persistence, and energy expend on that behavior are based on a self-efficacy formulation.</p><p>Fundamentally, self-efficacy represents a cognitive schema or "impetus" that captures whether an individual perceives that he/she has the skills to cope with the situation and to engage in the behavior in question. Self-efficacy comes from past performance linked with response contingencies and is motivational because individual engages a task after evaluating their efficacy.</p><p>These and other dominant psychological theories argue that cognitive representations inside a person's head that take shape as "motivations" are responsible for an individual's behavioral activity and choice. In the psychological literature, the construct "motivation" has received a good deal of attention with respect to drug use (e.g., Cox <ref type="bibr">&amp; Klinger, 1988;</ref><ref type="bibr">Mook, 1996)</ref>, primarily highlighting the role of affect regulation (e.g., <ref type="bibr">Cooper et al., 1995)</ref>, psycho-biological factors (e.g., <ref type="bibr">Baker, Morse, &amp; Sherman, 1987)</ref>, and expectancy models (e.g., <ref type="bibr" target="#b122">Mann, Chassin, &amp; Sher, 1987;</ref><ref type="bibr">Smith, 1994;</ref><ref type="bibr" target="#b196">Stacy, Widaman, &amp; Marlatt, 1990)</ref>. According to expectancy theory, people drink alcoholic beverages, for example, because they believe the effects of drinking alcohol will be positive both now and in the future.</p><p>As we can see, the construct 'motivation' takes on a slightly different meaning for psychologists and economists. Economists believe that lack of income combined with drug price and opportunity cost might encourage users to network with other users in order to reduce or minimize cost and time spent procuring drugs in order to maximize happiness. Economists also believe that frequenting places where drugs are readily available results in reduced economic costs associated with a drugabusing lifestyle (i.e., attending rave parties where there is an abundance of Ecstasy).</p><p>Bars and restaurants, for instance, that make alcohol readily available during "happy hour," essentially offer a product at reduced monetary as well as opportunity costs.</p><p>Despite the relative strength of these economic and psychological arguments in studies of alcohol use, applications of these concepts together to study drug use have rarely been attempted. This suggests a tremendous need to combine these theoretical models and examine the relative influence of economic as well as psychological motivational factors in the prediction of drug user's behavior.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Conceptualizing a Psycho-Economic Model of Ecstasy Use</head><p>As mentioned in Chapter I, Ecstasy is one of several "club drugs" that has recently witnessed increased use by adolescents and young adults. The drug itself is avior in particular.</p><p>known to be both a stimulant and a hallucinogen, and its effects are potentially lifethreatening. However, users claim that Ecstasy produces an altered state of consciousness with sensual euphoria and heightened feelings of self-awareness. It has also been associated with sexual activity and other drug use. <ref type="foot" target="#foot_21">33</ref> In particular, numerous studies have documented close associations between high-risk sexual activity (e.g., lack of protection, multiple partners, sexual activity while under the influence) and Ecstasy use, pointing toward evidence of causality or shared common factors, such as risk-taking, compulsivity and/or vulnerability <ref type="bibr">(Cooper, Peirce, &amp; Huselid, 1994;</ref><ref type="bibr" target="#b98">Justin, Finn, &amp; Steinmetz, 2000;</ref><ref type="bibr" target="#b117">MacDonald, Zanna, &amp; Fong, 1998;</ref><ref type="bibr">Schafer, Blanchard, &amp; Fals-Stewart, 1994;</ref><ref type="bibr">Tapert et al., 2001)</ref>. Increasingly, these relations are more commonly observed among adolescents (e.g., <ref type="bibr">Graves, 1995;</ref><ref type="bibr">Lowry, Holtzman, Truman et al., 1994;</ref><ref type="bibr" target="#b132">Mezzich, Tarter, Giancola et al., 1997;</ref><ref type="bibr" target="#b198">Strunin &amp; Hingson, 1992)</ref> and young adult populations (e.g., Castillo, Barrio, Belza, &amp; De la Fuente, 1999). As with many drugs, the attractiveness of immediate gain and feelings of euphoria overshadows potential negative consequences that may be experienced down the road. This view has often had an effect on drug users' decisions in general and their addictive beh Sexual risk-taking and drug use are associated, due to intoxication leading to "disinhibition" or "impairment in judgment" that prompts increased sexual risk-taking <ref type="bibr">(Murphy, Monahan, &amp; Miller, 1998)</ref>. Economic views suggest that lack of buying power and the absence of wealth may prompt drug users to trade sex acts for drugs (or for money to buy drugs of their choice), thus increasing the likelihood users can acquire drugs at minimal cost to maximize their benefit or "high."</p><p>One other area of concern revolves around linkages between psychiatric disorders and substance use. Psychoactive drugs may also be consumed to escape negative physical and/or psychological feelings. A great deal has been written about substance use as a means of regulating affective distress, its role as a palliative coping mechanism, or form of self-medication for physical and mental health issues. In particular, drugs such as cocaine and marijuana, among other substances, have been associated with depression (e.g., <ref type="bibr" target="#b92">Johnson &amp; Kaplan, 1990;</ref><ref type="bibr">Swaim, Oetting, Edwards, &amp; Beauvais, 1989)</ref>. In many respects, the euphoric qualities associated with Ecstasy may help mask affective disturbance or ameliorate disturbing self-referent thoughts.</p><p>The possibility of third-variable alternatives including depression and/or sexual risk as valid explanations of Ecstasy use and dependence makes it essential to control for these and other motivational measures.</p><p>To summarize, the present study weaves together hallmark components representing both economic and psychological theories of addiction to account for Ecstasy use. Using external market-based factors including price and income departs significantly from the more traditional psychological views of addiction that showcase the strengths of internal characteristics and motivation (e.g., control, self-efficacy, and reasoned action to name a few) to account for addictive processes. The common or shared conceptual underpinnings hold that individuals make choices regarding consumption based on self-interest. In psychology, the Theory of Reasoned Action, and likewise in economics, Rational Choice Theory, identify reinforcement as critical in understanding drug use and abuse (in addition both disciplines regard tolerance as important components necessary to understand addiction).</p><p>Reinforcement, in economic terms, expresses the link between past and current drug use in terms of perceived utility. Increases in the addiction stock lead to increases in the utility (i.e., satisfaction) of current consumption and consequently tolerance.</p><p>Because of diminishing return (due in part to tolerance to the drug), current consumption fuels future consumption. The nature of reinforcement in this decision tree (and the suggested learning mechanism that is not too distant from what psychologists' term reinforcement) considers the weight given to current consumption, future costs, and the discounting process. In psychology, reinforcement plays a prominent role in linking external activity with internal cognitive processes and ultimately expression of behavior (e.g., <ref type="bibr">Bolles, 1972)</ref>. Where these two approaches depart is that psychologists herald the importance of internal (unobservable) processes as a fundamental part of the decision tree, whereas economists place greater emphasis on external (observable) market indicators beyond the immediate control of the individual as influential in consumption decisions (e.g., <ref type="bibr" target="#b136">Montoya, Atkinson, &amp; Trevino, 2000)</ref>. It goes without saying that, for a comprehensive and adequate understanding of such a complex behavior, the confluence of both economic and psychological theories is necessary. The combination of both theoretical views might shed additional light on our understanding of drug addictive behavior bringing into scrutiny at the same time both external and internal factors. This was the objective of the psycho-economic model.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">The Proposed Psycho-Economic Model and Research Hypotheses</head><p>Based on the above review of the most dominant theories of drug addiction, a structural equation model of Ecstasy use and its consequences was developed and tested. Figure <ref type="figure">1</ref> graphically depicts the conceptual framework underlying the proposed psycho-economic model. As depicted, the two major domains of influence included psychological (defined mainly by motivation to use drugs) and economic measures (income and monetary as well as opportunity costs), which are hypothesized to influence the designated outcomes of Ecstasy use (or Consumption)</p><p>and Dependence (included in oval frames). 34 A third domain of influence, referred to as "Other Risk Factors," entailed personality characteristics (Risk Taking) and 34 There is no precise definition of addiction, per se, albeit many consider "compulsive use" as a singular defining feature. There are other ways to conceptualize addiction including based on problems from continued use, which by necessity occur from consumption. "Problems from drug use" were categorized by the American Psychiatric Association "Diagnostic and Statistical Manual" (DSM) into "Abuse" and "Dependence," representing two different facets of addiction. The latter measure was chosen for two reasons, (1) dependence captures more serious consumption level, and</p><p>(2) dependence problems are directly associated with the motivational strength (due to the craving and/or tolerance) that characterizes drug users compulsive behavior to procure and consume a drug. Dependence provides a viable behavioral analog to consumption by measuring the severity of the individual's drug use practices.</p><p>psychological status (Depression). Additionally, other individual characteristics (i.e., demographics) were included in a separate domain to assess the broader implications of whether immutable factors such as gender, race, age, and education would enhance the explanatory power of the model. Because variables forming each domain might measure common constructs, latent-variable methods were used in the actual model.</p><p>Specifically, the psycho-economic model was hypothesized to include four latent constructs (Ecstasy Use, Dependence, Motivation, and Depression), several observed measures (income, price, opportunity cost, and risk-taking), and demographics.</p><p>In Figure <ref type="figure">1</ref>  As a consequence of the potential legal consequences if caught, illicit drug users are generally inaccessible for direct inquiry regarding their drug involvement.</p><p>Information regarding the use of controlled substances and related activities therefore must be obtained from alternative sources including archival records. Examples of useful official record sources include information culled from police reports about drug arrests and narcotic seizures, drug-use treatment admissions, and drug-related medical emergencies.</p><p>Information abstracted from official records offers several advantages, including immediate accessibility to the data, the potential quality of information that could be available, the unobtrusive nature of the data collection (extraction) method, and its relative cost-effectiveness. However, there are a number of limitations with this type of data source that can restrict its utility for research. In particular, information from official records may not always be entirely satisfactory and/or error free. The accuracy of such information depends mainly on the consistency of record keeping, which may be questionable <ref type="bibr">(van Kerckvoorde, 1995)</ref>.</p><p>In addition to their potential deficiencies, official records on drug arrests are susceptible to administrative and policy changes. <ref type="bibr">McAuliffe et al. (1999</ref><ref type="bibr">&amp; 2002</ref><ref type="bibr">), among others (e.g., DeFleur, 1975;</ref><ref type="bibr">MacDonald, 2002;</ref><ref type="bibr" target="#b184">Schmidt &amp; Weisner, 2000)</ref>, suggested that "public pressures," the "quality of leads" from "cooperating arrestees"</p><p>and other "drug-trade informants," as well as "changes in funding" may exert a huge influence on drug enforcement arrests. The operation of these external forces may bias drug use data, limiting what we truly know about the actual patterns of drug market activities <ref type="bibr">(McAuliffe et al., 2002)</ref>. Seconding this concern, DeFleur pointed out that "these biases distorted the validity of drug arrest rates as measures of drug use to unknown degrees" <ref type="bibr">(1975, p. 102)</ref>.</p><p>The biggest problem with official records is that they reflect merely the "tip of the iceberg" thus providing only a snapshot of what may really be going on. In other words, official records document occurrences of individuals who came in contact with the criminal justice system or sought treatment. For example, given the fact that the prevalence of treatment is notoriously low among drug users, there is a large and inherent bias resulting from the fact that treatment records reflect only a subset of the large population of drug users.</p><p>These concerns suggest that measures of illicit drug use collected from official sources should not be used for research purposes, particularly in etiological studies of drug use and abuse. In fact, today, more than ever, most drug addiction researchers bypass official agencies and access directly the relevant drug-using population, applying standard self-report and semi-structured interview survey methods to gather information from the drug users themselves.</p><p>Survey methods have been used routinely in social and behavioral sciences to gather information about personal, sensitive, and delicate matters, including opinions, attitudes, perceptions, and even behaviors or experiences known only to the respondent. It is obvious, for instance, that questions addressing motivations to use illicit drugs can only be obtained from the drug user. Also, given the clandestine nature of illicit drugs, survey questionnaires provide ideal tools for accessing and engaging out-of-treatment drug users who are usually difficult to reach <ref type="bibr" target="#b40">(Cottler et al., 1996)</ref>. It is therefore not surprising that self-report surveys are the most widely used means of data collection for exploring drug-users' behavior.</p><p>The basic approach to survey methods requires asking questions and recording the respondents' answers. Such a "direct method" of data collection can provide a wealth of information, including patterns of use, risk and protective factors, and consequences of use. Over time, the survey methods have become sophisticated, incorporating various improvements particularly in question design and techniques of administration, expanding its applicability to various sensitive areas such as sexual practices, victimization, and even crime <ref type="bibr">(Hagan, 1993;</ref><ref type="bibr">Thornberry &amp; Krohn, 2000)</ref>.</p><p>Despite the enormous advances made in these techniques and their wide applicability, survey methods have continued to face great skepticism concerning the reliability (consistency of the collected information over time) and validity (accuracy of the data) of information obtained using this approach <ref type="bibr">(Hagan, 1993)</ref>. In particular, there has always been doubt about whether respondents would voluntarily disclose accurate information about their own drug consumption and reflect accurately on their habits and motivations for drug use. Whether caused by intentional distortion (due to "social desirability" or "fear of repercussions") or simply inaccurate recall (poor introspection), "response biases" associated with survey data can systematically distort and even bias the hypothesized relations between a self-reported measure and other variables of substantive interest. Despite these concerns, careful research has shown that "self-reports of drug users are sufficiently reliable and valid to provide accurate descriptions of drug use, drug-related problems and the natural history of drug use" <ref type="bibr">(Drake, 1998, p. 253)</ref>.</p><p>Beyond the credibility of respondents, there has also been a concern about other sources of measurement error, which may occur at any stage in a survey-based research. These concerns include but are not limited to problems of sample selection, poor questionnaire design, and inadequate survey administration <ref type="bibr">(Pepper, 2001)</ref>.</p><p>Methodological or measurement issues can contaminate the data, which can, in turn, reduce the precision of the models being tested and affect the power of the study. The potential effect of "measurement error" can however be avoided, if not reduced to a negligible level, by 1) conducting a validation sub-study prior to the actual data collection, using focus groups and pilot studies to help formulate better questions that can improve the precision of responses, 2) selecting an adequate study sample size in order to have sufficient statistical power to address the research questions, 3) implementing stringent study protocols and appropriate data quality control procedures to manage the conditions of the survey administration and eliminate any possibility of interviewer-induced systematic errors in the data, 4) carefully choosing and appropriately training interviewers to improve data quality and minimize the risk to study participants <ref type="bibr" target="#b55">(Ellsberg et al., 2001)</ref>, 5) replicating the findings with different samples under the same conditions, and 6) accounting for possible residual measurement error by choosing appropriate statistical techniques for data analysis.</p><p>The concern over having error-free survey data particularly when dealing with illicit-drug users transcends finding "relevant" information to answer the research questions. It requires a thorough knowledge and solid understanding of the data collection procedures and study protocols used to assemble such information as well as implementation of appropriate statistical data analysis procedures.</p><p>Another concern stemming from reliance on secondary data analysis is the challenges of locating an appropriate and comprehensive source of data that incorporate all of the relevant information needed. Toward this end the present Several factors suggest this study provides a unique opportunity for secondary data analysis: The CDSLAM is a multi-site study establishing the reliability and validity of diagnostic criteria for substance use disorders. Furthermore, the study involved specifically examining the suitability of the DSM-IV (APA, 1994) classification of "club drugs," including Ecstasy, which has yet to be classified as a separate drug category in the DSM <ref type="bibr" target="#b83">(Cottler et al., 2001</ref><ref type="bibr">(Cottler et al., , 2009))</ref>. The CDSLAM (hereinafter referred to as the "parent study") also included the largest known sample of out-of-treatment Ecstasy users, amassed comprehensive and detailed self-report data, covering most aspects of substance (alcohol and drugs, including Ecstasy) use and related consequences that are central to DSM-IV abuse and dependence criteria.</p><p>Moreover, self-report data from this study was found to be highly reliable and valid <ref type="bibr">(Cottler et al., 2009;</ref><ref type="bibr">Shacham &amp; Cottler, 2009)</ref>.</p><p>One other concern underscores perhaps the most significant challenge faced in this investigation. Even though the parent study provides a rich resource for developing and testing the model under consideration and answering related research questions, its data were not specifically collected for the purpose of the present investigation. In other words, the CDSLAM measures were not originally designed with the aim of testing a psycho-economic model of Ecstasy use. For instance, in some cases, the variables of interest for testing a psycho-economic model may have been coded or treated differently than expected. To exemplify this concern, the survey questions pertaining to respondents' income were coded as categorical rather than as continuous measures. Although the categorical levels of an income measure should indeed underlie its continuous dimension, the latter type of measurement is generally more precise and therefore more informative than the former. This does not however invalidate the data in any way, but highlights the problems that may arise from obtaining data through secondary data analyses.</p><p>There are other measurement considerations that reinforce similar concerns.</p><p>Economists have long debated whether current income or earnings provide an "absolute" indicator of the consumer's "purchasing power." Some suggest that other measures of economic status such as "permanent (also known as lifetime) income" or wealth should be given a more prominent role in empirical analyses of the pattern of consumption behavior <ref type="bibr">(Friedman, 1956;</ref><ref type="bibr" target="#b135">Modigliani &amp; Brumbergh, 1955)</ref>. For drug users, in particular, this matter is even more complicated, as some users may turn to illegal and criminal activities to pay for their drug habits. There is considerable debate whether "financial reward" obtained thorough criminal activities should be considered as part of income. It is common practice, in this situation, to create a composite variable (or multi-item scale) consisting of all available information (encompassing a broad spectrum of survey items) related to potential sources of income, and using this proxy measure to indicate purchasing power. Such an aggregate measure may require additional data transformation (dichotomizing some variables and/or re-categorizing others) and decisions regarding proper weighting schemes to enhance the formulation of a composite score <ref type="bibr" target="#b122">(Markus, 2008)</ref>. In certain instances, these same concerns were addressed in the present study through data manipulations to create unit-weighted composite scores that provide the type of information needed <ref type="bibr" target="#b10">(Bentler, 2004;</ref><ref type="bibr" target="#b131">Mentzer &amp; Flint, 1997)</ref>.</p><p>Modern innovations in statistical modeling also influence the way we can test various hypotheses. For example, individuals providing information in this study responded to multiple questions about specific behaviors. As is common when more than one question is used to query a particular behavior, there was some conceptual and empirical overlap between these items, reinforcing shared variance. The moderate associations between multiple items or indicators (scales) are hypothesized to be "statistically caused" by an unobserved latent factor (also called a latent "construct'). This type of latent variable approach is common in psychological research, where researchers often infer a "hypothetical" construct based on the shared association among multiple items or indicators. Depression is one good example and problems from consumption or "dependence" provide another. In the case of depression, a person will report that they are slow to get out of bed; they experience mood swings or sad affect, and also note somatic experiences (i.e., loss of appetite).</p><p>These items often appear related statistically and they are common features of "depression." The point is that by itself, depression is not observable but rather inferred from the collection of symptoms reported. In other words, one does not "see" depression, rather one infers that a person is depressed based on a collage of symptoms or behaviors reported by the individual.</p><p>The same conceptualization of latent variable methods holds for problems that arise from chronic drug use, which is termed in the extreme form "dependence." Here a drug user taking a survey might report they cannot control their urges, cravings, or desires to use drugs and even indicate that during the day they constantly think about using drugs. The same person might also answer affirmatively that they continue to use drugs even though they experience side effects that impair their normal day-today functioning. In this brief example, the "inference" about a drug user's consumption is they may be addicted or dependent again based on the collage of symptoms reported and the strength of empirical association between these items.</p><p>As these two examples show, there is a conceptual argument that supports hypothesizing a latent construct, given that symptoms of sad affect, feeling blue, behavioral and somatic complaints, are all signs or markers of depression. There is also an "empirical" side to consider given that inspection of a correlation matrix containing these items would reveal modest overlap or shared variance between these items. Using covariance structure analysis a researcher hypothesizes a latent construct that statistically "causes" the association among the symptoms. In other words, the variation underlying the latent construct is attributed to the close correspondence between the multiple measures. In the case of depression, the symptoms are observed responses on a survey but the latent construct is inferred based on the statistical association between the symptoms.</p><p>Self-report information is not always one hundred percent accurate, suffering Trained interviewers located at all three sites received the same instructional procedure and followed the same research design and study protocol, including identical subject recruitment procedures and applying the same assessment strategy.</p><p>Potential study participants were presented with detailed information at each site outlining the purpose of the study and their rights as research subjects. Participants</p><p>were also told that their information was completely confidential; written consent was obtained from each participant prior to the start of the interview. All human subject and study protocol procedures for data collection received approval from the three respective institutional review boards.</p><p>Research Design --The CDSLAM project employed a mixed-design approach <ref type="bibr">(Green et al., 1989)</ref>, combining elements of both quantitative and qualitative research methods <ref type="bibr" target="#b41">(Creswell &amp; Plano, 2007)</ref>. Specifically, the study was carried out in two phases. The first phase involved focus group discussions (unstructured "group" interviews) that were used to engage club drug users in discussion about their consumption preferences. Focus groups are part of an exploratory qualitative (ethnographic) phase that provides in-depth information confirming special idiomatic expressions used to describe drug-related experiences and how individuals "think" about socially or culturally taboo subjects. 36 This ethnographic component of the study was done to acquire a better understanding of the subculture and the contextual factors that promote club drug use. The groups were audio taped and then transcribed, coded, and analyzed to develop an understanding of the thoughts, feelings, and behaviors described by the respondents <ref type="bibr">(Reich et al., 2006)</ref>. The findings from the focus groups were then later used to guide the development and/or refinement of the survey questionnaires used in the quantitative portion of the study.</p><p>The second (or quantitative) phase of the CDSLAM project involved psychometric evaluation, including establishing the reliability and validity of selfreported data pertaining to the potential abuse and dependence liability of each club drug. This phase also involved establishing the psychometric properties of various risk factors that have been suggested in the literature as putative causes of drug use and drug consequences. This phase began with a pilot study conducted in each site to determine the applicability, acceptability, and practicality of the questionnaires that have been developed and further revised based on the focus groups information.</p><p>The pilot study focused first on comprehension issues (e.g., clarifying terminology, and gaining insight whether respondents had difficulty answering and/or 36 Focus groups are a common practice in behavioral science and entail group discussion involving anywhere from 8 to 12 individuals who informally "chat" about some topic of interest. The topics are presented in order by a moderator or trained facilitator and the group discusses the topic from several different angles. Subject Recruitment --The CDSLAM study recruited out-of-treatment, community club-drug users in order to ensure a broad cross-sectional representation of the research sample. Given the difficulty in randomly (probability) sampling such a hard-to-reach, illicit-drug-using population, the CDSLAM sampling plan used a modified "non-probability" approach, combining "targeted" sampling <ref type="bibr">(Carlson et al., 1994;</ref><ref type="bibr">Watters &amp; Biernecki, 1989</ref>) with a "chain-referral network" or "respondentdriven" sampling technique that draws on the drug users' social networking familiarity <ref type="bibr">(Heckathorn, 1997)</ref>.</p><p>Both sampling methods have been widely applied to reach hidden or "hard-toreach" populations including drug users <ref type="bibr" target="#b76">(Heckathorn et al., 1999</ref><ref type="bibr">(Heckathorn et al., , 2002;;</ref><ref type="bibr" target="#b191">Semaan et al., 1998;</ref><ref type="bibr">Peterson et al., 2008)</ref>. Also, since the parent study emphasized establishing the psychometric properties of DSM-IV adopted criteria for club drugs use, it did not require validating prevalence information, making the applied sampling techniques appropriate. More importantly, the combined sampling procedures minimize as much as possible their respective sources of biases 37 and create statistically representative samples of hard-to-reach subjects <ref type="bibr">(Heckathorn, 2002;</ref><ref type="bibr">Magnani et al., 2005;</ref><ref type="bibr" target="#b165">Robinson et al. 2006;</ref><ref type="bibr">Salganik &amp; Heckathorn, 2004)</ref>.</p><p>Based on the combination of these two sampling methods, a number of distinct subject recruitment techniques were implemented to ensure diversity in the final sample. Recruitment efforts included posting and/or distributed flyers in public areas and locations frequented by young adults, including dance clubs and bars;</p><p>running advertisements in local newspapers; postings in high-school and college newspapers; internet postings on bulletin board systems, blogs and social network sites (such as "FaceBook" and MySpace); and referrals from the community.</p><p>Additionally, the study also used respondent-driven recruitment techniques <ref type="bibr">(Watters &amp; Biernacki, 1989)</ref>. Once the Time-2 interview was completed, recruited participants were asked to refer acquaintances and friends from their social networks.</p><p>An incentive of $5 was offered for each recruited referral.</p><p>Potential participants approached directly on the streets or referred to the study were briefly informed about the study aims and given a flyer providing them information on the CDSLAM project. The flyer included the local study-site phone number that participants were asked to call to find out more about the study and/or to confirm their willingness and eligibility to participate. During the call, a trained</p><p>Research Assistant (RA) verified the caller's eligibility and addressed relevant questions about the study.</p><p>To be eligible for enrollment in the quantitative study phase, participants in all three sites were required to be between 15 and 45 years old, and to have used at least one club drug (i.e., Ecstasy, Ketamine, GHB, and Rohypnol) more than five times lifetime, with the most recent use occurring within the last 12 months.</p><p>In addition to these study eligibility criteria, potential participants were also required to a) provide a signed parental permission for legal minors, younger than 18 years; b) have not participated in the study's prior focus group phase; c) be willing to take part in potentially three interview sessions within a 10 days period; and d) speak and understand English, as all interviews were conducted in English. Once eligibility of the prospective calling-participant was determined, a verbal consent was sought while on the phone and Time-1 &amp; 2 interviews were scheduled.</p><p>Study Protocol and Procedures --Figure <ref type="figure" target="#fig_3">3</ref>.1 below outlines the CDSLAM study protocol and "timeline" (i.e., flow chart) for the procedures and measurements used. The three study sites followed this same protocol for data collection with two non-essential exceptions to the current investigation. Specifically, St. Louis, the home-study site, had an additional ethnographic sub-study aimed to provide an indepth understanding of Ecstasy withdrawal and tolerance. In addition, Sydney participants were not tested for "Human Immunodeficiency Virus" (HIV) nor were they tested for other sexual transmitted diseases (STDs), such as Chlamydia, Gonorrhea, hepatitis B and C, Herpes and Syphilis. 38 As Figure <ref type="figure" target="#fig_12">2</ref> shows, the qualitative phase included three interviews: the two test-retest (reliability) interviews and an in-depth clinical (validity) or ethnographic interview. 39 For the reliability arm of the study, all confirmed eligible subjects were required to participate in at least two interview (Time-1 &amp; 2) sessions. After the second interview (Time-2), respondents were randomized to have either a clinical or an ethnographic interview. 40 At all three sites all of the interviews were conducted by independent interviewers.</p><p>Prior to initiating Time-1 interview, each participant was provided important details about the study, consented in writing, and informed that all information gathered are protected (using a NIDA Certificate of Confidentiality) and treated as confidential. 41 At that point, all participants were reminded that one of the aims of the CDSLAM study was to examine item-specific reliability of DSM-IV criteria as adopted for club drugs, based on their Time-1 &amp; 2 interviews. They were also told that the same questions are asked at both interviews and that the same answers could be given each time. Additionally, study participants were advised that they could 39 Reliability refers to the extent to which, if repeated, the same questionnaire leads consistently to the same answer. Validity, on the other hand, refers to the extent to which the questionnaire measures what it is supposed to measure <ref type="bibr">(Joppe, 2000)</ref>. 40 Randomization to the ethnographic interview applied to St. Louis participants only.</p><p>Participants in Miami and Sydney where only randomized to have the clinician interview.</p><p>41 Several steps were taken to assure the confidentiality of data, including deidentifying each individual record and storing the final data on a secure and privately managed server. Only research staff with the highest investigator clearance could access personal records (FaceSheet &amp; Contact data). All data were only accessible through password protected files and secure servers.</p><p>withdraw from the study at any time and that there would be no penalty or loss of compensation. Following a discussion of these study and other ethical issues, detailed locating information on each participant was solicited to facilitate mailing study reminders and/or tracking each one for follow-up (Time-2) interviews.</p><p>After gathering the locating information, urine and hair samples were Once Time-2 interview was completed, all participants were interviewed with the Discrepancy Interview Protocol (DIP) to determine the reasons for any differences in their answers at both times <ref type="bibr">(Cottler et al., 1994)</ref>. Immediately after completing the DIP interview, each participant was handed a sealed envelop concealing their random assignment to the validity portion of the study, including the clinical interview (referred to as Time-3 interview). In each site, only half of the participants were randomly selected and scheduled for a clinical appraisal. The other half were either told that the study was completed or invited to participate in a oneon-one ethnographic interview to discuss their experience with tolerance and withdrawal from club drugs. <ref type="foot" target="#foot_24">42</ref> The clinician (or Time-3) interview was conducted using a revised substance use section of the World Health Organization (WHO)</p><p>Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Either (the clinical or ethnographic) interview was conducted within the next four days following Time-2.</p><p>The clinician as well as the ethnographic interview took less than one hour each. After revisions, the selected assessments were computerized for ease of use Manual (DSM) for mental and behavioral disorders (WHO <ref type="bibr">CIDI, 1990)</ref>. The CIDI-Core questionnaire was intended to "serve cross-cultural epidemiologic and comparative studies of psychopathology" <ref type="bibr">(Robins et al., 1988</ref><ref type="bibr">(Robins et al., , p. 1069))</ref>. In field trail testing across 18 sites in major geographic regions of the world during 1988, the CIDI-Core was reported to be generally reliable and valid <ref type="bibr" target="#b215">(Wittchen et al., 1991)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interviews Setting and</head><p>However, certain symptom questions and diagnoses for substance use disorders (SUD) were reported difficult to understand, had less then ideal reliability, and therefore required further revisions for a better acceptability and consistency across cultures <ref type="bibr" target="#b215">(Cottler et al., 1991)</ref>.</p><p>The CIDI-SAM, which started as a revised version of the SUD sections of the WHO-CIDI <ref type="bibr">(Cottler et al., 1989;</ref><ref type="bibr">Cottler, 1990;</ref><ref type="bibr">Cottler &amp; Compton, 1993)</ref>, was soon expended to thoroughly assess psychoactive substance use, abuse, and dependence based on criteria for DSM-III, DSM-IIIR and ICD-10 diagnostic systems. Over time, the CIDI-SAM has undergone further refinement and expansion and started being referred to as the SAM (Version 4.1). In 1992, the SAM was updated to include DSM-IV SUD taxonomy; was subsequently computerized in 1998 (C-SAM); and field tested for validity in 2000 by its developer Dr. Cottler and her Washington University team with support from NIDA (DA05585) <ref type="bibr" target="#b82">(Cottler et al., 2000)</ref>. The C-SAM has also been used in numerous "nosological" (i.e., classification of SUD) studies in the U.S. as well as abroad and was deemed to be acceptable with good to excellent psychometric (reliability and validity) properties (see, for example, <ref type="bibr" target="#b40">Compton et al., 1996;</ref><ref type="bibr">Cottler et al., 1993</ref><ref type="bibr">Cottler et al., , 1995</ref><ref type="bibr">Cottler et al., , 1997</ref><ref type="bibr" target="#b83">Cottler et al., , 2001</ref><ref type="bibr">Cottler et al., , 2009;;</ref><ref type="bibr" target="#b82">Horton et al., 2000;</ref><ref type="bibr">Howard et al., 2001)</ref>.</p><p>Consistent with its parent interview format (the CIDI), the SAM is a highly structured instrument with closed-ended questions; each question included specific instructions for the interviewers. The SAM instrument contains five sections: Section A covers socio-demographic questions, Section B is reserved for questions relating to tobacco, Section C contains alcohol questions, Section D asks about drug use, and</p><p>Section E deals with caffeine.</p><p>More specifically, Section D assesses lifetime as well as current (in the past 12 months) abuse and dependence on substances and categories of substances used more than five times lifetime such as those defined by the DSM and ICD taxonomies. The RBA was designed to identify risk factors for HIV acquisition and perceptions of risk as well as belief in risk reduction behaviors). All questions pertaining to drug use practices and sexual behaviors refer to past 30-days period from the interview date to reduce "response biases" that could be attributed to inaccurate recall. The drug section covers also last 48 hours drug usage, corresponding to the approximate maximum time period during which urinalysis is sensitive for drug detection. The reliability and validity of the original RBA questionnaire has been thoroughly tested with favorable results. In particular, the drug-use questions have been found to have excellent test-retest reliability and good 44 Dr. Cottler and the EPRG team were one of several NIDA grantees on the CA study tasked with conducting a randomized intervention study (referred to as "Each One Teach One [EOTO], conducted from 1993 to 1999). The study focused on providing educational information on the risk of transmission of HIV and STDs among crackcocaine users and drug injectors in St. Louis <ref type="bibr">(Cottler et al., 1998)</ref>. Dr. Cottler was a member of the NIDA consortium of CA-funded researchers who developed the original RBA.</p><p>concurrent validity as demonstrated by the urine test <ref type="bibr" target="#b48">(Dowling-Guyer et al., 1994;</ref><ref type="bibr" target="#b51">Edwards et al., 2007;</ref><ref type="bibr" target="#b137">Needle et al., 1995;</ref><ref type="bibr" target="#b210">Weatherby et al., 1994)</ref>.</p><p>Over the past few years and in response to specific study requirements, Dr.</p><p>Cottler and the EPRG team at Washington University have made several revisions to the original RBA to increase its utility with female drug users, heavy drinkers, and offenders; as well as male and female inhalants users and club drug users. For the CDSLAM study the RBA was significantly modified based on the findings from focus group discussions (qualitative phase of the CDSLAM study) and refined later through several rounds of pilot-testing, as described earlier.</p><p>The RBA has always been used to enrich the data provided in the SAM, which serves primarily a diagnostic purpose. The RBA for Club Drugs (RBA-CD)</p><p>focused not only on HIV risk-taking behaviors, as they relate to drug use and sexual behaviors, but also on situations and events that could shed more light on the abuse and dependence liability of each club drug; such as bingeing, concomitant use of over-the-counter drugs (like 5HTP) to "come down," school or work performance, and parental monitoring history. Additional information on the reasons for drug use, rave party attendance, religion and music preferences, and perception of harms were also added. The original sections on IDU habits (needle sharing) and sex practices were replaced with more relevant questions about sex practices while under club drugs influence as well as sharing drugs at parties.</p><p>The RBA-CD assessment also included questions to gather a wide range of economic data; such as drug availability, dealer access and user network, lifetime quantity of each club drug used and other detailed information on past 30 day consumption, actual price paid last time using a particular drug as well as were interviewed, yielding slightly more than a 70% overall recruitment response rate.</p><p>Additionally, 5 (0.5%) respondents were eliminated for various reasons;</p><p>including relocation too far for staff to conduct cost-effective interviews, the participant withdrew from the study or was noticeably intoxicated on some substance during the interview. Among the remaining 644 surveyed respondents at Time-1, 4</p><p>did not have complete information on all the study variables needed for this investigation and were therefore eliminated, leaving a final analysis sample of 640 participants [296 (46%) subjects from St. Louis, 186 (29%) from Miami, and 158 (25%) from Sydney].</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement Specification</head><p>Data for the present modeling efforts were gathered from 83 questions that appeared in five sections (Socio-demographics, Ecstasy use, Ecstasy abuse and dependence, depression, and HIV-related sexual risk behaviors) of the three assessment batteries described earlier (SAM-CD, RBA-CD, and CES-D). All of the questionnaire items were used in the construction of measured indices (or multi-item scales). For some measures a single questionnaire item was used. When multiple indicators were used to reflect latent constructs, these indicators were generally constructed with several items averaged, or in some cases a summed unit-weighted index was created. The three different approaches to creating measures are briefly described below.</p><p>Ecstasy Use --Four measured indicators reflected a latent construct of Ecstasy "Consumption," one of the two main outcomes or dependent measures used in this study (labeled 'Ecstasy Use'). These included:</p><p> A measure of lifetime number of pills used [The RBA-CD asks (QNTYLT):</p><p>"If you were to add up all of the Ecstasy pills you have used since you first started using Ecstasy, about how many pills would that be?"], with response values recoded in increments of 10 pills ranging from 'Less than 10 pills' (coded as "1") to 'greater than 100 pills' (coded as "11");</p><p> Number of times using Ecstasy in the past 30-day period [The RBA-CD asks (TMSP30DAY): "How many days have you used Ecstasy or MDMA in the last 30 days?"], with responses coded in terms of total number of days used;</p><p> Frequency of Ecstasy use per day in the past 30-day period [The RBA-CD asks (FRQP30DAY): "During these days {when you used}, how many times a day did you usually use Ecstasy or MDMA?"], with responses coded in terms of number of times Ecstasy was consumed per day;</p><p> A measure of recency of Ecstasy use [The SAM-CD asks (RECENT): "When was the last time you used {Ecstasy}?"], with response categories ranging from 'within past 30 days' (coded as "1"), 'not in the past 30 days but during the last 12 months (coded as "2") to 'more than 12 months ago' (coded as "3").</p><p>Descriptive statistics revealed highly skewed distributions for the last two items (recent use and frequency). The data were accordingly transformed. Categories 2 and 3 for recent Ecstasy use were recoded to "0" to avoid sparse numbers in the cells. The frequency of Ecstasy use per day in the past 30-day period showed that responses ranged from 0 through 12, which was then truncated (due to low frequency of response for number of times greater than 4) to range between 0 and 4.</p><p>Ecstasy Dependence --Standard DSM-IV abuse and dependence criteria were used to mimic the diagnostic classification techniques used with other illicit drugs.</p><p>For this investigation, only the items reflecting dependence were modeled as the second outcome measure. <ref type="foot" target="#foot_26">45</ref> A latent construct of "Dependence" was assessed using the seven adopted DSM-IV diagnostic criteria. The criteria included: (1) tolerance,</p><p>(2) withdrawal, (3) increased use of larger amounts over a longer period of time than intended, (4) persistent desire or unsuccessful efforts to cut down or control use, ( <ref type="formula">5</ref>) "homemaker," "student," and "disabled." Based on sound judgment, these categories were reduced to dichotomous categories including: "Employed and having an income" (coded as "0") versus "Unemployed and not having a visible means of support" (coded as "1"). The measure of sources of income included 12 different response categories, which were further dichotomized into those representing legal means (e.g., paid job, welfare, social security, and alimony) coded as "0" and those representing illegal means (e.g., dealing drugs, prostitution, or sex) coded as "1."</p><formula xml:id="formula_0">great</formula><p>Reported earnings contained response categories in $5,000 increments, ranging from $0-3,999 through $25,000 and thereafter in $10,000 increments through $65,000, and then $65,000-$100,000). The index was reduced to a binary variable approximating the federal income poverty level (less than $15,000 for a family of three: Department of Health and Human Services, 2005) coded as "1" and those earning in excess of this amount coded as "0". The resultant 'Income Index' comprised of the four unitweighted composites assessed 'social anomie' and ranged from 0 through 4 with higher scores indicating participants with lower earning potential and experiencing economic displacement.</p><p>Another important measure of economic influence is the cost to acquire an illicit drug. In economics, such a cost is referred to as the "full price" which generally includes a monetary price paid for a unit of the drug purchased, a value of the time and effort spent to get the drug, and an expected cost for future health consequences as well as potential penalties for illegal use of psychoactive substances. In this study, only the first two components (unit price and time spent obtaining Ecstasy) were considered. <ref type="foot" target="#foot_27">46</ref> The unit price of Ecstasy (labeled 'Monetary Cost') was self-reported [The RBA-CD asks (UPRICE): "How much did you pay for one pill of Ecstasy the last time you bought it?"], with response categories recoded as 'under $10', '$10-$20', '$21-$30', and 'greater than $30'. These categories were then dichotomized to '$20 or less' coded as "1" and 'greater than $20' coded as "0". A latent factor of depression (labeled "Depression") was reflected by four five-item random parcels capturing the behavioral (e.g., "I talked less than usual"), somatic (e.g., "I did not feel like eating, my appetite was poor"), affective (e.g., "I had crying spells"), and cognitive (e.g., "I had trouble keeping my mind on what I was doing") components of depression. Random parcels represent an excellent means of preserving scale integrity, homogeneity, and capturing the underlying multidimensional structure of depression (e.g., Radloff, 1977; Bagozzi &amp; Heatherton,   1994; MacCallum et al., 1992; Little et al., 2002). Items were distributed evenly across the four parcels (CESD-1 through CESD-4) with consideration of content balance and reliability.</p><p>Additionally, we included a unit-weighted index of HIV sexual risk-taking Control Variables --The model also contained several exogenous measures to control for potential subject differences. These included demographic characteristics, including gender (male coded as "1"), race [White (coded as "1") and racial minorities and others (coded as "0")], age ['less than 21' (coded as "1") versus 'older' (coded as "0")], and education ['less than high school' (coded as "1") and 'beyond high school including vocation and technical education' (coded as "0")].</p><p>These subject characteristics were modeled into a single structural equations model and then further used to examine subgroup differences through more refined tests of moderation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Statistical Modeling Method</head><p>As previously stated, the present study applied Structural Equations Modeling (SEM) analyses to test the hypotheses regarding a psycho-economic model of Ecstasy consumption and Dependence. For this purpose, all statistical computations including model parameters estimation and fit indices were performed using the EQS 6.1 for</p><p>Windows statistical program <ref type="bibr" target="#b10">(Bentler, 2004)</ref>. EQS was specifically chosen for this investigation because it offers distinctive advantages, including its built-in robust statistics function to correct for non-normally distributed data (i.e., reducing Type I error in parameter estimates; <ref type="bibr" target="#b23">Byrne, 1994)</ref>.</p><p>Preliminary descriptive, bivariate correlation, reliability, and other standard statistical data analyses were carried out using the SAS  9.2 software package for <ref type="bibr">Windows (SAS Institute Inc., 2009)</ref>. The rest of this section provides the basic underlying principles behind SEM and describes how this statistical modeling procedure was specifically utilized in the analyses.</p><p>Basics of SEM ---The SEM technique has been in use since the early 1970s, but its origin can be traced back to 1904, when Charles Spearman first used "factor analysis" to identify common factors underlying the association among manifest indicators. Also, Sewall Wright made a substantial contribution in 1921 as he was credited with testing the first path model (with observed measures). Early historical reviews of the development of SEM have been provided by <ref type="bibr">Bentler (1986)</ref>, <ref type="bibr">Jreskog (1982), and</ref><ref type="bibr">Mueller (1996)</ref>. Economists have also adopted this approach <ref type="bibr">(Duncan, 1975;</ref><ref type="bibr" target="#b60">Goldberger, 1972;</ref><ref type="bibr" target="#b104">Kline, 2005)</ref>; however, SEM was "greatly misused" and "inadequately formalized" by economists very early on and never became a standard practice in causal economic modeling <ref type="bibr">(Freedman, 1987)</ref>.</p><p>In general, SEM provides a statistical tool for validating the psychometric properties of multi-item scales and also for testing causal multivariate processes. In the economic and social science literatures, SEM has been exclusively applied to analyze consumer behavior with regard to travel choice (see, for example, <ref type="bibr" target="#b63">Golod, 2001;</ref><ref type="bibr">Kim, 2008;</ref><ref type="bibr" target="#b155">and Rangaswamy et al., 2008)</ref>, decision making as well as participation in organizations and management <ref type="bibr">(Rosa Diaz, 2002;</ref><ref type="bibr">Salo &amp; Karjaluoto, 105 2007;</ref><ref type="bibr" target="#b190">Shook et al., 2004)</ref>. It has also been used to estimate the determinants and size of underground (hidden or shadow) sectors in the economy <ref type="bibr">(Brambila-Macias, 2008;</ref><ref type="bibr" target="#b43">Dell'Anno &amp; Schneider, 2009;</ref><ref type="bibr">Schneider, 2007;</ref><ref type="bibr" target="#b207">Vuletin, 2008)</ref>.</p><p>What is SEM? --SEM is a second generation, multivariate technique for analyzing theory-driven and complex interrelations among directly observable and latent variables in a predictive framework <ref type="bibr" target="#b18">(Bollen, 1989;</ref><ref type="bibr">2002)</ref>. SEM is widely recognized as a powerful model-building and theory testing methodology because it combines different aspects of various traditional multivariate statistical procedures including factor analysis, regression, and path analysis <ref type="bibr">(Cudeck, du Toit, &amp; Srbom, 2001)</ref>. Although these procedures have high utility individually, by integrating them together into a single procedure, SEM provides a superior statistical framework for testing and validating theories <ref type="bibr">(Bentler, 1978;</ref><ref type="bibr" target="#b104">Kline, 2005)</ref>. Lomax (1989) even suggested that SEM has been "the single most important contribution of statistics to the social and behavioral sciences during the past twenty years" (p. 171).</p><p>Typically, when elaborating SEMs, a researcher is required to specify a priori a given theoretical model <ref type="bibr">(Bentler, 1978)</ref>. The implied model is then tested against the sample data and evaluated with several absolute and inferential measures of fit <ref type="bibr" target="#b33">(Bentler, 1990;</ref><ref type="bibr">Bentler &amp; Bonnet, 1980;</ref><ref type="bibr" target="#b104">Kline, 2005)</ref>.  <ref type="bibr">Bentler, 1999;</ref><ref type="bibr" target="#b104">Kline, 2005)</ref>.</p><p>One other indication of model "fit" relies on an assessment of model "parsimony" or the ability of the specified model to account for structural relations with the fewest parameters <ref type="bibr">(Bentler &amp; Mooijaart, 1989)</ref>. The Law of Parsimony is achieved through an iterative process of model specification, estimation, and validation. are allowed to freely covary (restrictions can be imposed and tested against the more "relaxed" model). An observed measure can be posited to load on only one "factor" as with simple structure or allowed to load on more than one factor as with a complex factor loading. Errors that reflect variance net of prediction (a factor is hypothesized to predict the manifest variable) can also be correlated to represent "measurement or time-specific variance." These model modifications are made using empirical specification searches that can improve the overall fit of a model <ref type="bibr" target="#b33">(Chou &amp; Bentler, 1990)</ref>. Usually a researcher desires a more pure (and replicable) model so the simple structure approach without correlated errors is most commonly used.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What is the</head><p>In order to deal with problem of "identification," the latent variables are assigned a unit of measurement either by fixing the loading of a reference indicator to one or standardizing the factor variance. This provides a "metric" and helps identify Another significant feature of SEM is its ability to account for measurement error (or "noise") that occurs at the level of manifest or measured variables. This specific feature alone gives SEM an advantage over other simpler, relational modeling techniques (such as path or ordinary least-squares regression analysis), which assume that all variables are measured without error.</p><p>There is one other noteworthy feature of SEM that distinguishes it from other traditional modeling procedures (such as simultaneous [or system] equations [SE]).</p><p>Indeed, like SE techniques, SEM provides estimates for all direct and indirect effects based on theoretical specification of causal effects. Unlike SE however, SEM also estimates associations (non-directional relations) between dependent variables net of prediction and allows models to have correlated errors of measurement <ref type="bibr" target="#b18">(Bollen, 2002)</ref>. In other words, if there are several predictors and two dependent or outcome measures in an equation, SEM will estimate the effects of the predictors on both of the dependent measures and then estimate the association between the dependent measures net of prediction. This extra step provides a more accurate estimation of the model, drains meaningful variation from the covariance matrix, and provides a more optimal fit between the sample data and the implied population model. Related to this last point, SEM estimates the entire set of regression equations simultaneously. It can test whether one regression parameter is different (null model) from another as a whole system. In other words, SEM examines the entire architecture of the underlying relations in the model of interest rather than invoking a "straw-man" alternative <ref type="bibr" target="#b97">(Jreskog et al., 1999;</ref><ref type="bibr">Tomarken &amp; Walker, 2005)</ref>.</p><p>There are also several weaknesses associated with SEM procedures. SEM is mainly a confirmatory technique, which requires a priori theoretical specification of a model. Thus, a researcher must have a fairly good indication of the theoretical linkages (i.e., postulates, syntax, and axioms) before the model is tested. SEM does not compensate a researcher for a poorly generated model or unreliable constructs. In other words, SEM is highly recommended for theory testing in a confirmatory framework and not considered the optimal approach for testing preliminary models in their developmental stages. Overall, these limitations should not however decrease the importance of using SEM for this study. Their mention merely emphasizes the need for thorough knowledge of theory, a complete specification of the model, and a systematic process for analyzing and assessing the model results using the best psychometric tools available <ref type="bibr">(Bentler &amp; Mooijaart, 1989)</ref>.</p><p>Model Estimation and Testing Strategy ---Estimation of SEM proceeds in a systematic fashion. This process includes model identification, estimation, evaluation of fit, and then possible re-specification (i.e., fine-tuning) followed by estimation again <ref type="bibr">(Bollen &amp; Long, 1993;</ref><ref type="bibr" target="#b104">Kline, 2005)</ref>. Furthermore, SEM is a two-step procedure with the psychometric [confirmatory factor analysis (CFA)] part of the model tested prior to its structural component <ref type="bibr" target="#b1">(Anderson &amp; Gerbing, 1988)</ref>. Any changes in the CFA that provide insight to the psychometric properties of measures and latent constructs are considered prior to estimation of structural regression effects. This iterative process was thoroughly followed in this investigation. A description of the adopted estimation and evaluation strategies are presented next.</p><p>Model Estimation Procedure --The EQS approach to SEM analysis works by providing parameter estimates that minimize the discrepancy between the modelimplied population covariance matrix and the actual (observed) covariance matrix based on the sample data. In particular, the observed covariance matrix is assumed to be based on a random sample drawn from the entire population. EQS offers a number of estimation methods based on different fitting functions. These include fullinformation maximum likelihood (ML), weighted least squares (similar to ML under full data normality), and asymptotic distribution-free estimators (no distribution required) among others <ref type="bibr">(Bentler &amp; Wu, 1995)</ref>.</p><p>The ML estimation technique is the most commonly applied method for estimating SEM models. It proceeds iteratively and estimates all model parameters simultaneously. The ML technique has been shown to provide consistent, efficient (having minimum standard error variance) estimates, assuming multivariate normally distributed continuous variables <ref type="bibr">(Kline, 1998)</ref>. The EQS program provides several remedies for dealing with violations of normality (i.e., when data violate requirements for multivariate normality or when the underlying distributions of the data represent a mixture of categorical and continuous scales). The EQS program provides adjustments for non-normality, offering distribution-free estimation methods and statistical means to test for these violations <ref type="bibr">(Satorra &amp; Bentler, 2001)</ref>.</p><p>Additionally, EQS provides "robust" standard errors of the estimates to account for the extent of non-normality <ref type="bibr" target="#b10">(Bentler, 2004)</ref>. For all these reasons, the EQS ML method option was adopted for estimation of the models tested in this study.</p><p>Sample Size Requirement -Because the covariance structure (SEM) method of analysis is based on large sample theory, the correct sample size becomes an important issue for the estimation of stable parameter values <ref type="bibr" target="#b104">(Kline, 2005)</ref>. In particular, parameter estimates and overall  2 -test of model fit are sensitive to sample size. Therefore, the greater the number of free parameters specified in a model, the larger the sample size that is required to achieve a desired level of statistical power.</p><p>There is, however, a lack of general agreement about how large is large enough to obtain reliable model estimates. Some researchers have suggested a range of sample sizes for the use with ML estimation methods; including less than 100 observations defined as a small sample, between 100 and 200 as a medium size sample, and more than 200 as a large sample <ref type="bibr" target="#b104">(Kline, 2005)</ref>. Parameter estimates should be reliable and stable with small standard errors given the relatively large sample size of this study.</p><p>Other researchers have recommended a "rule of thumb" to determine the minimum sample size for SEM model. The rule stipulates that an adequate sample should include at least 10 to 20 cases (or observations) for each independent variable included in a model <ref type="bibr" target="#b71">(Hair et al., 1998)</ref>. Applying this rule, and given the number of independent measures, the psycho-economic model would require a minimum of 220 to 440 case; thus, the dataset we are using is more than adequate and sufficiently powered to detect effects. <ref type="bibr" target="#b34">Bentler (1995)</ref> has suggested using the number of estimated parameters rather than the independent variables for power computation. Following this suggestion, reliable estimates for the present model would require a sample size varying between 550 and 1100 observations. Since a saturated model will not be the goal of this analysis, the actual sample of N = 640 is determined to be adequate. Moreover, EQS offers test statistics to evaluate whether the size of the sample applied is appropriate <ref type="bibr" target="#b9">(Bentler &amp; Yuan, 1999)</ref>. The latter fully conditioned model was then re-estimated using empirical specification searches to capture any nonstandard effects (details on these methods are explained below) that were not hypothesized a priori. In light of the obtained mean differences based on race, age, education, and site we added these measures to the final model to examine whether obtained parameter estimates dramatically changed following their inclusion.  <ref type="bibr" target="#b84">&amp; Bentler, 1998)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Model Testing Strategy</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Goodness-of-fit criteria</head><p>In sum, this chapter presented the study methodology, including the methods for data acquisition and measurements formulation, as well as the statistical modeling approaches used. The chapter also introduced the basic tenets of SEM and outlined the principles of model estimation and the validation strategy adopted. These tools were fully implemented and the results are presented next.</p><p>47 Acceptance criterion for  2 /df varied in the literature, ranging from less than 2 <ref type="bibr" target="#b204">(Ullman, 2001)</ref> to less than 5 <ref type="bibr" target="#b188">(Schumacker &amp; Lomax, 2004)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CHAPTER IV: RESULTS</head><p>This chapter presents the results of the statistical analyses conducted. In order to integrate the voluminous material, the chapter is organized into three sections. The first section describes the demographic characteristics of the participants as well as their history of illicit-substance use and problems associated with drug use. This interrelationships among the latent constructs and also associations between constructs and measured variables <ref type="bibr" target="#b71">(Hair et al., 1998)</ref>. All of these preliminary factor-to-factor relations, these associations are disattenuated for error of measurement.</p><p>A second step included testing and refining the "structural model" (referred to here as the SEM). The SEM procedure assesses the fit of the hypothesized psychoeconomic model in the sample data against the implied population model. The SEM was tested in a stepwise manner, starting with the economic measures to derive their unbiased parameter estimates and then adding the psychological measures (i.e., Motivation) and other selected risk factors (i.e., Depression and sexual risk) in an incremental fashion until all the measures and constructs were incorporated. The final model-parameter estimates (standardized regression coefficients) are adjusted for all the variables included in the model. This forward "inclusion" procedure was chosen to arrive at an acceptable model and eliminate any potential confounder bias, spuriousness, and inconsistent effects <ref type="bibr">(Nachtigall et al., 2003)</ref>. The final and most parsimonious model was then used to examine possible gender as well as site differences. The suitability of a particular model was determined using several overall fit indices, including Chi-square ( 2 (df)), Normed Fit Index (NFI), Comparative Fit Index (CFI), Standardized Root Mean Square Residual (SRMR), Root Mean Square Error of Approximation (RMSEA), and the Adjusted Goodness of Fit Index (AGFI).</p><p>All of the CFA and SEM models were tested using the EQS software program for Windows Version 6.1 <ref type="bibr">(Bentler &amp; Wu, 1995)</ref>. The chapter concludes with a brief summary of the findings.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Descriptive Data Analysis</head><p>As previously described in the methodology chapter, this investigation used Participants' Demographic Profile ---Table <ref type="table" target="#tab_0">4</ref>.1 shows descriptive statistics for the total sample (N=640) and by site. A total of 46% of the participants were from St. Louis (N=296), 29% were from Miami (N=186), and 25% were from Sydney, When participants were asked to indicate their race (or ethnicity), 62%</p><p>(N=400) identified themselves as "White" (or "Caucasian"), 18% (N=113) selfidentified as "Hispanic," and 9% (N=55) classified themselves as "Black" (or "African American," all of these individuals were from the US). The remaining 11% of the sample (N=72) opted to choose "Other" as their racial designation. Included in the "Other" group, 30 participants (about 5%) were Asian and 42 (about 7%)</p><p>participants were from various ethnic groups, including 1 Alaskan Native, 2 American Indians, 6 Middle Easterners, 3 Pacific Islanders, 18 Biracial, and 12</p><p>Multiracial. The Pearson chi-square test indicated statistically different racial composition across the three sites,  2 (6)=296.4, p&lt;.0001. Indeed, while most Whites [N=343 out of 400 (86%)] were from St. Louis [N=217 (54%)] and Sydney [N=126 (31%)], nearly all of the Hispanics [N=102 out of 113 (90%)] were from Miami.</p><p>Table <ref type="table" target="#tab_0">4</ref>.1 also shows that 93% (N=598) of the participants reported they were "Never Married;" only 3% (N=19) were "Currently Married," and 4% (N=23) indicated they were "Separated," "Divorced" or "Widowed." Proportional tests of independence indicate no statistically significant differences for marital status across the three sites. This most likely resulted from the high proportion of "single" participants at each site (92%, 91%, and 99%, respectively at St. Louis, Miami, and Sydney).</p><p>When asked about their educational status 63% (N=402) of the participants reported that they received a "High School Diploma" or a "G.E.D." certificate, and 123 approximately 31% (N=196) indicated that they held a college degree ("Bachelor" or "Master" degree). On the other hand, only 42 participants (about 7%) had an "Elementary or Junior High" level of education. Participants' education was significantly different across the three sites,  2 (4) =15.25, p = .0042. There were relatively more college level participants in both Miami (39%) and Sydney (33%) than in St. Louis (24%). On the other hand, St. Louis had more participants that were high school graduates (69%) than Miami (57%) or Sydney (58%).</p><p>Participants were also asked to describe their "current work situation." For all three sites combined, 29% (N=187) of the participants reported they were currently working [Either "Working full-time (35 hours a week)" 17% (N=112) or "Working part-time (less than 35 hours a week)" 12% (N=75), not shown in Table <ref type="table" target="#tab_0">4</ref>.1] and 44%</p><p>of the total sample (N=280) reported they were students, including 143 participants who were "Full-time students and working part-time," 51% (N=29) were "Full-time students and working full-time" (10%), and the remainder, 39% (N=108), were fulltime students and not currently employed. The remaining participants consisted of 16% (N=100) that indicated they were "Unemployed or laid off and looking for work" and 11% (N=73) who were "Unemployed or laid off and not looking for work." Overall, the participants' current working situation was not statistically different across the three study sites.</p><p>Participants were also asked to add up all money they collected from all sources of income in the past 12 months and to report their total by income ranges or brackets. Not surprising, given the participants' somewhat youthful age and the high proportion that were students at all three sites (see Table <ref type="table" target="#tab_0">4</ref>.1), the distribution of a measure of their purchasing power (total income) was positively skewed. More than half of the sample (57% or N=365) earned less than $15,000 during the past 12 months period prior to their interviews. <ref type="foot" target="#foot_28">48</ref> The remaining 43% (N=279) earned substantially more money, including 38 participants (6%) reporting a total income of $45,000 or more. Specifically, the positive tail of the distribution included 16 participants (about 3%) (Not shown in Table <ref type="table" target="#tab_0">4</ref>.1) that reported total income between $65,000 and $100,000 or more. By contrast, the low income side of the distribution included 120 participants (19%) who reported total income less than $4,000 in the 12 month time frame. Moreover, there was a significant difference in the distribution of the participants' total income across the three sites,  2 (18)=38.75, p=.0031. While a majority (51%) of participants from St. Louis and Miami earned less than $11,000 a year and the rest of the participants had higher income stretching out to more than $100,000, participants from Sydney were more evenly spread out from the lowest income bracket "$3,999 or less" to the highest bracket "$45,000 or more."</p><p>Although not shown in Table <ref type="table" target="#tab_0">4</ref>.1, participants were also requested to indicate their sources of income over the past 12-month time frame from a list of 16 categories. The income question provided a response format indicating "Anything  <ref type="table"></ref>and<ref type="table">3)</ref> and<ref type="table" target="#tab_23">site (columns 4, 5</ref> and<ref type="table">6</ref>). Indeed, a vast majority of both female (84%) and male (75%) were younger than 21 years old when they first used Ecstasy. There was, however, a statistically significant difference between the ranges of age of onset for each gender,  2 (3)=8.92, p=.0304.</p><p>In particular, the distributions for age of onset indicate that females initiated their use of Ecstasy at a younger age than males. Participants also differed with respect to their age of onset across the three sites,  2 (6)=12.80, p=.0464. While the reported age of onset patterns for Miami and Sydney are quite comparable, individuals in the St.</p><p>Louis site began their use of Ecstasy at an older age than their counterparts in the other sites. One-way analysis of variance indicated significant differences in the mean number of years since Ecstasy was first used by study participants across the three sites, F(2)=7.99, p.001. Current Use of Ecstasy --In addition to their lifetime and past year Ecstasy use, participants were also asked "How many days have you used Ecstasy in the past 30 days?" The combination of past year and past 30 day pattern of use indicated that 42% (N=270) of the total sample used Ecstasy within the past 30 days, while 58%</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Years since First Ecstasy</head><p>(N=370) used it more than 30 days ago, but within the past 12 months. The distribution of current users was not statistically different for male (41% used Ecstasy within the past 30 days and 59% used it more than 30 days ago) and female (44% and 56%, respectively) participants. However, there were significant site differences in current use of Ecstasy,  2 (2)=117.33, p.0001. Specifically, participants in Sydney reported more recent use than those in St. Louis and Miami (79% vs. 30% and 31%</p><p>for the three sites, respectively).</p><p>Participants were also asked about the intensity of their Ecstasy use (number of times a day they used the drug) and the number of days they used Ecstasy in the past 30 days (frequency of use). Gathering information on quantity and frequency is consistent with previous studies seeking to clarify 'regular' and more moderate patterns of use <ref type="bibr" target="#b82">(Cottler et al., 2000</ref><ref type="bibr" target="#b42">, Degenhardt, Barker, &amp; Topp, 2003;</ref><ref type="bibr">Forsyth, 1996;</ref><ref type="bibr" target="#b201">Topp et al., 1999;</ref><ref type="bibr" target="#b183">Sherlock &amp; Conner, 1999;</ref><ref type="bibr">Riley et al., 2001)</ref>. The category of 'Regular' users was defined as those who take Ecstasy at least once a week on a regular basis (partying on weekends) and 'moderate patterns of Ecstasy use' was defined as taking one or two Ecstasy pills per occasion/episode. Based on these definitions, Table <ref type="table" target="#tab_0">4</ref>.2 shows the responses to the two quantity-frequency questions assessed among the 42% (N=270) of the participants who consumed Ecstasy within the past 30 days prior to their interview (hereinafter, referred to as "recent users").</p><p>Overall, recent Ecstasy users reported using the drug for an average of 2.81 days (SD=2.69), ranging from 1 to 15 days a month. There were no observed gender differences in the patterns of recent (30-day) Ecstasy use, as both males and females reported using the drug on average 2.80 days (SD=2.69). In contrast, there were significant site differences for the average number of days participants used Ecstasy, F reported taking it 1 to 3 days, whereas 26% (N=70) used the drug on four or more days (about once a week, on average) during the same 30-day period. This suggests that only one quarter of the current sample of users can be qualified as "regular users." Furthermore, there was no statistically significant gender difference in the days of Ecstasy consumption over the past 30 days (76% of male used Ecstasy between one and three days and 24% used it four or more days vs. 72% of female used Ecstasy between one and three days and 28% used it on four or more days).</p><p>There were, however, significant site differences in the number of Ecstasy use </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consumption Patterns of Other Substances ---Recent evidence suggests that</head><p>Ecstasy is used alone or in combination with other licit and/or illicit drugs <ref type="bibr" target="#b83">(Cottler et al., 2001;</ref><ref type="bibr">Wu el al., 2009)</ref>. To examine further the patterns of drug use habits in the current sample, CDSLAM participants were asked about their consumption of alcohol and a variety of other drugs. Self-reported prevalence rates of lifetime (more than 5 times) use of some of these substances among the study sample are reported in  Table <ref type="table" target="#tab_0">4</ref>.3 also shows that consumption of other drugs is quite prevalent in this sample. When asked about their use of other "club (or party) drugs," 34% (N=219) of the participants reported using Ketamine, 18% (N=112) used GHB, and 12% (N=76) used Rohypnol, all three examples of other popular "club drugs." There were, however, statistically significant differences by gender and site with regards to the use of each one of these drugs. Males were significantly more likely to report using one or more of these drugs than female participants,  2 (1)=14.36, p=.0002 (49% for males and 39% for females, respectively). On the other hand, with the exception of Ketamine, which was used by about a third of the participants in each site, more</p><p>Ecstasy users in Miami reported having used GHB and Rohypnol than those in St.</p><p>Louis and Sydney. Also, the participants' earliest exposure to any of these partydrugs was between the age of 19 and 20 years regardless of their gender or site, suggesting that Ecstasy was the first substance to be used among all four common club-drugs.</p><p>Measures of drug consumption also included questions about lifetime use of other illicit drugs from a list of nine commonly known drug categories <ref type="bibr" target="#b82">(Cottler, 2000)</ref>. Examination of the age-of-onset when any illicit drug was used in comparison to the age of first time use of Ecstasy revealed that only 14 (2%) participants started using Ecstasy before using other drugs. On the other hand, a vast majority (N=497, 78%) of the participants started using Ecstasy and other drugs at the same age. The remaining (N=129, 20%) participants started using Ecstasy after using a variety of other drugs. There was no significant difference by gender in the order of first use of drugs, as a large majority of both female and male were found to have used Ecstasy for the first time either at the same age (77% &amp; 78%, respectively) or a few years after using other drugs (20% of each gender). There were however significant site differences,  2 (2)=24.15, p&lt;.0001. Specifically, while about 85% of the participants in Sydney and Miami initiated their Ecstasy use before or at the same age they experimented with other illicit drugs, almost 100% of St. Louis study participants started using Ecstasy either at the same age or years after using various drugs.</p><p>DSM-IV Diagnostic Information ---Table <ref type="table" target="#tab_0">4</ref>.4 contains the lifetime substance use diagnoses for Ecstasy, alcohol, other club-drugs, and other licit and illicit drugs.</p><p>This information is based on diagnostic algorithms from the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition). Participants are asked a variety of questions about symptoms or problems that may result from their drug use. These symptoms are then clustered into "criteria" based on defined algorithms. The diagnostic results for Ecstasy use indicated that 25% (N=163) of the participants received no diagnosis, 15% (N=97) met criteria for DSM-IV "abuse," and 59% (N=380) of the sample met DSM-IV threshold (3 or more criteria experienced simultaneously within a 12 month period) for "dependence." Similar proportions were observed for female (23% no diagnosis, 13% abuse, and 64% dependence) and male (27%, 17%, and 56%, respectively) participants. There were also no significant site differences for diagnosis of abuse (17%, 16%, and 12%, respectively for St. Louis, Miami and Sydney), but there was a significant difference for diagnosis of dependence,  2 (2)=10.56, p=.0320 (66%, 63%, and 53%, respectively for Sydney, Miami, and St. Louis).</p><p>A diagnosis of "dependence" represents the most severe level of substance use disorder. In this respect, Table <ref type="table" target="#tab_0">4</ref>.4 shows that an overwhelming majority (N=520 or 81%) of the participants were diagnosed with alcohol dependence. There was no significant gender difference in diagnosis of alcohol dependence. There were, however, statistically significant differences by site,  2 (2)=9.00, p=.0111. Ecstasy users in Miami and St. Louis were found to be more alcohol dependent that those in Sydney, as 85% and 82% vs. 73% of the participants in those three sites were diagnosed with alcohol dependence, respectively.</p><p>Similar patterns where observed for dependence with other club-drugs as well as other illicit drugs. Although the prevalence of DSM-IV dependence was lower for "any other club drug" (i.e., Ketamine, GHB, and Rohypnol) (N=132 or 21% of the sample) than for "Any other licit or illicit drug" (i.e., marijuana, stimulants, sedatives, cocaine, heroin/opioids, PCP, hallucinogens, and inhalants) (N=573 or 90%), there were statistically differences by gender and site. More males were found dependent on "Any other licit or illicit drug" (24%) and "Any other licit or illicit drug" (92%) than females (16% and 86% for each group of drugs respectively). Additionally, more individuals from Miami were diagnosed as "other club drug" dependent (31%) than among participants in Sydney (17%) or St. Louis (16%). On the other hand, while the prevalence rates of dependence among Ecstasy users in Miami (92%) and St. Louis (90%) were very comparable, more participants were dependent on "other licit or illicit drug" in Sydney than their Miami and St. Louis counterparts (85%).</p><p>To summarize the descriptive information, the analyses indicated that although Ecstasy users in this sample were a homogenous group with respect to several key demographic measures, they differed across sites on numerous facets of their lifetime and current drug consumption patterns, including patterns of Ecstasy use and dependence.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Exploratory Data Analysis</head><p>Prior to empirically testing the proposed psycho-economic model, the raw data was further scrutinized for potential violations of the basic assumptions of multinormality and non-multicollinearity (or singularity) required for the maximum likelihood estimation procedure used for the SEM parameters estimation <ref type="bibr" target="#b5">(Bagozzi &amp; Yi, 1998)</ref>. Failure to address these two conditions may bias SEM parameter estimates, produce unreliable standard errors, and more importantly violate basic assumptions underlying the  2 statistic as a measure of overall fit the SEM <ref type="bibr" target="#b71">(Hair et al., 1998)</ref>. The results from this preliminary exploratory analysis are discussed in the present section.</p><p>Tests of Normality ---As a necessary, but not sufficient, condition for multivariate normality of data, the univariate normal distribution should be checked for each individual variable in the model. This was accomplished by examining the skewness and kurtosis as measures of central tendency for each observed variable.</p><p>Both statistics provide univariate point-estimates of deviation from normality. A common rule-of-thumb dictates that the skew should be within the range of -2 to +2</p><p>and the kurtosis should be within the range of -3 to +3 for a variable to be described as normally distributed <ref type="bibr" target="#b71">(Hair et al., 1998)</ref>. <ref type="bibr" target="#b104">Kline (2005)</ref> advocates that skewness greater than 3 in absolute value and kurtosis values greater than 10 in absolute value should be described as extreme non-normality conditions. In this study, the most commonly used rule-of-thumb required cutoff values within 2 range for skewness and 3 range for kurtosis.</p><p>Accordingly, the 85 separate questionnaire items were regrouped into five major conceptual domains: Demographics (gender, age, race, education, and site), Furthermore, it should be noted that, with the exception of three items (e.g.</p><p>'number of days used Ecstasy in past 30 days,' 'continued to use despite knowledge of potential problems,' and 'average time it would take to get Ecstasy'), the highly skewed or kurtotic variables were transformed and parceled into aggregate composites, as described earlier. Such practice of item parceling is often recommended to summarize a large number of homogeneous or conceptually similar variables and reduce the influence of their restricted variances <ref type="bibr" target="#b6">(Bandalos, 2002;</ref><ref type="bibr">Hau &amp; Marsh, 2004;</ref><ref type="bibr" target="#b115">Little et al., 2002)</ref>. In this study, parceling not only reduced the number of observed variables from 80 to 23 (making the model more parsimonious), but also resulted in more normally distributed measures than the original items.</p><p>Indeed, as shown in Table <ref type="table" target="#tab_0">4</ref>.5, the univariate skewness of each of the 12 created itemparcels varied between -0.68 and 1.59, while their respective kurtosis varied between -1.86 and 2.18, both of which are well within their acceptable (2 &amp; 3) ranges. The improvements in central tendency and close approximation of normality argued convincingly for using parcels and composite indicators without data transformations (e.g., logarithm, spline, square root, or inverse weighting) or deleting specious outliers <ref type="bibr" target="#b113">(Liang et al., 1990)</ref>. Furthermore, the EQS Maximum likelihood estimation procedure provides the Satorra-Bentler scaling corrections for the  2 -statistic (SB  2 )</p><p>to adjust for any overall bias in estimation from multivariate non-normality <ref type="bibr" target="#b34">(Chou &amp; Bentler, 1995;</ref><ref type="bibr">Satorra &amp; Bentler, 1988)</ref>.</p><p>In addition to the descriptive statistics, Table <ref type="table" target="#tab_0">4</ref>.5 also includes gender (fifth column) and site (sixth, seventh, and eighth columns) mean differences for all the observed items and scales used in the model estimation. Overall, the results indicate there were several gender differences. For example, female Ecstasy users were more likely to endorse the "adopted" DSM-IV Dependence Criteria for Ecstasy than males.</p><p>However, although females were more likely than males to endorse six out of the seven dependence criteria, only three out of the six mean differences were at an acceptable statistically significant level (p.05). The remaining three criteria indicated a trend (.05&lt; p  .10, not shown in Table <ref type="table" target="#tab_0">4</ref>.5) for females to indicate they experienced problems from their Ecstasy use. Also, with the exception of these noted differences in the "adopted" Ecstasyuse-disorder criteria, there was no consistent pattern in the observed gender differences. Gender had a significant effect on most of the measures lumped into the Economic Factors domain. Females were more likely to report being "unemployed, last 12 months," M F-M =.12, t=3.13, p=.002, and have a "total income below poverty level, last 12 months," M F-M =.12, t=3.09, p=.002. Males, on the other hand, were more likely to report that they "had an illegal source of income, last 12 months," M F- M =-.21, t=-6.04, p&lt;.0001.</p><p>Similar results were observed for the measures constituting the Psychological Factors domain. For instance, females were more likely than males to report getting Ecstasy "from spouse or partner," M F-M =.27, t=7.12, p&lt;.0001, and sharing it "with spouse or partner," M F-M =.10, t=3.16, p=0.002, while they were less likely than males to acquire Ecstasy "from dealing," M F-M =-.14, t=-3.77, p=.0002, or "as a payment for service," M F-M =-.16, t=-4.53, p&lt;.0001.</p><p>For the measures categorized as Other Risk Factors, males were more likely than females to report that they "talked less than usual," M F-M =-.15, t=-2.21, p=.0277.</p><p>Conversely, females were more likely than males to report that they "had crying spells," M F-M =.41, t=7.58, p&lt;.0001. Males and females also differed with regard to the Sex Risk domain. In particular, while males were found to be more likely than females to have "had 3 or more sex partners, in the last 3 months," M F-M =-.10, t=-3.56, p=.0004, females were more likely than males to have "ever experienced forced sexual contact," M F-M =.14, t=4.95, p &lt;.0001.</p><p>Taken together, the above findings suggested that male and female Ecstasy users may differ with regard to their Ecstasy consumption patterns and its consequences as well as over the behaviors that may place them at risk. However, it is unlikely these gender differences were preserved once aggregate scales were formed. As can be seen in Table <ref type="table" target="#tab_0">4</ref>.5, most of the composite indices employed in this study showed no statistically significant differences by gender. One exception is the psychological motivation subscale labeled "opportunity to get Ecstasy." This composite score was calculated based on four alternative ways to get Ecstasy other than paying money for it. Analyses indicated that males were more likely than females to report using three out of the four ways: "by stealing it," M F-M =-.03, t=-2.03, p=.0423, "as a payment for service," M F-M =-.14, t=-3.77, p=.0002, and "From dealing," M F-M =-.16, t=-4.41, p&lt;.0001. On the other hand, females more frequently obtained Ecstasy "for free" but not significantly more than males, M F-M =.04, t=1.34, p=.1797. As a result, males scored significantly higher than their counterpart females on the overall subscale, M F-M =-.30, t=-3.92, p&lt;.0001.</p><p>Table <ref type="table" target="#tab_0">4</ref>.5 also shows slightly more site than gender differences for most of the variables just discussed. As shown, there were some marked site differences in all of the consumption pattern measures. Participants from Sydney were more likely to report greater number of Ecstasy pills used lifetime than their counterparts from St.</p><p>Louis, M SL-SDY =-1.98, t=-5.10, p&lt;.0001, and Miami, M MI-SDY =-0.97, t=-2.30, p=.022, whereas Miami participants reported more lifetime number of pills used than those from St. Louis, M SL-MI =-1.0, t=-2.66, p=.008. Moreover, while participants from St.</p><p>Louis and Miami were comparable on the rest of the consumption measures, Sydney There was also a clear site differences in the prevalence rates of DSM-IV criteria for Ecstasy dependence. Overall, Ecstasy users from Miami and Sydney were more likely to endorse a greater number of symptoms of Ecstasy-use disorder than their counterparts in St. Louis, while users at the Miami and Sydney sites did not show striking differences for endorsement of Ecstasy-related symptoms. Among the most noted site differences, participants from Sydney were more likely than participants from St. Louis to report tolerance, M SL-SDY =-.12, t=-2.54, p=.0113, withdrawal, M SL-SDY =-.13, t=-2.93, p=.0036, spend a great deal of time to acquire, use, and/or recover from Ecstasy, M SL-SDY =-.14, t=-2.81, p=.0052, and reduce or give There were also significant site differences with respect to economic and psychological measures as well as in the levels of Other Risk Factors reported. More importantly, however, is the fact that these site differences appeared at both the item and composite score levels. Since only the aggregate indices (scales &amp; subscales)</p><p>were modeled in the SEM, the discussion will be limited from now on to these composite measures.</p><p>With regard to the economic measures, Sydney participants were at an advantage in terms of the resources available to them when compared to participants from St. Louis and Miami. Income (an index of social anomie), serving as a proxy measure of "purchasing power" or marginalization differed across sites. Ecstasy users from Sydney were more likely to be at a lower level of anomie than their counterparts in St. Louis, M SL-SDY =.22, t=2.04, p=.0421, and Miami, M MI-SDY =.18, t=2.0, p=.0513.</p><p>There was also no significant difference in the income index level between St. Louis and Miami sites. Additionally, substantial differences in the "monetary cost" (or unit price) per Ecstasy pill used were observed across the different sites. The unit price of a pill paid (in USD) in Sydney was significantly lower than the price paid in St.</p><p>Louis, M SL-SDY =.49, t=12.77, p.0001, and Miami, M MI-SDY =.85, t=29.20, p.0001.</p><p>On the other hand, the monetary cost per Ecstasy pill for Miami residents was significantly higher on average than the rate paid in St. Louis, M SL-MI =-.36, t=11.41, p.0001. However, Ecstasy was less likely to be available for users in Sydney than for their counterparts in both St. Louis and Miami. Sydney participants were found to spend significantly more time and therefore paid higher "opportunity cost" to acquire Ecstasy than those participants from St. Louis, M SL-SDY =-.18, t=-4.13, p.0001, and Miami, M MI-SDY =-.12, t=-2.41, p=.0163. No significant difference was found between the "opportunity costs" incurred by Miami or Sydney participants.</p><p>Findings were somewhat mixed when examining site differences for the components of the Psychological Domain. Overall, Ecstasy users from St. Louis were less likely to report Motivation for their consumption based on "opportunities to get</p><p>Ecstasy" than their counterparts from Miami, M SL-MI =-.19, t=-2.15, p=.0321, or Sydney, M SL-SDY =-.12, t=-1.84, p=.0448. Also, St. Louis participants reported significantly less motivation based on "places and/or people to get Ecstasy from" than those from Miami, M SL-MI =-1.05, t=-5.27, p.0001, and Sydney M SL-SDY =-1.07, t=-4.97, p.0001. There was however no significant differences in the reported "opportunities to get Ecstasy" or "places and/or people to get Ecstasy from" between Miami and Sydney participants. Additionally, all three sites did not differ significantly in their "specific motivation to use Ecstasy."</p><p>Table <ref type="table" target="#tab_0">4</ref>.5 shows significant differences in the reported depressive symptoms across sites. In particular, three out of the four CESD depression parcels suggest that Ecstasy users from Sydney tended to endorse significantly lower levels of depression than their counterparts from the other two sites. Specifically, Sydney participants were less likely to report behavioral depressive symptoms than participants from St.</p><p>Louis, M SL-SDY =.28, t=3.22, p=.0014, and Miami, M MI-SDY =.36, t=3.55, p=.0004.</p><p>Likewise, Ecstasy users from Sydney were less likely to report affective and cognitive depressive symptoms than those from St. Louis [M SL-SDY =.28, t=3.11, p=.0020, and M SL-SYD <ref type="bibr">=.34, t=3.46, p=.0006, respectively]</ref> or Miami [M MI-SYD =.23, t=2.31, p=.0215, and M MI-SYD =.39, t=3.61, p=.0004, respectively]. Conversely, no significant differences were found between St. Louis and Miami participants' scores for the same three depression subscales or for the fourth subscale tapping somatic depressive symptoms.</p><p>The proxy measure sexual risk captures individual differences in risk-taking and was comprised of 10 items. These items tap the propensity to engage in high-risk behaviors without planning or forethought including having sex without protection, multiple partners, having "forced" sex, and using drugs while having sex. Significant site differences were observed with participants from Sydney being more likely to were examined for the full sample. With very few exceptions, the Pearson's correlations and Spearman's correlations for each pair of variables were identical. For this reason, only the former [Pearson's product-moment correlation coefficients (r)]</p><p>and their corresponding level of significance are presented in Table <ref type="table" target="#tab_0">4</ref>.6. Also, because the correlation matrix is symmetric, only the upper triangle is presented.</p><p>Additionally, the table includes "Adjusted Item-to-Total Correlation," measuring the correlation of each item with the total construct score based on the rest of the items contained in the same domain. This latter statistic should be reasonably large in magnitude to indicate sufficient conceptual overlap between the components, with some unique variability as well.</p><p>As Table <ref type="table" target="#tab_0">4</ref>.6 depicts, there are overall small to relatively moderate but significant inter-correlations between all the variables selected for the model. In  Turning first to the measures of Consumption, the largest association was observed between times used per day in the past 30 days and recent use (r = .68) and the smallest association was observed between lifetime quantity and both number of days used in the past 30 days and recent use (r's = .26). Overall, the moderate associations between the different measures of consumption and the information from the adjusted item-to-total correlations (ranging from .53 to .70) indicate these different measures of use are likely tapping an underlying frequency/quantity dimension.</p><p>The inter-correlations between the seven indicators (i.e., DSM-IV diagnostic criteria) of Dependence were all positively correlated with one another and highly significant (all ps  .001). Their values ranged from a low of r = .16 to a high of r = .43, again reinforcing that the values were in the small to relatively moderate range and confirmed the absence of empirical redundancy. The adjusted item-to-total correlations were also moderate, ranging from a low of r = .30 to a high of r = .55, suggesting that each criterion measure is a suitable representation of the hypothesized latent construct.</p><p>Turning next to the economic measures, there are three measures including economic well-being or "social anomie" (labeled income index), "unit price" indicating how much is actually paid for an Ecstasy pill, and "opportunity cost", assessing the amount of time required to obtain and use Ecstasy. It was not expected that there would be considerable overlap between these items as they tap distinct economic facets driving drug consumption. Indeed, the inter-correlations between these items were very small in magnitude and none were significant. They ranged from a low of r = .01 between "income and opportunity cost" to a high of r = .09</p><p>between "income and unit price," and all of these associations were in the expected direction. In particular, the Pearson product moment correlation between unit price and opportunity cost was negative, indicating that users might have to search longer and expend more time traveling to obtain less expensive Ecstasy pills (The more time spent searching for Ecstasy, the higher the chance to buy it at lower price). The relatively small magnitude of association between the economic indicators supports the assumption of minimal redundancy among the three items (or measures) comprising this domain. Additionally, the adjusted item-to-total correlation for each of these measures was also small and further indicates there is no "latent" dimension underlying these associations.</p><p>A latent construct of Motivation from the "Psychological Factors" domain was hypothesized based on the assumed inter-relationships between four indicators:</p><p>"opportunity to get Ecstasy," "places/people to get Ecstasy from," "people to get/share Ecstasy with," and "motives to use Ecstasy." The correlations between these indicators were positive and highly significant (all ps.001). The absolute magnitude of these associations ranged from a low of r = .30 between "opportunity to obtain Ecstasy and motive to use Ecstasy" to a high of r = .62 between "people and places to get Ecstasy and "people to get/share Ecstasy with," suggesting a moderate amount of conceptual overlap but limited empirical redundancy. Adjusted item-tototal correlations were also within an acceptable moderate range from a low of r = .40 to a high of r = .63, reinforcing the hypothesis that there is some conceptual similarity within the four indicators that reflect an underlying "impetus" for consuming Ecstasy.</p><p>A latent construct of Depression in the domain labeled "Other Risk Factors"</p><p>for using Ecstasy was reflected by four indicators tapping "behavioral," "somatic," "affective," and "cognitive" symptoms. Inter-correlations between these four indicators ranged from a low of r = .59 between "behavioral and somatic" to a high of r = .72 between "affective and cognitive" and were significant (all ps  .001). The parcel containing affective symptoms was moderately related with both the indicator containing somatic symptoms (r = .70) and the one containing cognitive symptoms (r = .72). As far as benchmarks go, these values are respectively at the low end of the spectrum for "large" associations, suggesting that there may be a modest amount of conceptual overlap between the items used to construct these different indicators.</p><p>Adjusted item-to-total correlations ranged from a low of r = .71 to a high of r = .82, indicating considerable overlap between the indicators and the hypothesized latent construct of Depression.</p><p>Cross-Domain Associations --Overall, the cross-domain item-paired correlations [see highlighted (shaded) areas in Table <ref type="table" target="#tab_0">4</ref>.6] were generally small to moderate, but varied in magnitude, direction, and statistical significance, depending on the particular association that was examined. Relations between the three measures from the economic domain ["social anomie" (or income index), "unit price," and "opportunity cost"] differed with the indicators of the two outcome latent constructs (Consumption and Dependence). Specifically, most of the associations between the three economic measures and the four indicators of Consumption were moderately small, significant, and in the expected direction. The associations between opportunity cost and the four indicators reflecting Consumption were consistent in magnitude ranging from a low of r= .14 for recent use to a high of r = .22 for quantity lifetime and number of days used past 30 days. Next largest in magnitude were the relations between unit price and the four consumption indicators, ranging from a low of r = -.01 for lifetime quantity to a high of r = .21 for number of days used past 30 days. Relations between social anomie and the four consumption indicators were much smaller in magnitude with the exception of quantity (r = -.19), the remainder were all quite small and none was significant.</p><p>The relations between the economic measures and the dependence indicators were all relatively small and none were significant. The largest magnitude was observed between increased use over a longer period and opportunity cost (r = .10).</p><p>Only three of the possible 12 relations between economic measures and the indicators of motivation to use Ecstasy were significant, and all involved opportunity cost with "places and people to get Ecstasy" (r = .21), "opportunity to get Ecstasy" (r = .16),</p><p>and "people to get and share Ecstasy" (r = .14).</p><p>With few exceptions, associations between the indicators of Motivation and indicators of Consumption were modest in size and significant. The non-significant relations were between motives to use Ecstasy and all three measures of recent use (but not lifetime use). The magnitude of relations between the indicators of Dependence and Motivation were similar in size and only one ("continued use despite problems" with "opportunity to get Ecstasy") did not achieve significance.</p><p>Relatively speaking, the bivariate associations between the components of "Other Risk Factors" ("Depression" and "sexual risk") and the indicators of Consumption and Dependence were smaller in absolute size and there was no observable pattern in their signs. The relations between indicators of Depression and Consumption were quite small and none achieved significance. The same relations between indicators of Depression and Dependence, respectively, were considerably larger in magnitude and 14 of the 28 achieved significance. Among the significant associations they ranged in magnitude from a low of r = .11 between "cognitive symptoms" and "great deal of time spent in activities looking for drug" and r = .17</p><p>between "somatic symptoms" and "persistent desire or unsuccessful efforts to cut down" (all ps &lt; .0001).</p><p>On average the composite unit-weighted index of sexual risk-taking had a greater magnitude of association with indicators of Dependence compared to Consumption. The largest relation overall was between quantity (lifetime) and sexual risk (r = .20) and this was followed by "reduce or avoid important social, occupation, or recreational activities" and sexual risk (r = .15), both ps &lt; .001.</p><p>In contrast to these relatively small associations, sexual risk taking was more moderately associated with the indicators of Motivations. These associations ranged from a low of r = .16 for "motive to use Ecstasy" to a high of r = .30 for people to get/share Ecstasy with" (all ps &lt;.0001).</p><p>To summarize, the preliminary statistical tests contained in this section helped verify that the data comforts with the underlying assumptions of normality and the absence of multicollinearity required for robust estimation of SEMs. In particular, univariate measures of kurtosis and skewness indicated non-significant departures of the item and scale distributions from normality. Additionally, the moderate associations of items or indicators within certain domains supported the hypothesized latent constructs. In the case of the four measured indicators of Depression, the associations among these measures are moderate and consistent suggesting they tap an underlying tendency of participants to consistently report a wide range of somatic, behavioral, cognitive, affective problems they experience when they feel depressed.</p><p>Likewise the magnitude of association between items from the different domains, reinforces that the domains do not overlap conceptually and suggests there is a modest amount of conceptual "divergence" in the way these measures were constructed. Having established the suitability of the data using the traditional approach of item level of analysis, the next step proceeded with the multivariate analyses intended to examine the fit of the sample data to the hypothesized model.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">SEM Testing Results</head><p>This section contains two interrelated parts:  Dependence after all the effects of all exogenous predictors have been accounted.</p><p>When squared and subtracted from 1.0, these terms indicate the proportion of variance accounted for in the particular construct.</p><p>Empirical Analysis of the Hypothesized ---As mentio el that incorpo ned previously, the model testing procedure followed a two-step process recommended by <ref type="bibr" target="#b1">Anderson and Gerbing (1988)</ref>. The first step includes specification of the psychometric model. This portion of the model is used to ascertain if the latent constructs are statistically reliable and are hypothesized correctly in terms of their respective indicators. In addition, the CFA model provides a means to inspect the error-free correlations between the latent constructs, a procedure that would not have been available using exploratory factor analytic techniques <ref type="bibr" target="#b71">(Hair et al., 1998)</ref>.</p><p>The CFA model is then followed by a structural path regression mod The parameters in both the measurement and structural models were estima he Maximum Likelihood estimation (MLE) method for SEM provided in the EQS statistical program <ref type="bibr" target="#b34">(Bentler, 1995)</ref>. MLE has been shown to be robust especially in the presence of normality violations <ref type="bibr">(Newcomb &amp; Bentler, 1988)</ref>. Several statistics were employed to gauge the overall performance of each model. The large sample chi-square ( 2 ) statistic was examined to determine how well the estimated sample covariance matrix in the hypothesized model reproduced the population covariance matrix. As discussed earlier, Satorra-Bentler  2 -statistic (SB  2 ) was applied instead of the traditional  2 to adjust for any possible multivariate non-normality. A smaller  2 indicates a better model fit, and the corresponding shrinkage in  2 when contrasting nested models indicates superior fit as well. Several other commonly used goodnessof-fit indices that were discussed earlier were also used to evaluate model fit. These included the comparative fit index (CFI: <ref type="bibr" target="#b33">Bentler, 1990</ref>), the root mean square error of approximation (RMSEA: <ref type="bibr" target="#b120">MacCallum, Browne, &amp; Sugawara, 1996;</ref><ref type="bibr" target="#b197">Steiger &amp; Lind, 1980)</ref>, and the Adjusted Goodness of Fit Index (AGFI: Arbuckle, 1997). The benchmark or "threshold" level conventionally required for "acceptable" model fit using these statistical measures are: CFI  .9 (range 0 to 1.0), indicating how much variance and covariation is accounted for in the sample data by the implied population model, an RMSEA  .08 (where close to .05 indicates a good model fit), and an AGFI  .9 <ref type="bibr">(Bentler, 1992;</ref><ref type="bibr">Hu &amp; Bentler, 1998;</ref><ref type="bibr" target="#b96">Jreskog &amp; Srbom, 1996)</ref>.  The AGFI, which shows the relative am ed by the covariance matrix specified by the model after adjusting for the degrees of freedom, is .574 in the constrained model and .899 in the unconstrained model (higher values are better). The ratio of  2 /df for the unconstrained model is 3.80 whereas the same comparison for the constrained model is 16.95. In general, this ratio, as a gross measure of fit, should be closer to 2.0 (where &lt; 4.0 is acceptable).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results of the</head><p>Taken together, these findings provided ample evidence that the correlations between latent constructs are different from one. Therefore, the constrained specification of the measurement model was rejected. Although the unconstrained model provided a superior fit, it is worth pointing out tha 2001). t the  2 -statistic for the base model was statistically significant, implying poor overall fit of the model. This should not be unexpected when testing SEMs because the large sample  2 statistic is sensitive to sample size and does not adjust for model complexity <ref type="bibr">(Marsh et al., 1988)</ref>. It is well known that large sample sizes can have excessive Type I error rates <ref type="bibr" target="#b18">(Bollen, 1989;</ref><ref type="bibr">Browne &amp; Cudeck, 1989;</ref><ref type="bibr">Marsh, 1994)</ref>.</p><p>Thus, trivial deviations between the sample data and the implied population model will cause the model to produce a significant  2 statistic. <ref type="bibr" target="#b18">Bollen (1989)</ref>, among others <ref type="bibr">(Bentler 1992;</ref><ref type="bibr" target="#b23">Byrne, 1994)</ref> suggest using a modified version of this statistic that takes into account the sample size, such as the ratio of  2 points to the model degrees of freedom ( 2 /df). Therefore, while the  2 -statistic was significant, the relative (or normed)  2 was still within the acceptable threshold of less than 4 times the degrees of freedom established for this study,  2 /df =3.80 <ref type="bibr" target="#b188">(Schumacker &amp; Lomax, 2004</ref>; Ullman, Second-Order Factor Model --Even though the CFA findings indicated there was acceptable support for the unconstrained model, several of the goodness-of-fit indices ctor loadings corresponding to the first-order latent constructs Depres exceeded their respective benchmarks. In particular, both the RMSR=.08 and RMSEA=.06 exceeded the .05 threshold. There are several model modifications that can be used to "tighten" up a model and enhance its overall fit. One such modification involves testing a higher-order structure based on the moderate associations between the first-order latent constructs. In other words, this model posits whether a single "second-order" latent construct can statistically account for the moderate associations among the first-order latent constructs <ref type="bibr">(Gribbons &amp; Hocevar, 1998)</ref>. The fit of this model was adequate,  2 (148, N=640) = 559.245, p  .001 (or  2 /df =3.78), NFI=.876, CFI=.905, GFI=.922, AGFI=.900, RMSR=.082 and RMSEA=.066 but did not improve on the fit of the first-order model,  2 (2) = 4.115, p &gt; .05.</p><p>A careful examination of the second-order model findings shows that the standardized fa sion, <ref type="bibr">Motivation,</ref><ref type="bibr">Consumption,</ref><ref type="bibr">and Dependence were .265,</ref><ref type="bibr">.881,</ref><ref type="bibr">.430,</ref><ref type="bibr">and .724</ref>, respectively. Such a wide range of estimates indicates lack of communality shared among the first-order factors. As a result, the first-order factor structure with its freely estimated factor inter-correlations provided the best fit of all the alternative models tested. Importantly, implementations of any further model refinements (e.g., elimination of weak items or freeing cross-construct loadings) were reserved for a later point in the model testing procedure with the fully conditioned SEM.</p><p>Factor Reliability -The loadings of the various indicators on their respective latent constructs provide another indication of the suitability of the model. These standardized factor loadings indicate the "strength" of the observed measures as an indicator of the hypothesized latent construct. This provides, in many respects, an alternative means to assess the internal consistency (reliability) of the four latent constructs. The reliability of any indicator is defined as the square of its loading on the latent factor <ref type="bibr" target="#b18">(Bollen, 1989)</ref>. In other words, the loading of any item is the square root of its reliability. Ideally, for construct reliability, the factor loading estimates should be above .5 to be reliable. Furthermore, the product of factor loadings of any two items on the same construct defines their inter-correlation. Cronbach's alpha () is essentially an average of the inter-item correlations underlying a construct.</p><p>However, Cronbach's alpha assumes that the observed items are perfectly measured without error. In order to separate measurement errors from model structural errors, Werts, <ref type="bibr" target="#b211">Linn and Jreskog (1974)</ref> proposed instead an error-disattenuated (measurement-error-free) formula for computing alpha. A disattenuated coefficient alpha of .7 or higher is commonly recommended for an adequate internal consistency of construct.  <ref type="table" target="#tab_0">4</ref>.8. Table <ref type="table" target="#tab_0">4</ref>.9 contains the corresponding standardized parameter estimates for the different models tested in the sequence.</p><p>Economic Model --The first SEM examined the hypothesized economic compon st step the model include ent of the conceptual psycho-economic framework, using the three economic measures (income, opportunity cost, and unit price) as predictors of the latent construct outcomes (referred hereafter as the "Economic Model").</p><p>The Economic Model was tested in two steps. In the fir d the three independent economic measures (income index, monetary price, and opportunity cost) as predictors of Ecstasy Consumption only. Even though this model is considerably pared down from the hypothesized psycho-economic model (and not nested with any more complex or subsequent models), it provides an ce as a second endogenous constru ied correlations (both for the exogenous and endogenous parts of appear that lower income drug users search for lower Ecstasy prices. As a follow-up test, and as a means of testing for suppression (this also has been termed</p><p>'interpretational confounding' by <ref type="bibr">Burt, 1973;</ref><ref type="bibr">1976)</ref>, the Economic Model was also specified and tested just modeling the income index as a predictor of Consumption (essentially constraining to zero the effects associated with opportunity cost and price). This model also showed that neither unit price nor opportunity cost was "masking" the relation between income and Consumption. The estimated path coefficient maintained roughly the same magnitude, there was no reversal of sign, and the parameter was not significant, =-.036, p &gt; .10.  <ref type="table" target="#tab_0">4</ref>.8 and Table <ref type="table" target="#tab_0">4</ref>.9 under the heading of "SubModel 2."</p><p>The Psychological Model showed a fairly adequate fit,  2 (161) = 565.13, p 2 /df = 3.51), NFI = .877, CFI = .908, SRMR = .078, RMSEA = .063, and AGFI = .902. In particular, the  2 was large and statistically significant, and the  2ratio was lower than 5.0 but still larger than the acceptable level of 2.0 indicating superior model fit ( 2 /df = 4). With the exception of the NFI, the overall goodness of fit measures (CFI and AGFI) exceeded their critical thresholds of .90, but only slightly. Although the RMSEA was below its acceptable level, SRMR was just near its cut-off value of .08. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Goodness of Fit Measures</head><p>An examination of the standardized parameters estimated for this model (see  the  2 was statistically significant, the  2 /df ratio achieved an acceptable level ( 2 /df  4). Also, while both the CFI and the AGFI statistics did not clearly meet their required criteria (CFI  .90 together with AGFI  .90), they were still both well within their acceptable .90 range. On the other hand, the SRMR and RMSEA were both below their recommended benchmark of .08. Furthermore, the fully saturated structural model accounted for 22% of the variance in Consumption and 41% of the variance in Dependence (see Table <ref type="table" target="#tab_0">4</ref>.9).</p><p>To further assess the contrib logical measures to account for Ecstasy Use and Dependence, two additional models were directly compared with the Full Model (referred to in this test as "Parent</p><p>Model"), using the  2 nested difference test. The importance of the three economic factors (income, price, and opportunity cost) was tested first. In this test, the "Parent"</p><p>Model with its freely estimated parameters was compared to a structural model that constrained the paths corresponding to the economic measures to zero. This model essentially posits there are null effects for the economic measures when juxtaposed against measures of psychological risk and structurally nested with the Parent Model.</p><p>The nested comparison of these two models was significant,  The Revised Model with the addition of these paths fit the data reasonably well,  2 (200) = 607.70, p  .001 ( 2 /df = 3.04), NFI = .879, CFI = .916, RMSR = .07, RMSEA = .05, and AGFI = .932. Specifically, the  2 /df ratio was smaller and below the critical 4.0 threshold. All three relevant model fit indices met their joint critical thresholds of "good fit" (CFI  .9 together with a RMSEA  .08 or with an AGFI  .9). The Revised Model explained 24% of the variance in Consumption (R 2 = .237) and 43% of the variance in Dependence (R 2 = .428). At this point, there were no more post-hoc additions that reflected unequivocal influence of economic indicators on the endogenous components and the overall model change in  2 points was not appreciable enough to warrant inclusion of additional specific relations.</p><p>Simulation and Bootstrap Analyses -On the basis of the above findings (see Table <ref type="table" target="#tab_0">4</ref>.9), a bootstrap analysis was undertaken to determine whether the obtained parameter estimates were stable or consistent. Bootstrapping is a nonparametric method ue" (or population) values of the parameters and usually used for both inferential and descriptive purpose based on the datadriven sampling distribution of estimates <ref type="bibr">(Efron &amp; Tibshirani, 1994)</ref>. In this study, the bootstrap procedure consisted of re-sampling from the available data repeatedly and re-estimating the model parameters. One thousand random "bootstrap samples" with a subset of 500 observations each were drawn with replacement from the actual sample data. The model selection for these bootstrap simulations was the Full Model as it was the most conceptually relevant specification of the proposed psychoeconomic model. From the empirically estimated sampling distribution, the parameter mean estimates, standard errors, and the ratio of the mean parameter estimate to its standard errors were computed and reported along with the actual Full Model parameter estimates in Table <ref type="table" target="#tab_0">4</ref>.10.</p><p>The bootstrap approach assumes that the model is theoretically correct, but that the estimates drawn through re-sampling sample data are not precisely accurate.</p><p>They are approximation of the "tr given t ases) and also relatively small standard errors (this indicat he hypothesized model. The ratio of the mean parameter estimate and standard error functions as a t-test or critical z-ratio statistic indicating the significance of the estimate. It should be noted that for a good approximation of the "true" parameter value, the ratio should be greater than two (1.96 is formally the critical z-ratio limit for a two-tailed hypothesis test). Table <ref type="table" target="#tab_0">4</ref>.10 contains the results of the bootstrap procedure. Overall, the mean bootstrap estimates and the Full Model parameter values were very close with very trivial deviations (.001 in many c es the estimates are quite efficient). Across the 1000 replications, Motivation (t = 6.326), monetary cost (t = -5.167), and opportunity cost (t = 2.906) were the more consistent predictors of Consumption, while Motivation (t = 8.691), Depression (t = 2.250) and sexual risk-taking (t = -2.167) were the more consistent predictors of Dependence. The income index was not a consistent predictor of either endogenous constructs (Consumption or Dependence). Of particular interest was the parameter estimates for the association between sexual risk-taking and Ecstasy Use. The absolute value of this parameter was very small but between the sample and bootstrap model's flipped signs. Of the 1000 bootstrap simulation results, 58% of its values were positive and the remainder was negative perhaps indicating suppression.</p><p>Therefore, although the results from this bootstrap analysis confirmed that in general the parameters of the full hypothesized model were stable (and efficient) over the 195 1000 replications, variables such as income, Depression and sexual risk-could perhaps be dropped to improve the fit of the model. The Conditioned Full Model --The final step in the model testing procedure involved estimation of the Full Model with demographic control variables. Inclusion of these control measures was based partly on the findings from the earlier descriptive and variance decomposition analysis that had reinforced clear gender, age, and site differences in model variates. Usually, the best way to evaluate the influence of exogenous "control" measures requires splitting the sample for each variable and conducting multiple group comparisons. In the case of gender, for example, a sample variance/covariance matrix would be generated separately for male and female participants and various equality constraints tested across these models. However, splitting the sample would result in highly uneven groups for most of the control measures (particularly race, age, education, and site), the comparison would be highly underpowered, and strain the robustness of the statistical methods. An alternative approach is to dummy code the control measures (male=1, female=0) and add them to the "Full" model as exogenous control measures (their influence is treated as "covariates" and the model assesses whether these measures "condition" the parameter estimates).</p><p>Demographics Control -An initial conditioned model included gender (male coded as "1"), race (white coded as "1" and 'racial minorities' coded as "0"), age ('less than 21' coded as "1" '21 and older' coded as "0"), and education ('less than high school' coded as "1" and 'high school and beyond' coded as "0") to examine whether they dramatically change the model fit and its parameter estimates. A model specifying these control measures indicated a "decrement" in fit from the "Full" model previously reported,  2 (296) = 1063.19, p  .001 ( 2 /df = 3.59), NFI = .814, CFI = .849, RMSR = .07, RMSEA = .06, and AGFI = .895. Although the  2 /df was still acceptable ( 2 /df = 4), the remaining model fit indices did not met their joint critical thresholds (CFI  .9 together with a RMSEA  .08 or with an AGFI  .9). Also, of all the demographic variables added to the model only education marginally predicted Consumption ( = .10, p = .05). On the other hand, gender (male participants reported less problems than females,  = -.10, p  .05) and age (younger users reported more problems than older ones,  = .16, p  .01) significantly predicted Dependence.  The parent study also included economic, epidemiological, psychological as well as psychiatric diagnostic information thus providing a broad assessment of factors that may increase or decrease consumption. While individually these measures may be parts of other studies it is rare they are collected under the umbrella of a single study and with such extensive data collection on the same person. On ata were obtained several steps were taken to ensure their suitability for the proposed multivariate statistical analysis. These preliminary steps included extensive checks and data manipulations at the item level. Each item or measure was checked for normality using key indicators of central tendency such as skewness and kurtosis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Site Comparisons</head><p>In all cases, the variables met the recommended criteria and were deemed suitable for analysis. In addition, steps were taken to summarize the large number of variables available for analysis into a more manageable set. In most cases, items were unitweighted and summarized into composite scores, which were then subject to further analysis. When these procedures are used higher composite scores indicate greater risk.</p><p>The study also used latent-variable structural equation modeling techniques which is considered a gold standard in procedures for theory testing. This is because the goal of SEMs is to evaluate the concordance between sample data (variances and covariances) and an implied population model. The closer the "fit" between the hypothesized model and sample d model included in the model there were observed measures primarily assessing econom fit indices, allowing a researcher to discard poor or "ill" fitting models. Such procedures are the backbone of logical positivist themes in science and a major part of "falsification" <ref type="bibr" target="#b149">(Popper, 1959)</ref>. In addition to these considerations, the models also contained latent constructs hypothesized based on multiple indicators. Overall, this specification provides a wider net to assess behavior (more measures can be included in a single model), improves model precision by reducing measurement error, and increases statistical power.</p><p>Of the four latent constructs included in the SEM, two (Depression and Motivation) were specified as exogenous predictors and two (Ecstasy Use and Dependence) were specified as endogenous outcomes. This was in no way meant to infer "causation" but rather developed and tested to ascertain "unique" variance contributions in a predictive framework. This particular procedure offers another </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Overview of the Study Findings</head><p>The study was guided by three hypotheses. The first hypothesis concerned whether economic measures including income, unit price, and opportunity cost would directly influence Ecstasy consumption and problems from its consumption (or dependence), controlling for psychosocial factors and other control measures.</p><p>Findings showed that only two of the economic measures, unit price and opportunity cost, were efficient predictors of consumption. The magnitude of the path from price to consumption was slightly larger than the one ption. Income was not a determinant factor for Ecstasy use. On the other hand, only opportunity cost was a significant predictor of dependence.</p><p>crease significantly the overall proportion of variance et of measures. Finding showed that when specifie</p><p>The second hypothesis stipulated that psychological measures (e.g., motivation) and other intra-individual characteristics (i.e., depression and risk-taking) would influence both Ecstasy consumption and dependence, controlling for economic factors and other control measures. Findings showed that only motivation for drug use significantly influenced consumption and this was the largest effect overall in the model. In the part of the model predicting dependence, motivation was once again the largest effect overall, however, both depression and sexual risk taking were also significant predictor of problems from consumption.</p><p>The third hypothesis stipulated that the combination of adding psychological and economic measures into a model of drug consumption will improve the overall fit of the model and will in accounted for by each respective s d as predictors of consumption, the economic measures accounted for R 2 = 13.5% of the variance. When the psychological measures were specified as predictors they accounted for R 2 = 15.5% of the variance in consumption. When both sets of measures were simultaneously specified they accounted for R 2 = 21.6% of the variance indicating an increase in predictive variance. Also, when both economic measures and psychological risk are posited simultaneously, the regression coefficients from each respective domain diminish in size but did not lose their significance. In fact, there was an increase in the overall variance explained by each set of predictors.</p><p>tween the different domains of influen hological predictors.</p><p>Overall, the results confirms the proposed psycho-economic model of Ecstasy use and dependence to be a valid conceptual representation of the determinants of consumption as well as the consequences that may arise from continued drug use.</p><p>Notably, the economic measures were smaller in magnitude compared to the effects of psychological risk factors but still retained their overall significance. Of all the parameters modeled, motivation accounted for the most variance in the outcomes, attesting to the strength of internal psychological states as impetus for drug use and dependence. One way to think about the balance be ce is that while psychological factors might explain the "wanting" or desire to use Ecstasy, the economic measures facilitate or make this process possible. This study also confirms that, among the economic measures considered, Ecstasy users not only pay attention to price but they also pay attention to how much personal resources must be expended in order to procure the drug.</p><p>Although not specified as a main research hypothesis the same question regarding incremental variance can be posed for dependence. In other words, does the Next in size was the relation between motivation and consumption. Motivation taps into "so continued use of the drug created certain cial milieu" and the various anticipated enhancements from using Ecstasy that clearly point toward the social functions of using this drug. Ecstasy has been noted to be very popular among young adults who use the drug as part of their attendance at all night dance raves. The drug is also reported to increase feelings of interpersonal closeness and enhance sexual experience. Thus, it is not surprising that motivation and Ecstasy use were moderately related.</p><p>The correlation between Ecstasy use and dependence was somewhat smaller in magnitude but still reinforced that problem s that chronic use of drugs carries certain "risks" and can lead to s. Relations between motivation and depression and likewise between depression and Ecstasy use were smaller in magnitude perhaps attesting to the fact that mental health problems are not a prominent feature of the "drive" to consume this particular drug. The relatively small association between depression and dependence also reinforce impairment at many levels. The fact is that Ecstasy users reported feeling blue, sad, having suppressed appetite, trouble concentrating and feeling lethargic and these feelings were associated with tolerance, withdrawal, using more of the drug, not being able to cut down, spending a lot of time trying to get the drug, giving up activities to be further involved in drug use, and continued use despite problems (physical and psychological) from use. It should also be noted that one of the criterion for dependence includes continued use despite psychological problems, which may reinforce that there is a "self-medication" function even to Ecstasy use.</p><p>Findings from the Empirical Specification Searches ---The final model reflects all of the hypothesized paths that support testing the research hypotheses.</p><p>However, hidden in the data are non-standard relations that represent "true" variance but were not conceived a priori. To illustrate these relations, consider that the three economic measures were hypothesized to influence consumption and problems from consumption at a very general level. However, it is also possible that economic measures can account for predictive variance in one or more specific features of consumption (lifetime vs. recent use). These relations go beyond the factor ut not at determined variances and capture "specific" relations. Models testing these relations were restricted (restricted empirical specification searches) to the economic measures and the two outcome latent constructs (a broader search may have uncovered relations between psychological risk and consumption that are not theoretically defensible).</p><p>Overall six relations were added that "augment" the overall model fit (capture meaningful variance that was relegated to the residual matrix). One of these involved income and number of pills used in the past 30 days and another involved income and lifetime quantity. In all of the other models income was not a significant predictor of consumption. However, once a search mechanism was implemented that attempted to indicated that four of the parameters were unstable. These included the path from sexual risk-taking to consumption, income to both outcome constructs, and depression to consumption. These paths appear fragile and not likely to represent the true population model given they appear as null effects in the bootstrapping procedure.</p><p>There are many factors that can contribute to a fragile effect with randomly simulated samples. One thought is that these paths indicate activity for a subset of the where this predictive variance represents true behavior (e.g., some participants take sexual risks and this is related to consumption). The key features of sexual risk included frequency of various forms of sexual activity, age of onset for sexual behavior. For instance, there is evidence that personality disposi s that the drug user reduces both opportunity and monetary cost anyway they ca (younger age coded as greater risk), multiple sex partners, forced sexual contact, frequency of condom use, and having sex while under the influence. Providing an accurate count of these behaviors only pays limited attention to a host of underlying "motivations" tion (tendency to engage in deviant or unconventional behaviors) may encourage some youth to engage in sexual behaviors and there is evidence that drugs impair decision-making and lead to poor judgment, including using sex as a ploy to get more drugs. Drugs also have "aphrodisiac effects" and can relax inhibitions, a feature of Ecstasy that has been reported in the literature. On top of these suggested motivation for Ecstasy use, drug users often associate within a social milieu that inculcates liberal values and attitudes, and trading sex for drugs is generally not discouraged.</p><p>Given these explanations, an economist also might conjecture that trading sex for drugs relaxes certain budget constraints, allowing the individual to generate income or its equivalent to build addictive stock. The long and short of a 'rational' perspective i n. However strong these relations may be from a theoretical perspective, they are not reflective of the overall tenor of the behaviors in the sample. Only a few of the participants endorsed these behaviors and when examined from an aggregate statistical level, they were not sufficiently strong to represent a stable and consistent effect throughout.</p><p>symptoms. On the other hand, site factore earch behavio type of model requires While there was no evidence that age or gender factor into consumption practices, both influenced reporting dependence d into consumption but not dependence, indicating that market factors such as price and time spent locating drugs (or negotiating their price) may vary geographically. It also may reflect subtle differences in the drug "culture" at the different sites. These differences were also noted in the mean levels of consumption that varied by site, with Sydney participants reporting more consumption and cheaper drugs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Limitations of this Res</head><p>As with any secondary data analysis there are limitations associated with the research. The measures used were gathered for the purposes of a different study, emphasizing reliability and validity of diagnostic information and there were limited measures assessing economic matters. In addition, there was also a limited set of measures used to assess psychological risk for drug use, although this was the widest set of measures by far. Still, depression is one of several mental health measures that could be used to account for drug use; others would include anxiety, antisocial r, personality or thought disorders (i.e., psychosis or delusions).</p><p>In addition, the data were cross-sectional, which limits making any causal inferences. Inclusion of longitudinal data, where temporal precedence can be illustrates this problem well. The o terms because it is hard to specify whether consumption causes problems or conversely that certain problems lead to more consumption. Common sense would dictate that using more drugs leads to problems including run-ins with the law, family disputes, relationship turmoil with significant others, and so forth. In addition, there are medical considerations that may arise from overuse of drugs, and psychological problems that can go undetected including depression, anxiety, psychotic thinking, and identity disruption (drugs disrupt the acquisition of requisite skills during critical stages of development). However, a more careful look shows this repr simplistic. For instance, it is also possible that by becoming dependent on a drug, which includes physiological indicators of tolerance and withdrawal, a drug user increases his/her consumption to diminish or forestall these negative experiences.</p><p>two views is that tolerance is part of depend eir predictive validity. For instance, there was clear evidence that the Tolerance means taking more of the drug to obtain the same effect or to get "high." Economists generally consider tolerance as the result of prior drug consumption or what they term "addictive stock." In other words, past consumption is a predictor of future consumption because the individual builds up a "history" of drug use that reinforces and even guides future use. In the current model, tolerance was specified as an indicator along with several other "consequences" that are features of dependence. The difference between these ence, representing a compilation of multiple problems that may stem from consumption whereas in the RAM tolerance would have been a predictor of consumption.</p><p>Withdrawal, on the other hand, results because the absence of the drug causes a physiological (or cellular) response where the body demands more drug. During withdrawal, users experience headaches, profuse sweating, they become febrile, shake, and lose concentration, to name a few key symptoms. Again, problems that arise from continued use serve as the stimulus for more consumption. It would be problematic then, to specify these relations as 'causal' because more of the drug leads to more symptoms and more symptoms generate the need for increased consumption.</p><p>Here, a causal relation is at best tenuous and the better way to represent the relation between consumption and dependence it to allow them to freely associate.</p><p>In addition, some of the measures may not be adequate or reliable thus diminishing th latent hat the measure of income needs to be strengthened by additional informa lowered correla construct of consumption tilted toward "recent" use and diminished the importance of "lifetime" use. An economic view would posit that consumption should really reflect "addictive stock" and go further back in time to capture the full spectrum of use (i.e., lifetime consumption as a measure of cumulative use), rather than relying on a more recent window. One way to avoid creating a bifurcated construct would be to increase the valence of "recent" use items by splitting the construct into two measures, one capturing addictive stock while the other assesses more recent use (they may be correlated but not perfectly).</p><p>Income too can fall prey to this situation and limit predictive variance. One possibility is t tion. Future studies may want to include an assessment of family financial resources, weekly pay (using pay stubs), a wider network of alternative income sources, and information on the precise methods of purchasing drugs, and a breakdown of expenses for the individual. This will serve to cast a wider net on the measure of social anomie to include accepted measures of poverty (based on Federal guidelines) and other indicators that tap feelings of marginalization that can accompany low income status. A second important consideration that may have limited the role of income is that most of the participants earned relatively the same (given their youthful age), which restricted the variance for income and tions between income and other measures in the model.</p><p>wider set of measures (precis tance of the null when it is false. The alternative approach sought to establish whether gender and site Furthermore, there may be concerns that accompany categorization of measures used to form composites. There is some loss of information when a continuous measure is categorized, leaving open the possibility that some true and meaningful variation is lost. Notwithstanding this concern, dimensional approaches were used with four latent constructs. However, additional dimensional assessments would improve the overall psychometric properties and the ecological validity of the model. As stated previously, one suggested area of refinement would include improving the measure of social anomie to encompass a e quantification of government or family support) that capture a more "veridical" picture of young people's earnings.</p><p>Finally, although the sample size was considered appropriate for obtaining proper parameter estimates, it was near impossible to conduct multiple group comparisons given the sample would be less than halved in some cases. Doing so, in order to compare models by gender or site, would strain the robustness of these methods. This is because with increasingly smaller samples there is a corresponding increase in the size of standard errors with concomitant greater influence of sampling error. This would increase the probability of making a Type I error. In SEM, the significance of a parameter estimate is calculated by the ratio of the nonstandard parameter divided by its standard error. Larger error terms would reduce the likelihood of statistically significant findings and lead to accep "condit ially small, as was the ion" model results and conclude that the model findings are thus moderated by important demographic characteristics.</p><p>Although not necessarily a true limitation of the current study, some decisions were made in the model testing strategy that may influence the final results. For instance, a decision was made to leave non-significant paths in the full model. An alternative model testing procedure might drop the paths that did not achieve significance and re-estimate the model. One consideration is that the procedure of fixing paths to zero does ultimately "bias" the remaining paths, because this approach specifies a prior relation as "null." Offsetting this proposed change to model testing procedures is, however, the observation that when these effects are triv case with sexual risk taking and income, the resulting bias is typically small as well.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Implications of this Research</head><p>The findings from this study underscore the continuing need to better understand drug user's behavior. As stated earlier, drug use and its related consequences is complex and multi-faceted. In this study, multiple tests of the psycho-economic model were performed to examine whether a model combining key elements from economic and psychological theories can sufficiently explain Ecstasy consumption and its related problems.</p><p>One important finding of this research was that market indicators (income and price) play a crucial role in the decision to consume drugs. For other commodities d uniquely on market price mechanisms. In fact, in hat is not only illegal, but also whose continued use produces dependence, mand.</p><p>internal self-regulatory cues all have a larger effect o (licit drugs included), this finding alone would argue strongly for and provide support in the formulation of drug policy base creasing the price of illegal drugs has been considered as an important objective of the US drug and law enforcement agency. The logic behind interdiction was that reducing illegal-drug supply and providing economic aid to illicit drug producing countries would reduce the drug availability on the streets, increase drug prices, and therefore discourage consumption. So far however, such a strategy has not been very successful. More drugs are available now than ever before and the prevalence of use has continued to rise, especially among young adults. Such an outcome of a drug policy based uniquely on reducing supply surely proves that economic principles may be less relevant than thought. This is particularly true for a product t which translates into an inelastic de What this study does support is the contention that economic factors do have an effect on a drug user's decision whether or not to purchase a drug. However, economic factors are not the only factors that shape this decision. Other factors play a role as well. In particular, psychological factors, reflected by the ways people get Ecstasy, people from whom they get it, places they go to use drugs (raves, clubs, and bars), people they share drugs with, and n drug consumption than income and prices alone. Combining both economic is strange animal. It was also at that point that on blind friends and said "So, the queer animal is just like that." He then walked back to measures and psychological motivations augments the overall model and accounts for a larger proportion of variance than when either set is considered alone.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Conclusions</head><p>Allegories are figurative ways to represent meaning and truth. They take shape as literary stories, various forms of artwork including paintings and sculpture, and visual symbolic representations that convey something special about life and the human perspective. There is an allegory for everything, even scientific research. An appropriate allegory for the current study is the three blind men and the elephant <ref type="bibr" target="#b106">(Kuo &amp; Kuo, 1976)</ref>. One day, three blind men sat by the side of a road engaged in conversation. As they spoke one blind man said to the others, "I have heard that elephants are queer animals." He went on to add that his blindness prevented him from knowing whether this is true. It was then that all three blind men agreed they lacked the good fortune to know about th e of the blind men suggested that just feeling the elephant would satisfy his curiosity.</p><p>A merchant happened to be walking by with a herd of elephants and overhead their conversation. He offered them a chance to "touch" an elephant and satisfy their curiosity. He then helped each one of them to walk over to an elephant and touch it.</p><p>The first blind man reached out and touched the elephant's left leg and then his right.</p><p>He ran his hands over each leg slowly and then with a beaming face, turned to his l Ben gram manual. Los Angeles,</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ben</head><p>On the fit of models to covariances and methodology to the Ben Windows User's Guide. Encino, CA:</p><p>Ben ll vioral <ref type="bibr">Research,</ref><ref type="bibr">34,</ref><ref type="bibr">[181]</ref><ref type="bibr">[182]</ref><ref type="bibr">[183]</ref><ref type="bibr">[184]</ref><ref type="bibr">[185]</ref><ref type="bibr">[186]</ref><ref type="bibr">[187]</ref><ref type="bibr">[188]</ref><ref type="bibr">[189]</ref><ref type="bibr">[190]</ref><ref type="bibr">[191]</ref><ref type="bibr">[192]</ref><ref type="bibr">[193]</ref><ref type="bibr">[194]</ref><ref type="bibr">[195]</ref><ref type="bibr">[196]</ref><ref type="bibr">[197]</ref><ref type="bibr">25,</ref> </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>Economic Model of Ecstasy Consumption and related Consequences: A Multi-Site Study with Community Samples by Arbi Ben Abdallah Doctor of Philosophy in Economics Washington University in St. Louis, 2011 Professor Robert P. Parks, Chairperson</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>Epidemiology and Prevention Research Group (EPRG) at Washington University, School of Medicine, who directly or indirectly supported me and continuously encouraged completion of this timely and important research project. Lastly, and perhaps most importantly, many thanks and appreciation should go to my wife, Melinda, and my daughters, Miriam and Leila. All three have been a major source of support and encouragement along this long journey. Thank you, Miriam and Leila, for being patient and never complaining about me skipping several of your school or sporting events while spending numerous weekends in my office poring over drafts of my dissertation. My wife Melinda was exceptionally patient and very understanding. Thank you, Melinda, for picking up the slack while I was engaged in a seemingly endless task. The completion of my Ph.D. degree marks the start of a new phase in our lives. I look forward to enjoying all the new opportunities that lie ahead. vii xi LIST OF TABLES Table 4.1: Socio-Demographic Characteristics of the Study Sample .............................</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>Figure 2.1: A Conceptual Psycho-Economic Model of Ecstasy Use and Dependence ...</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3</head><label>3</label><figDesc>Figure 3.1: CDSLAM Study Flowchart for the Psychometric Testing Phase .................</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 . 1 :</head><label>41</label><figDesc>Figure 4.1: The revised conceptual Psycho-Economic Model ......................................</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 . 2 :</head><label>42</label><figDesc>Figure 4.2: Measurement model depicting four hypothesized latent factors. ................</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 4</head><label>4</label><figDesc>Figure 4.3: Final SEM depicting influence of both economic and psychological factors on Ecstasy use and dependence .................................................................</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc>Importantly, increasing rates of individuals seeking treatment for drug addiction [Based on data from the Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use &amp; Health (NSDUH) 2010 and Treatment Episode Data set (TEDS) 2009] coupled with a relatively high rate of illicit drug use 2</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc>whether a model accentuating market factors can account for illicit drug consumption. To address these and related concerns, the present study uses "nosological" 5 data obtained from the "Tri-City Study of Club Drug Use, Abuse and Dependence" [a National Institute on Drug Abuse (NIDA) funded study (DA14854-01, PI: Dr. Linda B. Cottler), referred to as CDSLAM]. Access to the CDSLAM tricity sample provided a rare opportunity to test a psycho-economic model of drug use with the largest to date out-of-treatment sample of Ecstasy users.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head></head><label></label><figDesc>characterized as young adults between the ages of 18 and 25. National prevalence data gathered from representative samples of secondary school students (i.e., Monitoring the Future (MTF): Johnston et al., 2010b), households (i.e., National Survey on Drug Use and Health (NUSDUH): SAMHSA, 2010b), and medical information based on drug-related emergency department visits [i.e., Drug Abuse Warning Network (DAWN): SAMHSA, 2009 &amp; 2010a], all indicate that is spreading to the rest of the population, including adolescents. In particular, drug surveillance surveys show estimates of past year initiates of Ecstasy use among Americans aged 12 or older peaking between 2001-2002 aced these "</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head></head><label></label><figDesc>since 1994 (from 253 to 5,542 in 2001), only slightly decreasing in 2002 (4,026, a non-significant change), then rising significantly every year to reach 17,865 in 2008 (DAWN: SAMHSA, 2009). Further, since 2004, there has been a continuous drop in perceived risk of harm associated with Ecstasy use among adolescents, suggesting few barriers to their future use (DAWN: SAMHSA, 2009). The high prevalence of Ecstasy use among secondary school students, coupled with the medical and psychological problems reported after both recreational and prolonged use, argue for increased research attention to t More importantly, rising prevalence rates and knowledge of existing cost structures suggest that regular Ecstasy users may not be sensitive to economic factors. Shedding light on this important research question, in itself, makes the contribution of the psycho-economic model even more compelling for empirical study. 4. Organization of the Study This dissertation is structured as follows: Chapter II provides a brief theoretical background of drug use and abuse with further discussion of addiction as it relates to the current research. This material is not meant to represent an exhaustive review of all existing addiction theories per se, but rather a fairly comprehensive overview of the major models of substance use and addiction, including the key economic and psychological models, and an evaluative review of the factors highlighted in the recent literature that are pertinent to the argument being made in this thesis. The conceptual model and hypotheses of this dissertation are elaborated and also presented in Chapter II. Next, Chapter III describes in detail the study data and methods, including the derivation and construction of measures used in the psycho-economic model as well as the statistical modeling procedures utilized to test the specific research hypotheses. Chapter IV presents the study results based on a series of latent-variable structural equation models, testing the unique and combined influence of economic and psychosocial measures of influence on Ecstasy consumption and related consequences. Finally, Chapter V discusses the study findings in detail, including their relevance to previous work, with specific attention paid to the implications of joining theoretical models and the limitations of the study.This last chapter also elaborates the application of the findings for drug prevention as well as treatment, and provides directions for future research. of concentrated studies indicate that there are multiple pathways to substance use and misuse. These pathways involve a host of risk factors, mechanisms, and contexts that foster the early stages of drug consumption. Many of the same risk factors, mechanisms, and contexts are also implicated in the processes leading to addiction. The same research literature shows that no one particular etiological factor provides the best explanatory mechanism overall to account for behavior. There is historical context for the varied arguments why people take drugs with family, cultural, and environmental factors that seem to contribute to the use and abuse of drugs.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head></head><label></label><figDesc>, a straight line with a single-headed arrow indicates a causal process where one variable or construct directly influences another. A curved line with a double-headed arrow indicates a correlation, or statistical association. Thus, the relationship between Dependence and Consumption is posited as a covariance (correlation) because causal relations between these two measures are at best complex. It is common to think of using more drugs as causing more problems, or that consumption will "drive" the dependence on the drug. It is also possible that by becoming dependent, which includes physiological indicators of tolerance and withdrawal, the individual increases his/her consumption to diminish or forestall these effects, i.e., Dependence fuels Consumption. Another criterion for Dependence is continued use despite psychological problems, leading to the same interpretation. A person's continued drug use increases their dependence but also increases their psychological problems. Based on this theory-driven conceptual model, the following hypotheses were tested: Hypothesis 1. Economic factors such as price and income will directly influence Ecstasy consumption, controlling for psychosocial factors and other control measures. Hypothesis 2. The psychological measures (e.g., motivation) and other intraindividual characteristics (i.e., depression and risk-taking) will influence both Ecstasy Consumption and Dependence, controlling for economic factors and other control measures. Hypothesis 3. The combination of adding psychological and economic measures into a model of drug consumption will increase significantly the overall proportion of variance accounted for by the full set of measures.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head>Figure 2</head><label>2</label><figDesc>Figure 2.1. A Conceptual Psycho-Economic Model of Ecstasy Use and Dependence</figDesc><graphic coords="75,117.60,402.24,389.28,231.84" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head></head><label></label><figDesc>dissertation study was facilitated by the oversight provided by Dr. Linda B. Cottler, Principal Investigator (PI) of the "Tri-City Study of Club Drug use, Abuse and Dependence" (CDSLAM). This federally funded study was conducted by research staff working at the Epidemiology and Prevention Research Group (EPRG), affiliated with the Department of Psychiatry at Washington University, School of Medicine.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head></head><label></label><figDesc>from reliability concerns as with any measure. The problem of accuracy in recall or measurement error is just one of the many factors that can influence self-report or interview data at any moment in time. The lack of total reliability introduces measurement error into the model that can be accounted for statistically. The standard approach to deal with these measurement problems is to a) use an appropriate statistical technique that combines information from multiple indicators, b) disaggregate the measurement error using techniques from classic psychometric theory; and c) create hypothesized latent constructs to account for the moderate association among the multiple indicators. Latent-variable Structural Equation Modeling (SEM) is one of several covariance structure techniques that can handle these measurement issues in a unified statistical framework. As detailed below, the SEM combines the strengths of confirmatory factor analysis (CFA) with multivariate structural regression. The confirmatory factor analysis represents relations between latent constructs and measured or observed indicators in a single measurement model. This portion of the model addresses how well we have conceptualized the latent factors based on the hypothesized model. The CFA provides "error-free" estimates of factor loadings indicating the magnitude of relations between an observed (manifest) indicator and a hypothesized latent construct. The model is specified in such a way that the factor loading represents true or shared variance (representing the overlap between several items) and a separate variance term indicates the error component. Following estimation of the measurement model, the structural equation portion of the model then provides estimates of the relations between latent constructs and also between measured variables and latent constructs in a single multivariate model. The structural component is unique in that it can estimate several multiple regressions simultaneously posting both independent predictors and dependent outcome measures (both latent and observed). Combining the measurement and structural portions of the model into a single overarching framework increases the reliability of the model, provides a more parsimonious way to represent the multiple relations, and increases power. For these reasons a latent-variable SEM procedure was used to test a psycho-economic model of drug use and abuse in this study.Having discussed the conceptual and methodological challenges faced by the current investigation and the appropriate resolutions, the next sections in this chapter present the research data used and the method of statistical analysis used to test a latent-variable psycho-economic model of Ecstasy consumption and addiction.2. Data Source and Concepts MeasurementThis section begins with a description of the parent study, the "Tri-City Study of Club Drug use, Abuse and Dependence" (CDSLAM). It includes formal discussion of the study design focusing on participants' eligibility and recruitment, survey instruments, research protocols, and data collection procedures. The section ends with a presentation of the measures used to test the psycho-economic model.The CDSLAM Study: An OverviewThe CDSLAM is a multi-site study funded in 2001 by the National Institute on Drug Abuse [NIDA, (R01 DA14584)],35 Generally speaking, the CDSLAM was designed to examine whether club drugs (i.e., Ecstasy, Ketamine, GHB, and Rohypnol) form a separate class of psychoactive drugs, requiring their own set of DSM diagnostic criteria. The DSM or "Diagnostic and Statistical Manual of Mental Disorders" currently in its fourth edition (DSM-IV), contains the official diagnostic nomenclature of the American Psychiatric Association(APA, 1994). Specifically, the CDSLAM was designed to 1) ascertain the utility of using the DSM-IV diagnostic criteria for each specific club drug, including tolerance, withdrawal, loss of control and other social and personal consequences; and 2) assess the reliability and validity of club-drug users' self-reported drug use practices and habits and any associated problems and consequences that stem from continued drug use. The CDSLAM study recruited out-of-treatment, club-drug users starting in November, 2002 to January, 2005. Participants were drawn from geographical areas indicated by NIDA's International Epidemiology Work Group (IEWG) surveillance network as "emerging or current high-risk areas" for club drugs (IEWG on Drug Abuse, 1999). Three sites were selected: St. Louis [Missouri, US; PI: Dr. Linda B. Cottler, Ph.D. -Washington University (data collection lasted between 2002 and 2004)], Miami [Florida, US; Co-Investigator (Co-I): Dr. Jim A. Inciardi, Ph.D. -University of Delaware (2002-2004)], and Sydney [New South Wales, Australia; Co-I: Dr. Jan Copeland, Ph.D. -University of New South Wales (2003-2005)].</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_15"><head></head><label></label><figDesc>interpreting questions) and the flow of the questions asked (e.g., problems with interview skip patterns). Members of the evaluating team [including the study PI,Co-  PIs, Project Director (or Coordinator), and interviewers (or raters) hired in St. Louis] took turns experimenting with the assessments by interviewing each other. Findings from this intense pilot test were subsequently used to revise and improve the computerized interviews.The computerized version of each assessment was carefully tested locally for contents (e.g., no spelling errors or missing survey items) and programming errors.Next, all the assessments were tested by conducting interviews with a small (5 to 10) number of drug users in each of the three sites for final pilot validation. The information gathered from this step was also used to correct or refine the final version of the computerized instruments. The revised questionnaires were finally implemented first at the home-study site, St. Louis, and then distributed to the other sites for their own data collections.The instruments for the CDSLAM project were administered to the same individual at two separate (about one week apart) occasions (referred to as "Time-1 &amp; Time-2" interviews or "test-retest"). A different lay interviewer was used at each time to provide estimates of inter-rater reliability (i.e., assessing the concordance of the interview process). A diagnostic validation component included a semi-structured interview that was later administered (Time-3) by a certified clinician. Additionally, the test-retest component included a short debriefing and a Discrepancy Interview Protocol (DIP) to identify the reasons for inconsistencies between the respondent's answers at Time-1 and Time-2 interviews. Tests of research hypotheses for the psycho-economic model rely on Time-1 interviews only.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_16"><head>Figure 3 . 1 .</head><label>31</label><figDesc>Figure 3.1. CDSLAM Study Flowchart for the Psychometric Testing Phase</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_17"><head></head><label></label><figDesc>collected from each participant in all three sites and analyzed for marijuana, cocaine, heroin, PCP, and methamphetamine. The urine samples from St. Louis and Miami participants were also tested for the presence of STDs. Additionally, oral fluid collection device, "OraSure  ," was used to test participants in St. Louis and Miami for HIV/AIDS and other STDs. All HIV tested participants received counseling regarding HIV infection and were given up to one hour of individualized pre-and post-test counseling, as required by the funding institute (NIDA). Following the collection of biological specimens, the Time-1 interview proceeded. A week later, each participant was invited back for Time-2 interview.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_18"><head></head><label></label><figDesc>Quality Control --All interviews were conducted faceto-face by trained interviewers and a certified clinician in private settings (study-site office building, mostly) and behind closed doors to assure privacy. In each site, recruited interviewers underwent a week-long formal training on the protocol and the study assessment tools. The training was conducted by a St. Louis team, including the Principal Investigator (PI) and the Project Director, in all three sites. After the group training, interviewers were required to pass a final quality control check (a "mock interview") prior to interviewing in the field. Throughout the project, interviews were audio-recorded and their electronic medium was mailed to the St. Louis site for quality and accuracy evaluation. At the start of the data collection, all audiotapes of each interviewer were reviewed in their entirety by an experienced Quality Control supervisor. Later on during the study, a random sample of 20% and then 10% of each interviewer's tapes were reviewed to ensure quality of the data. Feedback on each reviewed tape was immediately sent to their appropriate site for the local Project Coordinator to discuss with the interviewers. In addition, teleconference meetings involving all three sites were held on a regular basis during which the Project Director, and Coordinators discussed the project progress and site specific issues. Participants were remunerated up to $70 as a compensation for their time and inconvenience completing up to three (Time-1, Time-2, and clinical or ethnographic) interviews. Study Instruments --The purpose of the CDSLAM quantitative phase was to collect information about various aspects of club drugs consumption and related consequences. Five standard research questionnaires were selected to fit the study areas of interest, revised to focus mainly on club drugs, and evaluated in terms of their content, depth, sensitivity, and responsiveness as described earlier. The originally selected survey questionnaires were: The Substance Abuse Module (SAM), The Risk Behavior Assessment (RBA), The Center for Epidemiological Studies Depression Scale (CES-D), The Discrepancy Interview Protocol (DIP), and The WHO Schedules for Clinical Assessment in Neuropsychiatry (SCAN).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_19"><head></head><label></label><figDesc>and to minimize interviewers' mistakes. The first four (SAM, RBA, CES-D, and DIP) instruments were used for the test-retest interviews [or reliability (Time-1 &amp; 2)] while the fifth (SCAN) instrument was used by the study clinician during the validity interview session (Time-3). Data gathered for the current investigation were derived directly from Time-1 interview, using the SAM, RBA, and CES-D instruments only.The remainder of this section provides a brief history and a description of each instrument.Substance Abuse Module for Club Drugs (SAM-CD) -The SAM-CD was a revised version of a preexisting instrument known as the Substance Abuse Module (SAM:<ref type="bibr" target="#b83">Cottler et al, 2001)</ref>. The original SAM (CIDI-SAM:Cottler, 1990) was an expansion of the substance use disorders (SUD) sections of the Composite International Diagnostic Interview (CIDI Version 1.0,WHO 1987; Robins et al,   1988; Robins, Cottler &amp; Babor, 1990), which itself was an amalgamation of two preexisting instruments at the time: The Diagnostic Interview Schedule (DIS) developed at Washington University(Robins et al., 1981)  and the Present State Examination developed at the Institute of Psychiatry, London<ref type="bibr" target="#b213">(Wing et al., 1974)</ref>.43   The CIDI was initially the product of a collaborative effort led by the World Health Organization (WHO) and the former Alcohol, Drug Abuse and Mental Health Administration (ADAMHA) [parent agency of the three current NIH institutes, including: National Institute of Mental Health (NIMH), National Institutes of Alcoholism and Alcohol Abuse (NIAAA), and National Institute on Drug Abuse (NIDA)] to facilitate collaborative psychiatric epidemiologic research throughout the world. Robins and colleagues from Washington University led the Psychiatric Assessment Task Force effort in the development of the original CIDI(Robins et al.,   1988). The WHO-CIDI (CIDI-Core) is a fully-structured diagnostic interview designed for use by well-trained lay interviewers, who are not necessarily clinicians, to assess lifetime as well as current mental disorders according to the definitions and criteria established by the two most widely endorsed diagnostic systems: the WHO International Classification of Diseases (ICD) and the APA Diagnostic and Statistical</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_20"><head></head><label></label><figDesc>These substances include: cannabinoids (marijuana and hashish), cocaine and crack, hallucinogens (DMT, LSD, acid, mescaline, mushrooms, peyote and psilocybin), inhalants (glue, toluene, gasoline, paint and paint thinner), opiates[opioids (codeine,   Darvon, Demerol, Dilaudid, methadone, morphine, Percodan, and Talwin), opium, T's &amp; blues and heroin], PCP, stimulants (amphetamines, diet pills, Ritalin, or any other stimulant), sedatives (barbiturates, Librium, Seconal, sleeping pills, tranquilizers, Valium, Xanax, or any other sedative), and other miscellaneous substances (amyl nitrite, poppers, anabolic steroids, and nitrous oxide).The SAM for Club Drugs (SAM-CD) included additionally a specific category for club drugs with individual questions for Ecstasy (or MDMA), GHB, Ketamine, and Rohypnol. The SAM and its predecessors contain numerous questions about symptoms from the use of each specific drug. The nosological classification of DSM divides these symptoms into those operationalizing abuse and dependence. An example of an abuse symptom includes "getting into physical fights" whereas a dependence symptom includes "continued use despite physical health problems." To gain clarity on these conceptual distinctions consider that abuse (either symptoms or criterion) refer to functional impairment in day-to-day functioning with regard to role responsibilities (obligations of work or social functioning), legal problems, or disruption to home life.Dependence symptoms, on the other hand, are those reflecting physiological manifestations (withdrawal and tolerance) and continued use despite warning signs of psychological or physical health problems (this is only meant to exemplify the bi-axial formulation). According to the DSM classification rules, the individual symptoms are then bundled into aggregate clusters or "criterion," which is then used to make clinical diagnoses of abuse or dependence, the latter two categories used to define substance use disorders as a basis for understanding addiction.A distinguishing feature of the SAM is its ability to provide information regarding age of onset and most recent occurrence of each of the bundled criterion, as well as the individual withdrawal symptoms, and specific physical, social, and psychological consequences of each substance. This information is then used to estimate duration and course of the individual symptoms as well as to formulate the criterion. Coupled with this information, additional data on the quantity and frequency of use are then used to judge the severity and course of each disorder. The SAM also provides an evaluation of each respondent's substance use impairment and treatment history.Risk Behavior Assessment for Club Drugs (RBA-CD) -The RBA-CD was adopted from the Risk Behavior Assessment (RBA) questionnaire, which was originally developed by the National Institute on Drug Abuse (NIDA) in the early-1990s as a standard method for collecting HIV risk-taking data related to drug abuse and sexual behaviors at the community level(NIDA, 1991). The original RBA was first used in a NIDA-funded, multi-site study conducted during the 1990s entitled "Cooperative Agreement on AIDS Community-Based Outreach/Intervention Program" (CA). The study targeted out-of-treatment crack-cocaine and injection drug users and included 38 cities throughout the U.S.44   </figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_21"><head></head><label></label><figDesc>respondent's own expected price, employment, current income and other relevant information detailing sources of income. The RBA-CD has been found to have good test-retest reliability(Shacham &amp; Cottler, 2009).The Center for Epidemiological Studies Depression Scale (CES-D) -TheCES-D is a 20-item self-report scale developed by the NIMH based on previously validated scales for depression(Radloff, 1977). The CES-D scale covers several aspects of depression within the past week (last 7 days). The items include depressed mood, lack of concentration, feeling of guilt, sadness and worthlessness, crying spells, loss of appetite, and sleeping disturbance, among others. All 20-symptoms are scored on a 4-point scale, ranging from rarely to almost always and four items are reverse coded for scale consistency. Validation studies with clinical populations have established well defined total scoring ranges: less than 15, indicating no endorsement of major depressive symptoms; 15-21, mild to moderate depression; and over 21, indicating major depression. The CES-D has been extensively used as a screening tool for assessing current depressive symptomatology in clinical as well as research settings using general population samples. Several branches at the NIH have used the CES-D questionnaire in their large, multi-site studies of diverse populations due to its excellent psychometric properties among general population samples(Beals et al.,   1995;<ref type="bibr" target="#b61">Golding &amp; Aneshensel, 1989)</ref>. The CES-D has been shown to have very high internal consistency and adequate psychometric properties among youth and young adults.Interview-Time Requirements --Time-1 interview sessions required between two and three hours. The CD-SAM took approximately 60 minutes, the RBA-CD took a minimum of 20 minutes, and the CES-D about 10 minutes. In addition, each participant spent about 20 minutes on average providing locator information to facilitate tracking during follow-up interviews (Time-2 &amp; 3). It was also estimated that respondents traveled 30 minutes on average to get to the interview site.Participants in the CDSLAM quantitative data collection were able to receive up to a maximum of $120 U.S. dollars in monetary compensation for their participation in three different time period interviews. The incentive included compensation for assistance with recruitment.Study Sample --The use of multiple sampling techniques (described earlier) in combination with the PI's weekly-meeting monitoring-system for recruitment progress proved to be a highly effective recruitment strategy. A total of 1084 individuals from the community responded to the targeted outreach efforts (e.g., flyers, newspaper ads as well as electronic advertisements, to name a few strategies) and respondent's referrals. As was described above, an initial eligibility screening was performed over the phone. Of the 1084 subject contacts, 157 (14%) respondents were immediately found ineligible through the telephone screen. The remaining 927 callers were invited to enroll in the study upon a final in-house determination of their eligibility. At this point, an additional 9 respondents were eliminated. As a result, 918 individuals consented and were enrolled in the study across all three sites [439 (48%) subjects in St. Louis, 317 (34%) in Miami, and 162 (18%) in Sydney]. Out of the 918 enrolled respondents, 269 (29%) never showed up to their Time-1 interview and 649</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_22"><head></head><label></label><figDesc>deal of time spent in activities to obtain substance, use substance, or recover from its effects, (6), giving up or reducing important social, occupational or recreational activities because of substance use; and (7) continued use despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by the substance. Each one of these criteria (referred to in the model as DEP-1 through DEP-7) was coded as "1" if endorsed by the subject and as "0" otherwise.Economic Predictors --Three conceptually distinct measures of economic importance were created through data transformations including: income, unit price, and opportunity cost. An index of income status (labeled 'Income Index') consisted of work status in the past 12 months [The SAM-CD asks (WRKP12M): "In the past 12 months, how many months did you work for pay full time?"], sources of income in the past year [The RBA-CD asks (SRCINCP12M): "In the last 12 months, what were your sources of income?"], reported earnings [The RBA-CD asks (TINCP12M):"Considering all sources of your income, how much money did you make altogether in the last 12 months?"], and current employment status [The RBA-CD asks (CEMPSTS): "Which of these best describes your current work situation?"]. Sample work situation items included "unemployed," "working full or part time,"</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_23"><head></head><label></label><figDesc>Users' time spent procuring Ecstasy (labeled 'Opportunity Cost') was also self-reported [The RBA-CD asks (TIME2GETX): "If you wanted to get Ecstasy right now, how long would it take you to get it?"], with response categories coded in minutes, hours, days, and weeks. This measure assesses the cost of passing up other opportunities, which can serve as a monetary motivation in the drug user's decision process. Based on inspection of the resulting distribution of this cost measure, we converted all responses to a daily metric and then further refined it to a binary form representing 'a day or less' coded as "1" and 'greater than one day' coded as "0."Other Explanatory Measures --The possibility of spuriousness and confounding relations makes it important to control for psychosocial functioning in a model detailing the unique role of economic measures to account for variation in consumption. A latent construct of "Motivation" for Ecstasy use was reflected by indicators assessing opportunities for obtaining Ecstasy [The RBA-CD asks (WAYS2GTX): "We are interested in all the ways people get ecstasy, have you ever gotten ecstasy from ," with response formats including "spouse, family member, roommate, stranger, and dealer" then forming an additive index ranging from 0 to 5]; places to use Ecstasy [The RBA-CD asks (PLACES): "We are also interested in all of the places people take or use Ecstasy. Have you ever taken or used it in ," with responses including a myriad of places including rave clubs, bars, and fraternities, to name a few, which were dichotomously coded ('yes/no') and summed into an additive index); a unit-weighted index of people to share Ecstasy with [The RBA-CD asks (PEOPLE): "Have you ever used Ecstasy with ", listing different people including spouse, friends, roommates, dealer, to name a few]; and a unit-weighted index assessing various affect regulation and positive enhancement motives for using [The RBA-CD asks (MOTIVE): "have you ever taken Ecstasy for ," with response categories including "stress relief, bonding, pressure, spiritual experience, and curiosity," among others, which were all coded 'yes/no' (1/0) and summed].</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_24"><head>(</head><label></label><figDesc>labeled "Sex-Risk"), including dichotomously scored items ('yes/no' coded 1/0) assessing frequency of vaginal intercourse [The RBA-CD asks (EHADVSEX): "have you ever had vaginal sex?"], repeated identically for oral and anal sex; age of onset [The RBA-CD asks (AOSEX): "How old were you the first time you had sex of any kind?"], coded as 'younger than 15' (coded as "1") and 'older than 15' (coded as "0"); number of sex partners in the last three months [The RBA-CD asks (SEXPARTNRS): "In the last three months, how many different sex partners have you had?"], dichotomized as more than three sex partners versus less ('yes/no'); forced sexual contact with a dating partner [The RBA-CD asks (FRCDSEX): "Have you ever been forced to have sex with a dating partner?"], coded 'yes/no' (1/0); frequency of condom use [The RBA-CD asks (CNDMVP12M): "In the last 12 months, how often have you used a condom or other barrier protection when having vaginal sex?" which was repeated for oral and anal sex] with response categories coded as 'Never' (coded as "0") through 'Always' (coded as "4"), which were further divided into 'Never and Rarely' (coded as "1") and 'More Frequent Use' (coded as "0") (designating lower risk with more frequent condom use), and having sex under the influence [The RBA-CD asks (SEXUNDER): Having ever been under the influence of Ecstasy while having any kind of sex" ('yes/no')]. The sexual behaviors used to index drug users' risk-taking in this study are consistent with Center for Disease Control and Prevention (1991) guidelines for "high risk" activity related to HIV and other morbid conditions (STD).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_25"><head></head><label></label><figDesc>The idea behind SEM is to minimize the difference between the observed variance/covariance matrix based on the actual sample data and the implied or hypothesized population matrix. No one single fit index adequately determines the overall fit of a SEM model or its 106 correspondence with theory. Rather several fit indices are used to gauge model fit including the standardized factor loadings (determining how well the latent factors were hypothesized), the large sample chi-square test (minimizing the discrepancy function between the sample and implied population variance-covariances), and the magnitude of the off-diagonal residual covariances (indexing poorness of fit) (Hu &amp;</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_26"><head></head><label></label><figDesc>Structure of a Typical SEM Model? --A typical SEM contains two components: a measurement model detailing the psychometric properties of the various latent constructs, and a second component detailing the structural relations (regressions) between measures and latent constructs. The measurement component specifies relations between latent (unobservable or hypothetical) variables and their respective manifest (observed) indicators. Typically, this component corresponds to a confirmatory factor analysis (CFA) in which each latent construct is operationally defined by a set of measures and then the fit of this configuration tested. A measurement model can be specified in several ways, but usually the latent factors</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_27"><head></head><label></label><figDesc>the model and yields its measurement properties. From the CFA portion of the model a researcher can learn about the reliabilities of various measures and from the pattern of their inter-correlation with other factors or measures learn about their construct, divergent, and convergent validity. The structural component of a SEM expresses the hypothesized interdependence and causal relations between latent factors and in certain cases with other observed variables. This part of the model represents the simultaneous estimation of several regressions at once, including direct effects, indirect effects (mediated by intervening variables), and associations (or correlations) among both exogenous and endogenous variables (indicators or latent constructs). Depending on the desired specification, a structural regression model can be regarded as: a) saturated (where all possible relations are included), b) independent [no relations among measured variables or latent variables ([i.e., null model)], or c) constrained. A "constrained" model can be tested or contrasted with a more "relaxed" model that has fewer parameter constraints and the difference in model Chi-square ( 2 ) compared with the nested likelihood test (yielding the  2 difference per degrees of freedom). A final structural equation model may include parameters that are fixed (set at some designated value usually zero) and/or freely estimated. When the number of freely estimated parameters equals (or exceeds) the number of variables in the data, the SEM model is said to be "just identified" (or "over justified") [i.e., the model has a unique estimate (or more than one potential value) for each parameter]. What are the Strengths and Weaknesses of SEM? --There are a number of strengths and weaknesses associated with SEM techniques. Perhaps the most important and appealing feature of SEM, making it a perfect tool for these analyses, is its ability to model hypothesized latent constructs in a regression framework. The psycho-economic model includes four hypothesized latent constructs; including Ecstasy Consumption, Dependence, Motives, and Depression. Each construct is reflected by multiple indicators (and indicators are constructed from multiple items), thus creating a more parsimonious representation of the data and increasing power.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_28"><head></head><label></label><figDesc>--An initial CFA model tested the overall statistical reliability of the hypothesized latent factors (Consumption, Dependence, Depression, Motives). The psychometric model indicates whether the latent constructs were conceptualized correctly. In addition, the CFA model provided a means to inspect the error-free correlations among the latent constructs and between latent constructs and any measured variables. Following the CFA model we conducted a series of structural models that incrementally tested the effects of economic indicators first on Ecstasy Consumption and then on Dependence. Additionally, given the crosssectional nature of the data the relation between Dependence and Ecstasy Consumption was estimated freely as a correlation rather than estimating a causal effect. Subsequent models estimated relations between latent constructs of Depression and Motives and their prediction of Ecstasy Consumption and Dependence controlling for the economic predictors. This model is one of several in a series that tests the unique influence of economic indicators on the two endogenous constructs controlling for psychosocial risk. A "fully conditioned model" specified the contents of the previous model containing the two endogenous constructs (Ecstasy Use and Dependence) along with the predictor constructs (Depression and Motives), and added the observed measure of sexual risk and the economic measures.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_29"><head>-</head><label></label><figDesc>Evaluation of the fit of SEMs involves several model fit indices. One measure of goodness-of-fit, the discrepancy function or large sample  2 examines the difference between the observed and implied population covariance matrices. A non-significant  2 value (p &gt; .05) indicates the model fits well and there is very little residual covariation in the matrix after imposing the model on the sample data. As a measure of fit, the  2 is sensitive to large sample sizes and the complexity (degrees of freedom) built into the model. Under such considerations, the  2 measure has been shown to increase the risk of Type II error, or the probability of rejecting a true model<ref type="bibr" target="#b104">(Kline, 2005)</ref>. As a result, additional goodness-of-fit indices have been proposed that provide additional model fit information(Hu &amp; Bentler,   1998). These indices can be grouped into: 1) Measures of absolute fit [such as the chi-square divided by its degree of freedom ( 2 /df, also called normed  2 ), Goodnessof-fit index (measuring the overall degree of fit), and Root Mean Square Error Approximation (RMSEA: measuring an error in approximation; Browne &amp; Cudeck, 1993)], 2) Incremental fit measures [such as Normed Fit Index (NFI: comparing the proposed model with a null model;Bentler &amp; Bonnet, 1980)  and Comparative Fit Index (CFI: similar to NFI but incorporating degrees of freedom and non-centrality parameter evaluation for the both models;<ref type="bibr" target="#b33">Bentler, 1990;</ref> Benter &amp; Yuan, 1999)], and 3) Measure of parsimony [Akaike information criterion (AIC: a composite measure of badness of fit and complexity of the model;Akaike, 1987)]. For model evaluation the  2 /df, NFI, CFI, RMSR and RMSEA were applied in this investigation. Standard benchmarks for these model fit indices include:  2 /df less than 4 47 , NFI, CFI and AGFI with values between .90 and 1.0, and an RMSEA and RMSR less than .08 (Hu</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_30"><head></head><label></label><figDesc>descriptive material includes their lifetime use and current (past 30-days) patterns (quantity and frequency) of Ecstasy consumption. Differences in the sample characteristics, patterns of substance use and complications are also described by site and gender. Section two presents summary statistics for all of the variables used in the model, including measures of central tendency (i.e., mean standard deviation, skewness, and kurtosis). These descriptive statistics provide a means to check violations of normality assumptions required for conducting the covariance structure analyses. Additional information includes the results of variance decomposition of the key measures presented by gender and site. Additionally, Pearson product moment correlations between all the latent constructs and measured variables/indices used in the model were examined to check for multicollinearity, possible suppression, and confounding. Information from the correlation matrix was used to examine</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_31"><head></head><label></label><figDesc>data from a NIDA funded "Tri-City Study of Club Drug use, Abuse and Dependence," referred to as the "CDSLAM." The CDSLAM study was designed to examine club drug (including Ecstasy, Ketamine, GHB, and Rohypnol) use behaviors between 2002 and 2005 at three sites [St. Louis (Missouri, US), Miami (Florida, US), and Sydney (New South Wales, Australia)]. These particular sites were selected based on epidemiological evidence suggesting an increased incidence of Ecstasy use. The study's main eligibility criteria required that participants must have used Ecstasy more than five times in their lifetime, with the most recent use being within the 12 month period prior to the CDSLAM survey. The parent study included test-retest reliability (Time-1 &amp; 2) and validity (Time-3) components. For the present analyses, only Time-1 interview data was used. The selected sample was further limited to current Ecstasy users who had complete data for all the variables of interest to this investigation. The final analysis sample consisted of N=640 participants. This first section provides brief background information describing the study participants and their pattern of drug use, including their consumption of Ecstasy and other substances.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_32"><head></head><label></label><figDesc>Use --The number of years since participants used Ecstasy for the first time was computed as the arithmetic difference between current age and age of onset of Ecstasy use for each participant. Table 4.2 summarizes these results. The overall mean number of years since study participants first used Ecstasy was 5.3 years [Range = 1-25 years (not shown) and SD=3.21]. A total of 16% of the sample (N=103) reported using Ecstasy for 2 or less years, 32% (N=207) used it for 3 to 4 years, 27% (N=171) used it for 5 to 6 years, and 25% (N=159) used Ecstasy for 7 or more years. No significant gender difference was found for the mean number of years since participants first tried Ecstasy.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_33"><head></head><label></label><figDesc>outcome measures (measures used to reflect Ecstasy Consumption and Dependence), economic factors [income index (as a measure of social anomie), unit price of Ecstasy pill, and opportunity cost of acquiring Ecstasy], psychological factors (indicators of Motivation), and other risk factors [indicators of Depression and a composite of sex risk (measuring risk-taking)]. Within each domain, and when possible, the observed items were parceled into groups of theoretically related-items to form reliable scales (unit weighted "index" measures or composites), as already discussed in the methodology chapter. A summary of descriptive statistics (e.g. mean, standard deviation (SD), skew, and kurtosis) provided by SAS  UNIVARIATE procedure for all of the individual items and index scales used in the model (except for the demographic variables) are shown sequentially in Tables 4.5. Overall, the skewness and kurtosis values for a vast majority of the observed variables (80% or 64 out of the 80 items reported) fell within the commonly acceptable ranges, fairly suggesting univariate normality of the data. The exceptions included sixteen (20%) variables identified as having values(highlighted in the tables, using italic font and underlined) outside the desired firstorder moment ranges indicating low to moderate non-normality. Transformation (both logarithm and square root) of these items alone and in combination with the removal of outlier values did not substantially lower the magnitude of skewness and kurtosis for most of these variables. Thus, violation of the normality assumption may be caused by the true skewness reflected in the consistent response of the participants rather than from the contribution of distinct outliers.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_34"><head></head><label></label><figDesc>participants reported significantly more Ecstasy-use days in the past 30 days than those in St. Louis, M SL-SDY =-1.85, t=-8.19 and p&lt;.0001, and Miami, M MI-SDY =-2.02, t=-8.88, p&lt;.0001. Participants from Sydney also reported significantly more number of times they used Ecstasy in the past 30 days compared to St. Louis, M SL-SDY =-1.02, t=-11.27, p&lt;.0001, and Miami, M MI-SDY =-0.92, t=-7.90 and p&lt;.0001. Furthermore, Sydney Ecstasy users were more likely to be more recent in their use of Ecstasy than those in St. Louis, M SL-SDY =-.47, t=-11.10, p&lt;.0001, and Miami, M MI-SDY =-0.45 with t=-9.43 and p&lt;.0001.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_35"><head></head><label></label><figDesc>up social, occupational, and/or recreational activities because of their Ecstasy use, M SL-SDY =-.14, t=-3.09, p=.0022. Likewise, Ecstasy users from Miami were more likely than St. Louis users to report tolerance, M SL-MI =-.13, t=-2.84, p=.0047, to use Ecstasy in larger amounts or over a longer period of time than was intended, M SL-MI =-.11, t=-2.25, p=.0248, and spend great deal of time to acquire, use, and/or recover from Ecstasy, M SL-MI =-.14, t=-3.04, p=.0025. On the other hand, users at the Miami site were significantly different from only those in Sydney reporting withdrawal, M MI-SDY =-0.10 with t=-2.01 and p=.0454, and reducing or giving up important activities because of their use of Ecstasy beach, M MI-SDY =-0.10, t=-.2.05, p=.0409.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_36"><head></head><label></label><figDesc>particular, the inter-correlations between each pair of the indicators used to reflect the hypothesized latent construct Consumption were significantly positive (all ps.001), ranging from a low correlation value of r=.26 to a high correlation value of r=.68 which is moderate but still in the acceptable range to imply little redundancy among the observed measures. On the other hand, the adjusted item-to-total correlations for the outcome construct Consumption ranged from a low of r=.53 to a high of r=.70, suggesting satisfactory magnitude of associations for the indicators of Consumption.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_37"><head></head><label></label><figDesc>(1) steps taken to construct and refine the conceptual model; and (2) empirical analyses of the hypothesized model. Construction and Refinement of the Conceptual Model ---The research hypotheses address the potential importance of combining economic and psychological domains to predict Ecstasy Consumption and problems associated with consumption (labeled Dependence).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_38"><head>Figure 4 . 1</head><label>41</label><figDesc>Figure 4.1 The revised conceptual psycho-economic model</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_39"><head></head><label></label><figDesc>rates the findings from the measurement portion of the model. The structural model tests whether measures and constructs on the left-hand side (Figure 4.1) can ortion of the model was also tested in a series of integrated steps. T latent constru account for significant variance in the designated constructs on the right-hand side.This portion of the model is a direct test of the research hypotheses and provides a means to evaluate the unique contribution of economic measures to the outcomes and also their unique predictive variances when controlling for psychological measures (and latent constructs).The structural p he first structural model examined the effects of economic measures (income index, monetary cost, and opportunity cost) on Ecstasy Use. Conceptually speaking, this is termed the 'unbiased' model, because it provides a picture of whether the economic measures are even statistically related to Ecstasy consumption in a multivariate framework (when their contributions are considered simultaneously) in the absence of any other measures. The same model was then estimated with the addition of the latent construct of Dependence (and the association between the two endogenous constructs is also estimated). Specification of an association between disturbance terms for the endogenous latent constructs is appropriate for a crosssectional model where any efforts to infer causation would be at best tenuous.The next series of models in the sequence incrementally specified cts tapping Motivation, and then Depression, and this was followed by the inclusion of sexual risk-taking as predictors of Ecstasy Consumption and Dependence. This model retained the economic measures and addresses whether the economic measures maintain their predictive variance while controlling for the procedure, and in light of the obtained mean differen ted using t domain of psychological risk. At this point in the sequence, the model testing procedure included empirical specification searches to capture any nonstandard relations that were not hypothesized a priori. Nonstandard relations (sometimes called "uniquenesses") capture relations between measured variable predictors (i.e., economic measures or sexual risk taking) and indicators of endogenous latent constructs as well as indicators of exogenous predictor constructs and indicators of endogenous constructs. These were not part of the original model nor are they "theory-driven" but their inclusion can approximate the "true model"(MacCallum,   1986). Failing to include these associations would lead to model misspecification and produce a biased or poor fitting model. At this point in the model testing ces in the preliminary descriptive analysis, other control measures were added. These measures include gender, age, race, and education, and study site. Estimation of the models specifying demographic characteristics provides an opportunity to examine whether the obtained parameter estimates for the economic and psychological factors dramatically change with the inclusion of these controls. All of the control measures were dichotomously scored for comparison purposes [for site the comparison include the US (St. Louis and Miami combined) vs. Sydney].</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_40"><head></head><label></label><figDesc>Measurement Model ---As noted earlier, the CFA model consisted of 19 observed items (or indicators) used to measure four latent constructs: Depression, Motivation, Consumption (or "Ecstasy Use"), and Dependence. The first three constructs (Depression, Motivation, and Consumption) were measured by four different indicators each, while Dependence was reflected by seven indicators. A first-order factor structure was estimated to assess the statistical reliability of each construct and obtain the standardized loadings for the entire sample.First-Order Factor Model --In the first-order CFA, simple structure was specifie for the constrained and unconstrained models.The ba d allowing only one non-zero loading per factor and thus no cross-factor loadings (an indicator for Depression could not load on Motivation) and the latent constructs were allowed to correlate freely. This means all six relations between the four latent constructs were estimated without any constraints. After this model was estimated, a constrained model was tested that fixed the latent construct correlations to unity (r = 1.0). The constrained model (compared to the maintained or less restrictive model) assesses whether the relations between the constructs are "perfect" and there is total conceptual overlap (this provides a test of construct validity). The nested likelihood  2 difference test comparing the constrained to the less restricted or unconstrained model indicates the suitability of the constraints (i.e., whether the correlations are different from 1.0).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_41"><head>Figure 4 . 2</head><label>42</label><figDesc>Figure 4.2 Measurement model depicting four hypothesized latent factors.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_42"><head></head><label></label><figDesc>The next Economic Model specified Dependen ct along with Consumption and included the three exogenous economic indicators (referred to as "SubModel 1"). Model fit statistics (see Table4.8) also showed a less than optimal fit by several criteria,  2 (70) = 274.09, p  .001 ( 2 /df = 3.92), NFI = .875, CFI = .890, RMSR = .071, RMSEA = .068, and AGFI = .919. Of all three exogenous predictors (see Table4.9), "time spent locating Ecstasy" (i.e., opportunity cost) significantly predicted Ecstasy Use ( = .214, p  .001) and Dependence,  = .126, p  .01, while unit price (i.e., monetary cost) predicted Ecstasy Use,  = -.226, p  .001.Among the specif the model), the positive association between income and unit price remained intact (r = .085, p  .05) and as expected higher Consumption was associated with hological Model more reported problems from Ecstasy use (i.e., Dependence criterion), r = .30, p  .001. Overall, the economic component of the structural model explained about 14% of the variance of Consumption (R 2 = .135) and 12% of the variance in Dependence (R 2 = .117). The income index was not a significant predictor of either outcome predictive relations between the hypothesized noneconomic "Risk Factors" and the two endogenous outcome constructs: Consumption and Dependence. This model does not include the economic measures and also provides an opportunity to examine the influence of psychological risk on Consumption and Dependence. The domain labeled "Risk Factors" included psychological functioning (Depression), situational motivations to use drugs, and sexual risk-taking, the latter serving as a proxy of the Ecstasy user's risk taking behavior. This model was referred to as the Psychological Model. Results of this model are reported in Table</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_43"><head></head><label></label><figDesc>Specification of th --The next in the series of SEMs tested the influen ptable fit was obtained when the model included both the economic and psy ce of both the economic and psychological domains in fully saturated model (and predicting both latent constructs of Ecstasy Use and Dependence). Estimates of the "Full Model" path coefficients were derived in an ordered sequence, starting with the Economic Factors (income index, monetary price, and opportunity cost) and adding incrementally the three risk factors (Motivation, Depression, and sexual risktaking). Running the model incrementally helps to identify problems with convergence and optimization as well as detect any suppression. The sequential nature of model testing also provides a means to compare the direct effects of each risk factor from a specific domain before and after controlling for measures from other domains. An acce chological components,  2 (206) = 671.23, p  .001 ( 2 /df = 3.26), NFI = .860, CFI = .898, SRMR = .071, RMSEA = .059, and AGFI = .897. Despite the fact that ution of combining key economic and psycho model that constrained these paths to zero.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_44"><head>Figure 4 . 3</head><label>43</label><figDesc>Figure 4.3 Final SEM depicting influence of both economic and psychological factors on Ecstasy use and dependence (Only significant paths are showing).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_45"><head></head><label></label><figDesc>Many people use Ecstasy to electrify their sexual experiences, hoping the drug will open portals of perception during physical contact. This has led several writers to coin the phrase e drug." Considerable field work now shows that many young people use Ecstasy in combination with other substances while attending raves, all night dances held in large open spaces or warehouses where they can experience the constant grind and rhythm of music. The effects of the Ecstasy can last several hours. Both laboratory and naturalistic studies of Ecstasy users indicate serious medical and psychological complications from even limited use. Side effects inc ng, racing heart and elevated pulse, some cognitive impairment including memory loss, and potentially harmful and often irreversible bodily effects. Special Features of the Data ---There are several strengths to the data used for this research that should be noted. First, the parent NIDA-funded study (CDSLAM) secondary analysis provides a cost-effective opportunity to examine the utility of DSM-IV diagnostic criteria for substance use disorders and their extension to club drugs, including Ecstasy use. As a result, extensive self-report information was collected that detailed the prevalence and patterns of Ecstasy consumption including consequences that arise from use and factors that regulate its consumption. Second, participants were extensively probed regarding their consumption patterns of not only Ecstasy but other licit and illicit drugs. This included their use and the effects of club drugs other than Ecstasy and what factors may have prompted their drug involvement. Fourth, participants were also asked questions about whether they engage a wide range of other high risk behaviors that may relate to drug use. The ability to collect such extensive and rich data and conduct bout drug etiology (and test the psycho-economic model) without expending large financial resources to collect the information needed for this study.Furthermore, the parent study was conducted by a team of highly respected and well qualified researchers, guided by Dr. Linda Cottler and the EPRG group. This led to the development of excellent and reliable measures, as well as strict adherence to research protocols, minimizing any bias in the data from uncontrolled sources. The data was also obtained from areas that had been identified by epidemiological surveillance methods with indications of high prevalence for Ecstasy use. d from a relatively youthful community sample of drug users (mean of 23 years), all of whom reported both lifetime use and current (recent) drug use patterns. come). The sample Additionally, the participants were not involved currently with drug treatment and they voluntarily consented to provide their information. This makes it more likely that the information they provided is a true reflection of what happens to people when they are involved in illicit drug use, including Ecstasy, and makes it more likely the information they provided would generalize to the larger population of drug users.The field methods used to recruit users and retain them in the study is easily replicable and familiar to the epidemiology literature. Minimal intrusion was used and subjects were compensated for their time and inconvenience. In addition, the sample was quite heterogeneous coming from three geographically dispersed sites, two located in the US (Miami and St. Louis) and one internationally in Sydney, Australia. Using data from such heterogeneous places provides a tremendous opportunity to examine cultural influences, along with other demographic features of a sample that can influence consumption (i.e., race, education, and in was predominantly white but included sufficient representation of racial minority groups to adequately sample their behavior. The sample characteristics also represented a wide range of age groupings ensuring that drug use was not an artifact of youthfulness or trend related. There was equivalent proportion of both sexes ensuring that any trends in drug consumption did not merely reflect gender specific socialization, which has been a factor contributing to differences in rates of alcohol consumption, among other drugs. ce these d ata, the more likely a researcher has specified the "true" model. The precision of models can be assessed by a wide range of inferential</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_46"><head></head><label></label><figDesc>refinement on previous research because it requires simultaneous multivariate estimation of multiple predictors whose effects are estimated on multiple outcomes. Also ic market forces and high-risk behaviors and their relations were also estimated as unique predictors of the outcome constructs.One other refinement in the modeling procedure included testing nested models comparing a constrained model with restricted parameters fixed to zero, against a less restricted model (with freely estimated parameters). The nested comparison for each degree of freedom difference provided a means to ascertain 207 ches into a single comprehensive model. In addition, model offers a more parsimonious and superior fit. This model testing procedure represents a further refinement on prior empirical tests of drug etiology, particularly with respect to economic measures and psychological risk as predictors of Ecstasy consumption.To summarize, while numerous studies have investigated the effects of economic measures and separately psychological risk factors on drug use, few have combined these two approa eal of research and empirical inquiry with regard to "rational" economic models has emphasized licit drugs (i.e., alcohol and tobacco), where regulatory measures like taxation and other measures to encourage production or restrict consumption can gain traction. This study extended this inquiry to include an illicit drug that has stimulated tremendous public health concern because of its deleterious effects but not received the same level of attention. Furthermore, economic models specify "consumption" as the sole outcome of interest, but problems from consumption may also play an important role determining how much of a drug a person consumes. Toward this end, this study included several measures of consequences that arise from consumption and modeled th h economic measures and psychological risk factors in one conceptual framework, referred to as the psycho-economic model.With regard to the selection of economic measures, prior models have included at most income and price, but have not directed much attention to the 208 mpairs other role obligations. To address this, the current from opportunity cost to consum amount of time a person spends finding sources for the drug, a factor that can severely affect consumption. By necessity, the actual time spent either searching and/or negotiating the purchase of an illicit drug can dampen enthusiasm when this commitment of personal resources i study included "opportunity cost" as a direct measure of time spent locating the drug. Finally, prior research was limited to exploratory statistical modeling leaving no way to "confirm" the study findings or test a specific theory. The present study relied on confirmatory modeling techniques for both the measurement and structural component using SEM technique, and provided a host of inferential fit statistics to examine the precision in modeling fit between sample data and an implied population model.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_47"><head></head><label></label><figDesc>addition of psychological risk factors to a model positing only economic measures increase the proportion of variance accounted for in problems associated with consumption. The results once again reinforce the additive value of having both sets of measures in one model. In this respect, the R 2 = 11.7% in the model with economic predictors of dependence increased to R 2 = 41.1% with a model specifying both economic and psyc There were a number of other findings from the model testing procedures that help clarify the etiology of Ecstasy use. These points are broken down into (1) findings from the measurement model; (2) findings from the empirical specification searches; (3) findings from the bootstrapping; and (4) findings from the model including demographics.Findings from the Measurement Model ---The results of the measurement model showed that the latent constructs were correctly hypothesized and were all statistically reliable. The correlations between all four constructs indicated divergent validity ensuring there was unique variance associated with each construct. The measurement model contained a total of six correlations between the latent constructs. Motivation and dependence shared the most variance, attesting to the large role played by "psychological impetus" in participant's continued drug use.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_48"><head></head><label></label><figDesc>identify variation beyond factor-determined variance income became integral part to the model. This means that available financial resources or budget constraints actually do factor into the decision to use drugs (both lifetime and in recent use) b the general level of consumption as hypothesized (rather at a more specific level looking at quantity). This may arise because as stated previously, the loadings for the latent construct of consumption pulled toward "recent use." In other words, income serves a form of budgetary constraint limiting overall lifetime consumption but conveys less influence with regard to whether a person has used Ecstasy recently.On the other hand, how much time a person spends searching for a drug also mattered in terms of how many pills they consumed in the past 30 days. Price also mattered in terms of lifetime quantity, reinforcing the importance of economic gs from the Bootstrapping measures in the decision process to consume drugs. Overall, the addition of these few modifications improved the fit of the model, adding meaningful variance and bringing the model closer to the true population model as indicated by its goodnessparameters showed indications of switching signs, diminishing in sheer magnitude or losing their significance. These examples of suppression are likely statistical artifacts of the sample data and suggest some concern for the stability of these effects with such a modest sample. The procedure for testing the stability of parameters either involves cross-validation or bootstrapping with replicate samples. A test of 1,000 replicate samples with 500 randomly drawn cases (with replacement)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_49"><head></head><label></label><figDesc>established, would lead to more precise tests of whether economic measures contributed unique predictive variance to consumption. This the con The specified relation between Dependence and Consumption constructs model construction posited a covariance between these tw esentation is overly ditions of causation be met by establishing association, temporality, andproper statistical controls to rule out spuriousness. A model such as this one would include economic measures and psychological functioning at baseline, and then repeat the same measures at follow-up. This type of "trend" analysis would provide a rigorous means to assess whether any one of the economic measures either individually or all of them together predict "future" consumption controlling for contemporaneous psychological functioning.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 4 .</head><label>4</label><figDesc>2: Ecstasy Use Pattern among Study Participants by Gender and Site ..............Table 4.3: Other Substances Used among Study Participants by Gender and Site ........ Table 4.4: Lifetime Addiction among Study Participants by Gender and Site ............... Table 4.5: Summary Statistics for the Selected Items &amp; Scales used in the Psycho-</figDesc><table /><note><p>Economic Model .................................................................................... 144-148 Table 4.6: Correlations among the 23 Observed Variables &amp; Constructs Used in the Psycho-Economic Model ............................................................................... Table 4.7: Comparative fit of the Measurement Model .................................................. Table 4.8: Goodness of Fit for the Structural Model ......................................................</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 4 .</head><label>4</label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>transmission. It was specifically used to collect self-reported data on sociodemographic characteristics (e.g., gender, age, race, education level attained, past 12 month employment and income, as well as general health status), recent drug use behaviors [including drug use patterns, injection drug use (IDU) habits, and drug use treatment history], and sex practices (e.g., type and number of sex activities, number of male and female sex partners, condom use patterns, sex trading behaviors, and</figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .1 Socio-Demographic Characteristics of the Study Sample</head><label>4</label><figDesc></figDesc><table><row><cell></cell><cell>Total</cell><cell></cell><cell>Site</cell><cell></cell></row><row><cell></cell><cell>Sample</cell><cell>St. Louis</cell><cell>Miami</cell><cell>Sydney</cell></row><row><cell></cell><cell>(N =640)</cell><cell cols="3">(N =296) (N =186) (N =158)</cell></row><row><cell>Characteristic</cell><cell>n ( % )</cell><cell>%</cell><cell>%</cell><cell>%</cell></row><row><cell>Gender</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Female</cell><cell>271(42%)</cell><cell>46%</cell><cell>39%</cell><cell>41%</cell></row><row><cell>Male</cell><cell>369(58%)</cell><cell>54%</cell><cell>61%</cell><cell>59%</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Minors(20 years or younger)</cell><cell>214(33%)</cell><cell>32%</cell><cell>33%</cell><cell>35%</cell></row><row><cell>Young Adults(21 -24 yrs)</cell><cell>246(38%)</cell><cell>42%</cell><cell>35%</cell><cell>35%</cell></row><row><cell>Adults(25 years or older)</cell><cell>180(28%)</cell><cell>25%</cell><cell>32%</cell><cell>29%</cell></row><row><cell>Mean Age(SD)</cell><cell cols="4">23.3(5.01) 23.2(5.08) 23.6(4.98) 23.2(4.94)</cell></row><row><cell>Race/Ethnicity</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>White/Caucasian</cell><cell>400(62%)</cell><cell>73%</cell><cell>31%</cell><cell>80%***</cell></row><row><cell>Black</cell><cell>55(9%)</cell><cell>16%</cell><cell>4%</cell><cell>0%</cell></row><row><cell>Hispanic</cell><cell>113(18%)</cell><cell>3%</cell><cell>55%</cell><cell>1%</cell></row><row><cell>Others</cell><cell>72(11%)</cell><cell>8%</cell><cell>10%</cell><cell>19%</cell></row><row><cell>Marital Status</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Currently married</cell><cell>19(3%)</cell><cell>4%</cell><cell>4%</cell><cell>0%</cell></row><row><cell>Separated/Divorced/Widowed</cell><cell>23(4%)</cell><cell>4%</cell><cell>4%</cell><cell>1%</cell></row><row><cell>Never married</cell><cell>598(93%)</cell><cell>92%</cell><cell>91%</cell><cell>99%</cell></row><row><cell>Education Level</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Elementary</cell><cell>42(7%)</cell><cell>6%</cell><cell>4%</cell><cell>9%**</cell></row><row><cell>Secondary(High School)</cell><cell>402(63%)</cell><cell>69%</cell><cell>57%</cell><cell>58%</cell></row><row><cell>Post-Secondary</cell><cell>196(31%)</cell><cell>24%</cell><cell>39%</cell><cell>33%</cell></row><row><cell>Current Work Status</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Working Full/Part-time</cell><cell>187(29%)</cell><cell>27%</cell><cell>25%</cell><cell>37%</cell></row><row><cell>Student Working Full/Part-time</cell><cell>280(44%)</cell><cell>44%</cell><cell>45%</cell><cell>41%</cell></row><row><cell>Unemployed and Looking for work</cell><cell>100(16%)</cell><cell>17%</cell><cell>17%</cell><cell>12%</cell></row><row><cell cols="2">Unemployed, not Able/Looking for work 73(11%)</cell><cell>12%</cell><cell>13%</cell><cell>10%</cell></row><row><cell>Total Income in the Last 12 Months</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>$3,999 or less</cell><cell>120(19%)</cell><cell>23%</cell><cell>19%</cell><cell>10%**</cell></row><row><cell>$4,000 -$6,999</cell><cell>78(12%)</cell><cell>11%</cell><cell>16%</cell><cell>10%</cell></row><row><cell>$7,000 -$10,999</cell><cell>100(16%)</cell><cell>17%</cell><cell>16%</cell><cell>13%</cell></row><row><cell>$11,000 -$14,999</cell><cell>67(11%)</cell><cell>10%</cell><cell>8%</cell><cell>15%</cell></row><row><cell>$15,000 -$18,999</cell><cell>88(14%)</cell><cell>16%</cell><cell>11%</cell><cell>14%</cell></row><row><cell>$19,000 -$24,999</cell><cell>62(10%</cell><cell>8%</cell><cell>14%</cell><cell>8%</cell></row><row><cell>$25,000 -$34,999</cell><cell>58(9%)</cell><cell>8%</cell><cell>8%</cell><cell>12%</cell></row><row><cell>$55,000 -$44,999</cell><cell>29(5%)</cell><cell>3%</cell><cell>4%</cell><cell>8%</cell></row><row><cell>$45,000 or more</cell><cell>38(6%)</cell><cell>5%</cell><cell>5%</cell><cell>9%</cell></row><row><cell cols="4">Notes: 1. Percents might not add up to 100% in some cases due to truncation</cell><cell></cell></row><row><cell cols="5">2. Sites comparisons were assessed with t-test for categorical variables and</cell></row><row><cell cols="5">ANOVA for continuous variables. Statistically significant levels are indicated by</cell></row><row><cell cols="2">* for p  .05, ** for p  .01, and *** for p  .001</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 .2 Ecstasy Use Pattern among Study Participants by Gender and Site (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell>Gender Site</cell><cell>Female Male St. Louis Miami Sydney</cell><cell>(N =271) (N =369) (N =296) (N =186) (N =158)</cell><cell>% % % % %</cell><cell></cell><cell>14% 8%* 9% 15% 10%*</cell><cell>70% 67% 66% 67% 76%</cell><cell>11% 15% 17% 12% 9%</cell><cell>5% 9% 9% 7% 4%</cell><cell>18.4(3.57) 19.4(4.42)*** 19.4(4.47) 18.8(4.13) 18.4(3.22)*</cell><cell></cell><cell>18% 15% 17% 14% 17%***</cell><cell>32% 33% 42% 22% 28%</cell><cell>27% 26% 23% 34% 25%</cell><cell>23% 26% 18% 31% 30%</cell><cell>5.1(2.91) 5.4(3.41) 4.7(2.83) 5.7(3.25) 5.8(3.67)***</cell><cell></cell><cell>208.4(489) 241.8(580.8) 184.7(526.1) 255.3(608.5) 275.6(489.9)</cell><cell></cell><cell>44% 41% 30% 31% 79%***</cell><cell>56% 59% 70% 69% 21%</cell><cell></cell><cell></cell><cell>72% 76% 82% 86% 63%***</cell><cell>28% 24% 18% 14% 37%</cell><cell>2.8(2.69) 2.8(2.69) 2.6(3.01) 2.0(1.95) 3.3(2.64)*</cell></row><row><cell>Total</cell><cell>Sample</cell><cell>(N =640)</cell><cell>Characteristic n ( % )</cell><cell>Age of Onset of Ecstasy Use</cell><cell>15 years or younger 66(11%)</cell><cell>16 -20 years 438(68%)</cell><cell>21 -24 25 years 87(14%)</cell><cell>25 years or older 46(7%)</cell><cell>Mean Age of Onset(SD) 19.0(4.11)</cell><cell>Years Since 1st Ecstasy Use</cell><cell>2 years or less 103(16%)</cell><cell>3 -4 years 207(32%)</cell><cell>5 -6 years 171(27%)</cell><cell>7 years or more 159(25%)</cell><cell>Mean years(SD) 5.3(3.21)</cell><cell>Lifetime Use of Ecstasy</cell><cell>Mean number of pills(SD) 227.7(543.7)</cell><cell>Current Use of Ecstasy</cell><cell>Within past 30 days 270(42%)</cell><cell>More than 30 days ago, but in past 12 months 370(58%)</cell><cell>Past 30 Days Use of Ecstasy (N =270)</cell><cell>Number of Days</cell><cell>1 -3 days 200(74%)</cell><cell>4 or more days 70(26%)</cell><cell>Mean number of days(SD) 2.8(2.69)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Number of Times per Day of Ecstasy Use</head><label></label><figDesc></figDesc><table><row><cell cols="6">46%*** between 21 and 25 years old, and only 46 participants (7%) were 26 years old or older 54% 1.9(1.14) when they first experimented with Ecstasy.</cell><cell></cell></row><row><cell cols="6">65% Table 4.2 also depicts essentially the same distributional patterns regarding 35% 2.1(2.19) the age of onset by gender (columns 2</cell><cell></cell></row><row><cell>70%</cell><cell>30%</cell><cell>1.5(1.24)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1 time 157(58%) 58% 58%</cell><cell>2 or more times 113(42%) 42% 42%</cell><cell>Mean number of times a day(SD) 1.8(1.46) 1.8(1.57) 1.8(1.38)</cell><cell>Notes: 1. Percents might not add up to 100% in some cases due to truncation</cell><cell>2. Sites comparisons were assessed with Chi-Square for categorical variables and t-Test for</cell><cell>continuous variables. Statistically significant levels are indicated by</cell><cell>* for p  .05, ** for p  .01, and *** for p  .001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head></head><label></label><figDesc>On average, participants in St. Louis reported fewer years since their first Ecstasy use [M years =4.7 (SD=2.83)] than participants in Miami [M years =5.7 (SD=3.25)] or Sydney [M years =5.8 (SD=3.67)]. Additionally, variability in the number of years since first use differed between St. Louis participants compared to those in Miami or Sydney,  2 (6)=30.99, p&lt;.0001. In particular, Ecstasy users in St.</figDesc><table><row><cell>(SD=489.0) with a range of 6 to 4000 pills]. There was a trend for site differences in</cell></row><row><cell>the mean number of pills used, F(2)=2.67, p.071, with mean levels of Ecstasy use</cell></row><row><cell>relatively higher for Sydney and Miami compared to St. Louis [M SYD =275.58 pills</cell></row><row><cell>(SD=489.88)] and M MI =255.34 pills (SD=608.49), and M SL =184.72 pills</cell></row><row><cell>(SD=526.08)].</cell></row><row><cell>Lifetime Use of Ecstasy --Participants were asked "if you were to add up all</cell></row><row><cell>of the Ecstasy pills you have used since you first started using Ecstasy, about how</cell></row><row><cell>many pills would that be?" The overall mean number of pills consumed was 227.7</cell></row><row><cell>(SD=543.7). Males and females did not differ significantly in their reported lifetime</cell></row><row><cell>use [M M =241.8 (SD=580.8) with a range of 6 to 5200 pills and M F =208.4</cell></row></table><note><p><p><p>Louis were relatively new to this drug. As shown in Table</p>4</p>.2, more than half of the participants (59%) in St. Louis were observed to have not more than four years since they first tried Ecstasy, while more than half of the participants in Miami (65%) and Sydney (55%) reported five or more years of Ecstasy use since they first experimented. The source of difference is most likely due to the fact that participants in St. Louis were on average older and started using Ecstasy at a much later age than participants from the other two sites.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head></head><label></label><figDesc>days in the past 30 days,  2 (2)=14.64, p=.0007. Although about the same pattern of Ecstasy use days was observed in St. Louis and Miami, Sydney had relatively fewer participants (63% vs. 82% in St. Louis and 86% in Miami) who used Ecstasy one to three days and more participants (37% vs. 18% in St. Louis and 14% in Miami) who</figDesc><table><row><cell>users with moderate consumption habits. However, site comparisons indicated</cell></row><row><cell>significant differences in the daily intake-frequency of use (a proxy measure of</cell></row><row><cell>quantity) among recent users,  2 (2)=13.64, p&lt;.0011. Whereas about a third of the</cell></row><row><cell>participants in St. Louis (30%) and Miami (35%) used Ecstasy two or more times per</cell></row><row><cell>occasion, more than half (54%) of Sydney participants did the same.</cell></row><row><cell>Taken together, these findings suggest that study participants in Sydney report</cell></row><row><cell>strikingly different Ecstasy consumption habits than their counterparts in St. Louis</cell></row><row><cell>Mean comparisons by gender and across sites showed no statistically significant</cell></row><row><cell>differences for the average number of times per day study participants used Ecstasy</cell></row><row><cell>over the designated study period.</cell></row><row><cell>As a point of further clarification, 157 or 58% of the 270 "recent" users used</cell></row><row><cell>Ecstasy one time a day, while 113 (42%) used it two or more times a day. These</cell></row><row><cell>proportions did not differ by gender, which suggests that the study sample included</cell></row></table><note><p><p><p><p>used it for four or more days. This observed difference suggests that there are relatively more "regular users" in the sample recruited from Sydney than from either one of the two U.S. sites.</p>Participants were also asked about the "number of times per day" they used Ecstasy. Table</p>4</p>.2 shows that on average, the 270 participants who used Ecstasy within the past 30 days reported taking it about two (1.82) times a day (SD=1.46). and Miami. Specifically, there are more "regular" Ecstasy users with more frequent pattern of use in Sydney than in the other two sites. This may explain why Sydney users reported taking more Ecstasy pills lifetime than those in St. Louis or Miami.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 4</head><label>4</label><figDesc></figDesc><table><row><cell>.3. The results show that most participants have used a number of other</cell></row><row><cell>substances over time. Alcohol, in particular, was very common, as almost 100% of</cell></row><row><cell>the sample reported having consumed alcohol beverages in the past and that they</cell></row><row><cell>started drinking at the age of 14. This was a consistent finding regardless of the</cell></row><row><cell>participant's gender or site.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>Table 4 .3 Other Substances Used among Study Participants by Gender and Site (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell>Total Gender Site</cell><cell>Sample Female Male St. Louis Miami Sydney</cell><cell>(N =640) (N =271) (N =369) (N =296) (N =186) (N =158)</cell><cell>Characteristic n(%) % % % % %</cell><cell>Use of Other Substances (Lifetime )</cell><cell>Alcohol</cell><cell>Drank alcohol beverages 638(100%) 100% 100% 99% 100% 100%</cell><cell>Mean age of onset (SD) 14.3(2.76) 14.3(2.62) 14.3(2.87) 14.3(3.02) 14.4(2.86) 14.3(2.07)</cell><cell>Other Club Drugs (Other than Ecstasy)</cell><cell>Ketamine 219(34%) 69(25%) 150(41%)*** 95(32%) 69(37%) 55(35%)</cell><cell>GHB 112(18%) 32(12%) 80(22%)*** 40(14%) 49(26%) 23(15%)***</cell><cell>Rohypnol 76(12%) 21(8%) 55(15%)** 14(5%) 54(29%) 8(5%)***</cell><cell>Used one or more club drugs 275(43%) 93(34%) 182(49%)*** 111(37%) 97(52%) 67(42%)**</cell><cell>Mean age of onset of 1st club drug (SD) 19.6(4.40) 19.6(4.81) 19.6(4.19) 19.6(4.25) 19.2(4.83) 20.3(3.95)</cell><cell>Other Illicit Drugs</cell><cell>Marijuana 624(98%) 264(97%) 361(98%) 292(99%) 182(98%) 151(96%)</cell><cell>Hallucinogens 410(64%) 153(56%) 257(70%)*** 196(66%) 142(76%) 72(46%)***</cell><cell>Stimulants 402(63%) 154(57%) 248(67%)** 172(58%) 87(47%) 143(91%)***</cell><cell>Cocaine 390(61%) 149(55%) 241(65%)** 194(66%) 133(72%) 63(40%)***</cell><cell>Mean age of onset of 1st illicit drug (SD) 14.8(2.97) 15.0(2.62) 14.7(3.21) 14.5(2.82) 15.0(3.53) 15.3(2.43)*</cell><cell>Order of 1st Use</cell><cell>5% 3%*** Ecstasy used before other illicit drugs 14(2%) 3% 2% 0%</cell><cell>82% 82% Ecstasy &amp; other illicit drugs used at the sam time 497(78%) 77% 78% 73%</cell><cell>13% 16% Other illicit drugs used before Ecstasy 129(20%) 20% 20% 27%</cell><cell>Notes: 1. Percents might not add up to 100% in some cases due to truncation</cell><cell>2. Sites comparisons were assessed with Chi-Square for categorical variables and t-Test for</cell><cell>continuous variables. Statistically significant levels are indicated by</cell><cell>* for p  .05, ** for p  .01, and *** for p  .001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_11"><head></head><label></label><figDesc>Table 4.3 shows the top four most prevalently used drugs. Marijuana was the</figDesc><table><row><cell>than females reported having used hallucinogens,  2 (1)=11.81, p=.0006 (70% vs.</cell></row><row><cell>56%), stimulants,  2 (1)=7.21, p=.0072 (67% vs. 57%), and cocaine,  2 (1)=7.01,</cell></row><row><cell>p=.0081 (65% vs. 55%).</cell></row><row><cell>Although study participants did not differ significantly in their use of</cell></row><row><cell>marijuana, the reported prevalence rates of hallucinogen use were highest among</cell></row><row><cell>Miami participants (76%) compared to St. Louis (66%) and Sydney (46%),</cell></row><row><cell> 2 (2)=36.25, p&lt;.0001. Likewise, the prevalence of cocaine use was significantly</cell></row><row><cell>higher among participants in Miami (72%) and St. Louis (66%) than Sydney (40%),</cell></row><row><cell> 2 (2)=40.81, p&lt;.0001. Also, while most of the participants in Sydney (91%) reported</cell></row><row><cell>having used stimulants, significantly lower proportions reported doing the same in St.</cell></row><row><cell>Louis (58%) and Miami (47%),  2 (2)=75.16, p&lt;.0001.</cell></row><row><cell>Additionally, while the overall mean age-of-onset of the first illicit drug used</cell></row><row><cell>was 14.8 years (SD=2.97) and did not differ by gender, the mean age for participants</cell></row><row><cell>first trying any illicit drug differed significantly across sites, F(2)=37.48, p=.0143,</cell></row><row><cell>with the age of onset slightly older in Sydney (15.3 years, SD=2.43) than in St. Louis</cell></row><row><cell>(14.5 years, SD=2.82) and Miami (15.0 years, SD=3.35).</cell></row><row><cell>primary drug reported by most (98%) participants, followed by (64%) hallucinogens,</cell></row><row><cell>(63%) stimulants, and (61%) cocaine. Both males and females were equally likely to</cell></row><row><cell>use marijuana (97% vs. 98% for females and males, respectively). The prevalence of</cell></row><row><cell>use of the other listed drugs differed, however, significantly by gender. More males</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_12"><head>Table 4 .4 Lifetime Addiction among Study Participants by Gender and Site (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell></cell><cell>Sydney</cell><cell>(N =158)</cell><cell>%</cell><cell></cell><cell></cell><cell>21%*</cell><cell>12%</cell><cell>66%</cell><cell>73%**</cell><cell>17%**</cell><cell>85%*</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Site</cell><cell>Miami</cell><cell>(N =186)</cell><cell>%</cell><cell></cell><cell></cell><cell>21%</cell><cell>16%</cell><cell>63%</cell><cell>85%</cell><cell>31%</cell><cell>92%</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total Gender</cell><cell>Sample Female Male St. Louis</cell><cell>(N =640) (N =271) (N =369) (N =296)</cell><cell>% Characteristic n(%) % %</cell><cell>DSM IV Substance Use Disorders (Lifetime)</cell><cell>Ecstasy</cell><cell>30% No diagnosis 163(25%) 23% 27%</cell><cell>17% Abuse 97(15%) 13% 17%</cell><cell>53% Dependence 380(59%) 64% 56%</cell><cell>82% Alcohol dependence 520(81%) 79% 83%</cell><cell>16% Any other club-drug dependence 132(21%) 16% 24%**</cell><cell>90% Any other licit or illicit drug dependence 573(90%) 86% 92%**</cell><cell>Notes: 1. Percents might not add up to 100% in some cases due to truncation</cell><cell>2. Sites comparisons were assessed with Chi-Square for categorical variables and t-Test for</cell><cell>continuous variables. Statistically significant levels are indicated by</cell><cell>* for p  .05, ** for p  .01, and *** for p  .001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_13"><head>Table 4 .5 Summary Statistics for the Selected Items &amp; Scales used in the Psycho-Economic Model (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell>Mean Gender Mean Site Difference</cell><cell>(Female-Male) St. Louis</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_14"><head>Table 4 .5 Summary Statistics for the Selected Items &amp; Scales used in the Psycho-Economic Model (N=640</head><label>4</label><figDesc></figDesc><table><row><cell>Mean Gender Mean Site Difference</cell><cell>(Female-Male) St. Louis -St. Louis-Miami-</cell></row></table><note><p><p>)</p>(Cont.)    </p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_15"><head>Table 4 .5 Summary Statistics for the Selected Items &amp; Scales used in the Psycho-Economic Model (N=640</head><label>4</label><figDesc></figDesc><table><row><cell>Mean Gender Mean Site Difference</cell><cell>(Female-Male) St. Louis -St. Louis-Miami-</cell></row></table><note><p><p>)</p>(Cont.)    </p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_16"><head>Table 4 .5 Summary Statistics for the Selected Items &amp; Scales used in the Psycho-Economic Model (N=640</head><label>4</label><figDesc>)(Cont.)    </figDesc><table><row><cell>Mean Gender Mean Site Difference</cell><cell>(Female-Male) St. Louis -St. Louis-Miami-</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_17"><head>Table 4 .5 Summary Statistics for the Selected Items &amp; Scales used in the Psycho-Economic Model (N=640</head><label>4</label><figDesc>)(Cont.)    </figDesc><table><row><cell>Mean Gender Mean Site Difference</cell><cell>(Female-Male) St. Louis -St. Louis-Miami-</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_18"><head>Table 4 .6 Correlations* Among the 23 Observed Variables &amp; Constructs Used in the PsychoEconomic Model (N=640) Outcome Measures</head><label>4</label><figDesc></figDesc><table><row><cell>Consumption</cell><cell>1. Quantity of Ecstasy used lifetime -.26  .33  .26  .40  .23  .34  .21  .38  .31  .20  -.19  -.01 .22  .48  .52  .52  .29  .11 .06 .02 .09 .20 </cell><cell>2. X use days in past 30 days -.58  .60  .13  .11 .10 .11 .08 .18  .08 .03 -.21  .22  .15  .19  .21  .12 .12 .05 .05 .09 .09</cell><cell>3. Times per X use day past 30 days -.68  .20  .11 .13  .09 .14  .20  .12 -.06 -.19  .17  .16  .24  .25  .09 .09 -.01 -.01 .05 .08</cell><cell>4. recency of X use -.12  .11 .09 .09 .08 .16  .11 -.05 -.20  .14  .10 .20  .20  .05 .03 -.04 -.03 -.01 .04</cell><cell>Dependence</cell><cell>5. Tolerance -.27  .33  .26  .37  .35  .18  -.03 .01 .07 .28  .31  .25  .25  .05 .09 .09 .08 .06</cell><cell>6. Withdrawal -.31  .25  .34  .26  .21  -.04 -.04 .05 .18  .20  .17  .24  .08 .10 .12  .14  .04</cell><cell>7. Increased use over longer period -.38  .43  .33  .20  -.02 -.01 .10 .24  .27  .26  .24  .07 .13  .05 .10 .07</cell><cell>8. Desire or inability to cut down -.29  .33  .16  -.02 -.03 .04 .16  .16  .19  .24  .14  .17  .15  .15  .04</cell><cell>9. Great deal of time spent -.40  .23  .04 .03 .10 .28  .30  .31  .29  .12  .15  .09 .11  .10</cell><cell>10. Reduce or avoid important activities -.18  -.004 -.07 .07 .28  .28  .33  .34  .13  .16  .12  .13  .15 </cell><cell>11. Continue to use despite problems -.04 .001 .03 .09 .18  .17  .19  .02 .10 .04 .03 .04</cell><cell>Economic Factors</cell><cell>12. Social Anomie (Income Index) -.09 .01 -.03 -.06 -.07 .003 .03 .05 .05 .06 -.09</cell><cell>13. Unit price of Ecstasy pill --.04 .11 .01 -.05 .04 -.03 .01 .03 .03 .06</cell><cell>14. Opportunity cost -.16  .21  .14  .04 .14  .11 .05 .08 .03</cell><cell>Psychological Factors</cell><cell>Motivation</cell><cell>15. Opportunity to get Ecstasy -.45  .46  .30  .10 .07 .09 .14  .20 </cell><cell>16. Places/People to get Ecstasy from -.62  .34  .10 .15  .10  .15  .28 </cell><cell>17. People to get/share Ecstasy with -.34  .14 .15  .14  .16  .30 </cell><cell>18. Motive to use Ecstasy -.19  .26  .21  .23  .16 </cell><cell>Other Risk Factors</cell><cell>Depression</cell><cell>19. Behavioral -.59  .64  .69  .07</cell><cell>20. Somatic -.70  .66  .13 </cell><cell>21. Affective -.72  .10</cell><cell>.09 22. Cognitive -</cell><cell>Risk Taking</cell><cell>-23. Sex risk</cell><cell>-Item-to-Total Correlation* .53 .61 .70 .67 .46 .43 .52 .43 .55 .49 .30 .12 -.06 .24 .51 .59 .63 .40 .71 .72 .81 .82</cell><cell>* This is a measure of interassociation of each item with the total correlation adjusted/corrected for the items (all standardized) in the domain.</cell><cell> Statistically significant levels at p  .001 (2-tailed)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_19"><head>Table 4</head><label>4</label><figDesc>constrained model by a nested likelihood difference test. The nested  2 difference test indicates the unconstrained model provides a better fit,  2 (6) = 2022.19, p &gt; .001. The CFI is .906 for the unconstrained model and .442 for the constrained model. The higher the value of the CFI, the better the fit (.906 means the hypothesized model accounts for 90% of the variances and covariances in the sample data). The SRMR, which measures the average difference across the residual variances and covariances between the predicted and observed covariance matrices, is .138 in the constrained model and .08 in the unconstrained model. Again, smaller numbers indicate a better fit (8% of residual variation is left in the off-diagonal of the covariance matrix by the hypothesized model).</figDesc><table><row><cell>.7 contains fit indices</cell></row><row><cell>se measurement model, provided an adequate fit to the data,  2 (146) = 555.13,</cell></row><row><cell>p  .001, NFI=.877 (not reported in Table), CFI=.906, GFI=.922, AGFI=.899,</cell></row><row><cell>SRMR=.080 and RMSEA=.063. The base model posits four latent constructs, but</cell></row><row><cell>allows them to freely correlate. Another way to structure this model is to fix the</cell></row><row><cell>correlations between latent constructs to r = 1.0 and test the adequacy of this fit</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_20"><head>Table 4 .7 Comparative fit of The Measurement Model (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell>Four First-Order</cell><cell></cell><cell cols="3">Degree of Chi-Square Chi-Square</cell><cell></cell><cell></cell></row><row><cell cols="3">Factor Structure Chi-Square Freedom</cell><cell>Test</cell><cell>Difference</cell><cell></cell><cell></cell></row><row><cell>Model</cell><cell>2</cell><cell>df</cell><cell>2/df</cell><cell cols="3">2 (df) CFI GFI AGFI SRMR RMSEA</cell></row><row><cell>Constrained</cell><cell>2577.32</cell><cell>152</cell><cell>16.96</cell><cell>N/A</cell><cell>.442 .659 .574 .138</cell><cell>.158</cell></row><row><cell>Unconstrained</cell><cell>555.13</cell><cell>146</cell><cell>3.8</cell><cell cols="2">2022.19(6)** .906 .922 .899 .080</cell><cell>.063</cell></row><row><cell cols="6">Note: 1. CFI = Comparative Fit Index; GFI = LISREL Goodness of Fit Index;</cell><cell></cell></row><row><cell cols="4">AGFI = LISREL Adjusted Goodness of Fit Index;</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="5">SRMR = Standardized Root Mean-Square Residual</cell><cell></cell><cell></cell></row><row><cell cols="5">and RMSEA = Root Mean-Square Error of Approximation.</cell><cell></cell><cell></cell></row><row><cell cols="3">2. **Statistically significant at p  .01</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_21"><head>Table 4 .8 Goodness of Fit for The Structural Model (N=640)</head><label>4</label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell cols="2">Degree of Chi-Square</cell><cell></cell><cell></cell></row><row><cell>Competing Model for</cell><cell cols="2">Chi-Square Freedom</cell><cell>Test</cell><cell></cell><cell></cell></row><row><cell>Ecstasy Use &amp; Dependence</cell><cell>2</cell><cell>df</cell><cell>2/df</cell><cell cols="2">NFI CFI GFI AGFI SRMR RMSEA</cell></row><row><cell>SubModel 1</cell><cell>274.09</cell><cell>70</cell><cell>3.92</cell><cell>.875 .890 .946 .919 .071</cell><cell>.068</cell></row><row><cell>SubModel 2</cell><cell>565.13</cell><cell>161</cell><cell>3.51</cell><cell>.877 .908 .925 .902 .078</cell><cell>.063</cell></row><row><cell>Full Model</cell><cell>671.23</cell><cell>206</cell><cell>3.26</cell><cell>.860 .898 .923 .897 .071</cell><cell>.059</cell></row><row><cell>Refined Model</cell><cell>607.70</cell><cell>200</cell><cell>3.04</cell><cell>.879 .916 .932 .906 .065</cell><cell>.055</cell></row><row><cell>Conditioned Model</cell><cell>1042.51</cell><cell>272</cell><cell>3.83</cell><cell>.829 .869 .901 .868 .081</cell><cell>.071</cell></row><row><cell cols="5">Notes: 1. SubModel 1 = Model with economic measures only (Income, Price, &amp; Opportunity Cost)</cell><cell></cell></row><row><cell cols="5">SubModel 2 = Model with psychological factors only (Motivation, Depression, &amp; Sex-Risk)</cell><cell></cell></row><row><cell cols="4">Full Model = SubModel 1 and SubModel 2 combined</cell><cell></cell><cell></cell></row><row><cell cols="5">Refined Model = Full Model + allowing for nonstandard effects</cell><cell></cell></row><row><cell cols="5">Conditioned Model = Full Model + controling for demographics (Gender, Age,  etc) and site</cell><cell></cell></row><row><cell cols="4">2. NFI = Normative Fit Index; CFI = Comparative Fit Index;</cell><cell></cell><cell></cell></row><row><cell cols="5">GFI = LISREL Goodness of Fit Index; AGFI = LISREL Adjusted Goodness of Fit Index;</cell><cell></cell></row><row><cell cols="4">SRMR = Standardized Root Mean-Square Residual; and</cell><cell></cell><cell></cell></row><row><cell cols="4">RMSEA = Root Mean-Square Error of Approximation.</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_22"><head>9 Parameter Estimates (Standardized Coefficients) of the Psycho-Economic Model (N=</head><label></label><figDesc> .01). It is worth noting also that of all the psychological risk measures Motivation had the largest influence on both Consumption ( = .417, p  .001) and Table4.Statistically significant levels are indicated by  for p  .10, * for p  .05, ** for p  .01, and *** for p  .001</figDesc><table><row><cell>(1) (2 ) Furthermore, there were several significant associations among the predictor -.015 011 -.250** 01 .100* 050 .310*** 659* -.020 067 .017 -.078 -.033 -.108 -.064 .150* .086 .460 o . -. 8 . . ** .   * ** ** es and constructs. Depression was significantly associated with sexual risk-oned M del .479*** .365 Conditi taking (r = .110, p  .05), as was Motivation with sexual risk-taking (r = .362, p  640) measur</cell></row><row><cell>Table 4 .9) showed that not all path coefficients were significantly different from zero (p &gt; .05). Neither Depression nor sexual risk-taking significantly predicted Ecstasy Use (Consumption). However, Depression was significantly associated with Dependence,  = .078, p  .001. Sexual risk-taking was not significantly associated with Consumption but negatively and significantly associated with Dependence ( = -.110, p Explanatory Variables (1) (2) (1) (2) (1) (2) (1) (2) Economic Factors Income Index -.043 -.009 -.028 .013 -.017 .028 Monetary cost -.226*** -.018 -.234*** -.033 -.245*** -.012 Opportunity cost .214*** .126** .137*** .024 .102** .026 Psychological Factors Motivation .417*** .654*** .384*** .661*** .386*** .647*** Other Risk Factors Depression -.056 .078*** -.054 .076* -.055 .085* Sex Risks -.047 -.110** -.024 -.107* -.024 -.104* Control Variables Gender Age . Study Site R-Squared .135 .117 .155 .414 .216 .411 .237 .001), and Motivation was significantly associated with Depression (r = .231, p  .428 Notes: 1. SubModel 1 = Model with economic measures only (Income, Price, &amp; Opportunity Cost) SubModel 2 = Model with psychological factors only (Motivation, Depression, &amp; Sex-Risk) Full Model = SubModel 1 and SubModel 2 combined Refined Model = Full Model + allowing for nonstandard effects Conditioned Model = Full Model + controling for demographics (Gender, Age,  etc) and site 2. For each model (1) referres to Ecstasy Use (or consumption) and (2) Dependence SubModel 1 SubModel 2 Full Model Refined Model e Full Model .001). The psychological component of the structural model explained (see Table 4.9) about 16% of the variance in Consumption (R 2 = .155) and 41% of the variance in 3. Competing Models for Ecstasy Use &amp; Dependence Dependence (R 2 = .414).</cell></row><row><cell>Dependence ( = .654, p  .001).</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_23"><head>Table 4 .10 Sample and Bootstrap of Model Parameter Estimates (1000 Replication, N=640)</head><label>4</label><figDesc>The model used in these simulations was the originally hypothesized "Full" model and did not include any non-standard effects/associations 2. Sample = ML non-standardized solution, Bootstap = Mean bootstrap results, SE = Estimated standard errors for bootstrap estimates, and t-Value = Mean bootstrap estimates to estimated SE (z-critical ratio)</figDesc><table><row><cell></cell><cell></cell><cell cols="2">Ecstasy Use</cell><cell></cell><cell></cell><cell cols="2">Dependence</cell><cell></cell></row><row><cell>Predictors</cell><cell cols="2">Sample Bootstrap</cell><cell>SE</cell><cell>t-Value</cell><cell cols="2">Sample Bootstrap</cell><cell>SE</cell><cell>t-Value</cell></row><row><cell>Economic Factors</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Income Index</cell><cell>-.004</cell><cell>-.003</cell><cell>.015</cell><cell>-.221</cell><cell>.007</cell><cell>.008</cell><cell>.012</cell><cell>.612</cell></row><row><cell>Monetary Cost</cell><cell>-.181</cell><cell>-.182</cell><cell>.035</cell><cell>-5.167</cell><cell>-.019</cell><cell>-.021</cell><cell>.026</cell><cell>-.816</cell></row><row><cell>Opportunity Cost</cell><cell>.110</cell><cell>.109</cell><cell>.037</cell><cell>2.906</cell><cell>-.014</cell><cell>-.016</cell><cell>.028</cell><cell>-.584</cell></row><row><cell>Psychological Factors</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Motivation</cell><cell>.145</cell><cell>.146</cell><cell>.023</cell><cell>6.326</cell><cell>.186</cell><cell>.189</cell><cell>.022</cell><cell>8.691</cell></row><row><cell>Other Risk Factors</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Depression</cell><cell>-.020</cell><cell>-.018</cell><cell>.0186</cell><cell>-.968</cell><cell>.021</cell><cell>.022</cell><cell>.010</cell><cell>2.250</cell></row><row><cell>Sex Risk</cell><cell>-.006</cell><cell>.012</cell><cell>.0119</cell><cell>1.008</cell><cell>-.019</cell><cell>-.020</cell><cell>.009</cell><cell>-2.167</cell></row></table><note><p>Notes: 1.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_24"><head></head><label></label><figDesc>-A second conditioned model added all the demographic measures along with site into the Full model (participants from Australia coded as humans; however, it has not come under scrutiny by economists until recently. This is Some of the more prominent concepts used to explain drug use behaviors have included motivation, desire, craving, urges, attitudes, beliefs, and affective experiences. ists and psychologists have two very unique approaches to explain behavior and while both seem necessary neither explanation alone is sufficient. After all, drug users consume drugs not only because they are cheap, but also because of their own desire and interest in the drug and their anticipated effects. It should be apparent then, that both arguments provide valid explanations for drug use behavior and should perhaps be considered together. The purpose of this study is to assess the theoretical importance of combining key factors from economic and psychological theories into a model of Ecstasy use and dependence.</figDesc><table><row><cell>most likely becau irrational behavior." se most economists would regard drug use as the end p assume explicitly or implicitly the "ceteris roduct of onstant) as pure market factors are used to " This seeming neglect changed entirely with the publication of the Rational Addiction Model (RAM) by Nobel laureate Gary Becker. According to Becker, man is purely rational, forward thinking, and seeks to maximize his utility (or satisfaction) subject to a budget constraint. In dramatic fashion, Becker then argued this approach can be used to account for drug use, which can readily be explained by "market factors." As powerful an argument as this may seem there are considerable issues that need to be addressed when behavior is approached from the RAM perspective. One in particular is that economists traditionally paribus" clause (i.e., hold all other factors c From this brief accounting it should be apparent that econom nly consumption as a reflection of drug behavio "psychological" measures were included that may enhance the prediction of drug consumption. These measures represent key etiological risk mechanisms that have been linked with various forms of drug use but are especially important in the consumption of Ecstasy. Third, the psycho-economic model also incorporated hypothesized "latent constructs." Reliance on "unobserved" constructs as opposed to measured or "manifest" variables attenuate measurement error and improve model precision. The parsimonious test of whether economic measures remained vital predictors of consumption when juxtaposed against psychological risk mechanisms. Fourth, the RAM considered o r. However, many drug users experience side effects or consequences from n upsurge in use by all ages across the lifespan, but mostly among that Ecstasy is the "lov physical harm, and can derail youth from achieving their full potential. For these and other reasons concern is raised when new drugs become available and appear attractive to youth. One drug in particular that has raised considerable concern is Ecstasy, which has seen a youth. Ecstasy is known for its hallucinogenic properties and for its ability to break down interpersonal inhibitions or social barriers. Users of Ecstasy report feeling interpersonally close, able to read other people more accurately, and warm to "other factors." Contribution of this Study ---There are several ways in which the current latent constructs modeled reflected both predictors and outcomes and enabled a more sensations and emotional feelings they don't normally have.</cell></row><row><cell>account for behavior. T he idea that one can artificially control important influences study improved upon previous research. First, as powerful as Becker's model of drug their drug use that can influence or regulate their consumption. These subtle relations</cell></row><row><cell>may present an impoverished view of behavior because in real life there are many consumption may seem, it has mostly been applied with legal or "licit" substances have not been traditionally modeled in economic models of consumption and have</cell></row><row><cell>factors that drive consumption and that go beyond price, opportunity cost, and like alcohol and cigarettes. In fact, no extensions of the RAM have ever fully been also been neglected when modeling psychological risk. The present study modeled a</cell></row><row><cell>income. In fact, people are dynamic and quite complex, always deliberating about a tested with "illicit" drugs. In the present study, the existing RAM was applied to an latent construct of "problems from Ecstasy use" reflecting currently diagnostic</cell></row><row><cell>host of factors when making decisions. It is thus overly simplistic to suggest that "illicit" substance that may not be bound by the same market factors used to explain nosology, termed Dependence, in addition to consumption. lude hyperthermia, jaw</cell></row><row><cell>price alone dictates choices over consumption when other "factors" also seem licit drug use. e for the Study Rational ---Any time youth become involved in psychoactive clenchi</cell></row><row><cell>relevant. Second, the existing RAM did not consider factors that may influence drug drugs there is considerable cause for alarm. Not only are psychoactive drugs illegal,</cell></row><row><cell>Psychology is one of several alternative disciplines that have spent consumption from outside the economic domain. Thus only market factors were they interfere with successful role socialization, impair cognitive functioning, and</cell></row><row><cell>considerable time attempting to explain behavior and looking into the role of these considered as vital predictors of consumption. In the present study, additional detract from living fully. Illicit drugs are also responsible for neurological problems,</cell></row><row><cell>200</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_25"><head></head><label></label><figDesc>532.Bentler, P. M.(1990). Comparative fit indexes in structural models. PsychologicaBulletin, 107,[238][239][240][241][242][243][244][245][246] </figDesc><table><row><cell>Ber</cell><cell></cell></row><row><cell>Ber</cell><cell>: the case for</cell></row><row><cell>Ber</cell><cell></cell></row><row><cell>Bic</cell><cell>mic</cell></row><row><cell></cell><cell>iatry,</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1" xml:id="foot_0"><p>For more details on this law and a complete description of these drug schedules, visit U.S. DEA website: http://www.usdoj.gov/dea/index.htm, last retrieved on December 12,</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="2010" xml:id="foot_1"><p></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="5" xml:id="foot_2"><p>Nosology refers generally to the classification of diseases. A "nosological" study in drug addiction deals with the classification of psychoactive substances based on their pharmacological, behavioral, affective, and cognitive properties.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="6" xml:id="foot_3"><p>Other street names for Ecstasy are Adam, E, eve, decadence, M&amp;M, X, and XTC.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="7" xml:id="foot_4"><p>Club drugs are also referred to as "party drugs" or "Recreational drugs" because, when first popularized, they were commonly used for "recreation" at dance parties or clubs. MDMA (or Ecstasy) is probably the most common of all the recreational drugs used at those parties. Other club drugs also used at dance or "rave" parties include Rohypnol (also called Roophies, Roche, Forget-me Pill), GHB [-hydroxybutyrate] (liquid Ecstasy, Georgia Home Boy), and Ketamine (special K, Cat Valiums)<ref type="bibr" target="#b38">(Cohen, 1998)</ref>.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="9" xml:id="foot_5"><p>The price per Ecstasy pill has gone down since then and became relatively cheaper due to its abundance through black market channels and illicit drug manufactures.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="10" xml:id="foot_6"><p>Recently, however, the U.S. Food and Drug Administration (FDA), with approval from the Drug Enforcement Administration (DEA), has given permission to a limited number of investigators from medical institutions (the University of South Carolina in Charleston, Harvard, and the University of San Francisco medical schools), to conduct clinical trials with Ecstasy. These studies involve the use of MDMA-assisted psychotherapy for subjects with treatment-resistant PTSD, for anxiety and depression in advanced-stage cancer patients(Doblin, 2002; Sessa &amp; Nutt, 2007).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="11" xml:id="foot_7"><p>While under its influence, Ecstasy users report feelings of happiness, energy, and greater acceptance of others. This allows them to party and dance for an extended period of time, hence the name party-or club-drug(Davison &amp; Parrott, 1997).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="12" xml:id="foot_8"><p>Stimulant-like effects include increases in energy, euphoria, and cognitive improvement, and hallucinogen-like effects include changes in perception, some dysphoria, changes in thought process, and reduced concentration(Harris et al. 2002;<ref type="bibr" target="#b79">Hernandez-Lopez et al. 2002;</ref> Tancer &amp; Johanson, 2001).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="15" xml:id="foot_9"><p>The influence of this view can still be found, though to a lesser degree, in the 12step program of the Narcotics Anonymous (NA). The NA requires each member "to confess" out loud during group meetings their addiction and that they lost control over their drug use. Also, the 'war on drugs' policy of the 1980's represented an antidrug policy to some degree based on shame, guilt, and personal character weakness.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="16" xml:id="foot_10"><p>A detailed discussion of these assumptions can be found in White, Kurtz &amp; Aker as part of a literature review available on the web at: http://www.bhrm.org/papers/addpapers.htm, last accessed February 15, 2011.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="17" xml:id="foot_11"><p>Several genes have, in fact, been identified as causing or at least linked to alcoholism and drug addiction. In particular, the D2 dopamine receptor A1 gene, for example, has been found to be more common in alcoholics and cocaine addicts(Comings et al. 1994). Researchers believe that as many as seven out of ten alcoholics carry this so-called "alcoholism gene," compared to only one in five (or two out of ten) in the general population(Hyman, 2001; Pandey, 2004; Uhl, 1999 Uhl,   &amp;  2004;; Uhl &amp; Grow, 2004; Wang et al., 2004).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="22" xml:id="foot_12"><p>A similar diagnostic classification system has also been established by the World Health Organization (WHO) in 1951, which led to the publication of similar clinical manual referred to as the International Classification of Diseases, or ICD for short.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="23" xml:id="foot_13"><p>The two categories of abuse and dependence are defined as independent substance use states, but the former can only be diagnosed if the threshold criterion for the latter state is not met. In other words, this "condition" has been made into a "conventional rule" stated commonly as "dependence takes precedence over abuse." This implies that dependence can be present with or without abuse(APA, 1994).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="26" xml:id="foot_14"><p>For a thorough review of the recent debate over the role of the dopaminergic neurons process in the brain reward system, see<ref type="bibr" target="#b194">Salamone et al., 1975;</ref><ref type="bibr" target="#b13">Berridge, 2007, and</ref><ref type="bibr" target="#b45">Di Chiara &amp;</ref><ref type="bibr" target="#b46">Bassareo, 2007.</ref> </p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="27" xml:id="foot_15"><p>This "trial and error" concept is taken from computational theory of "reinforcement learning", originally developed by Andrew Barto. For more details, seeSutton &amp;  Barto, 1990.   </p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="28" xml:id="foot_16"><p>All three models owe their foundation to the original behavioral theory of choice, the matching law(Herrnstein, 1970), which postulates that the value of drug use is a function of the relative cost/benefit ratio of its consumption. The three models differ however in their assumptions about the extent of rationality among substance users.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="29" xml:id="foot_17"><p>Becker and Murphy (1988)  actually claim that the RAM has important antecedents in the literature, including the work byRyder and Heal (1973), Boyer (1978<ref type="bibr" target="#b166">, 1983)</ref> andIannaccone (1986).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="30" xml:id="foot_18"><p>In the RAM, addiction is not limited to drug consumption. The model can be applied to a wide range of addictive products and behaviors, such as coffee drinking<ref type="bibr" target="#b144">(Olekalns &amp; Bardsley, 1996)</ref>, gambling, and watching TV/movies(Cameron, 1999).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="31" xml:id="foot_19"><p>Despite using different economic measures, relying on diverse samples, and applying different methodologies, these studies have provided empirical support for the RAM. In all of the examples provided, estimated models showed significant effects for price as well as past and future consumption, highlighting the basic notion that economic principles guide drug user's thoughts and actions(Caulkins &amp; Nicosia,  2010).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="32" xml:id="foot_20"><p>This feature of Becker's RAM represents a distinct departure from previous economic models; especially those based on a myopic view of addiction, where the user does not fully consider the future consequences of his/her present use of drugs.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="33" xml:id="foot_21"><p>More details on the subject can be found in Nicholas Saunders book "E for Ecstasy" published in 1993 and made available on the web at: http://www.ecstasy.org/books/e4x/e4x.ch.04.html, last accessed February 16, 2011.   </p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="35" xml:id="foot_22"><p>NIDA is one of many centers and institutes forming the National Institutes of Health (NIH).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="37" xml:id="foot_23"><p>This concern refers to the potential biases associated with a) the volunteerism in target sampling (participation from interested subject only) and b) the selection of initial respondent in chain referral sampling (i.e., referring subjects that are behaviorally similar through peer or friendship "selection" mechanisms:Salganik &amp;  Heckathorn, 2004).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="42" xml:id="foot_24"><p>Only St. Louis participants had these options. Miami and Sydney participants, who were not selected for clinical interview, were basically told that the study required no further participation after the Time-2 interview. The selection for the ethnographic interview was not randomized. Instead, it was based on whether the participant has endorsed tolerance and/or withdrawal symptoms, and was not eligible for the clinical (Time 3) interview.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="43" xml:id="foot_25"><p>The CIDI-SAM represents the third-generation of diagnostic schedules for psychiatric disorders. SeeRobins (2004)  for a detailed account of the historical evolution of the current psychiatric instruments.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="45" xml:id="foot_26"><p>Actually, diagnostic criteria for both abuse and dependence were included initially in the modeling procedure, as indicators of two separate latent constructs measuring the addictive potential of Ecstasy use. However, we were unable to obtain a satisfactory latent-variable model positing distinct constructs of abuse and dependence. The statistical artifact of an almost perfect correlation between the two constructs necessitated modeling only one construct. We also considered collapsing items from the two latent constructs into a single latent construct; however this procedure might go against the grain of certain diagnostic models. As a result the modeling efforts posited only the dependence construct. This also provides some clarity with respect to the consequences of Ecstasy consumption, and incorporates a construct possessing greater reliability (alpha for the Abuse construct was .91, whereas alpha for the Dependence construct was .96).</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="46" xml:id="foot_27"><p>The last two components of the economic cost (the future cost of health care and potential penalties) were not assessed in the parent study and the use of other sources was considered inappropriate, as explained earlier in this chapter.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="48" xml:id="foot_28"><p>Fifteen thousand dollars was defined as the threshold for the US federal income poverty level (less than $15,000 for a family of three). Source: Department ofHealth  and Human Services, 2005.   </p></note>
		</body>
		<back>

			<div type="funding">
<div><p>The <rs type="projectName">CIDI and CIDI Substance Abuse Module (SAM): Crosscultural instruments for assessing DSM-III, DSM-III-R and ICD-10 cri Problems of Drug Dependence, NIDA Res Monogr Series DHHS</rs> (<rs type="grantNumber">ADM 91-1753</rs>) 1990; 105:<rs type="grantNumber">220-6</rs>.</p><p>ttler, L. B., Robins, L. N., Sartorius, N. (1991). The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. The <rs type="institution">WHO/ADAMHA Field Trial</rs>. <rs type="person">Br J Psychiatry</rs>, 159 <rs type="funder">National Institute on Drug Abuse (NIDA)</rs>. 1991. NIDA, <rs type="person">Risk Behavior Assessment</rs>, <rs type="funder">Author, Rockville, MD. ional Institute on Drug Ab (Ecstasy)</rs>. Research Report Series. Bethesda, MD: <rs type="funder">NIDA</rs>, <rs type="funder">NIH</rs>, <rs type="funder">DHHS</rs>. Avai on the web at <ref type="url" target="http://nida.nih.gov/Research">http://nida.nih.gov/Research</ref> Reports/MDMA/, last retrieved on February 9, 2010. lubdrugs.html <rs type="funder">National Institute on Drug Abuse</rs> (2006b, May). <rs type="institution">NIDA InfoFacts: Club Drugs. Research Report Series. Bethesda, MD</rs>: <rs type="funder">NIDA</rs>, <rs type="funder">NIH</rs>, <rs type="funder">DHHS</rs>. Available on the web at <ref type="url" target="http://www.drugabuse.gov/infofacts/C">http://www.drugabuse.gov/infofacts/C</ref> , last retrieved on Nat h Report Series. Bethesda, MD: <rs type="funder">NIDA</rs>, <rs type="funder">NIH</rs>, February 9, 2010. ional Institute on Drug Abuse (2007, March). NIDA InfoFacts: <rs type="funder">Understanding Drug Abuse and Addiction. Researc DHHS</rs>. Available on the web at <ref type="url" target="http://www.nida.nih.gov/PDF/InfoFacts/Understanding.pdf">http://www.nida.nih.gov/PDF/InfoFacts/Understanding.pdf</ref>, last retrieved on April 10, 2011.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_f2ssv8C">
					<idno type="grant-number">ADM 91-1753</idno>
					<orgName type="project" subtype="full">CIDI and CIDI Substance Abuse Module (SAM): Crosscultural instruments for assessing DSM-III, DSM-III-R and ICD-10 cri Problems of Drug Dependence, NIDA Res Monogr Series DHHS</orgName>
				</org>
				<org type="funding" xml:id="_pxgk8Zd">
					<idno type="grant-number">220-6</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>descriptive analyses were carried out using the SAS  9.2 software package for <ref type="bibr">Windows (SAS Institute Inc., 2009)</ref>.</p><p>Section three presents results of a series of measurement and structural equation models implemented to test the specific research hypotheses. Briefly, the psycho-economic model was assessed using a two-step procedure <ref type="bibr" target="#b1">(Anderson &amp; Gerbing, 1988)</ref>: First a "measurement model" was tested using confirmatory factor analysis (CFA) procedure. This portion of the model assesses the psychometric properties of the hypothesized latent constructs and provides a means to examine "error-free" associations among the four hypothesized latent constructs. The four latent constructs included Depression, Motivation, Consumption, and Dependence.</p><p>Each construct was reflected by multiple indicators (observed measures), as described in the previous chapter.</p><p>The CFA model provides two distinct pieces of information: the reliabilities (i.e., accuracy of measurement) of the indicators used to reflect the latent constructs and also information detailing the statistical associations among the latent constructs and between measured variables and composite measures posited in the model. The reliabilities are computed based on methods for structural composites <ref type="bibr">(Werts, Linn, &amp; Jreskog, 1974)</ref>. The relations between the four latent constructs as well as the freestanding measured variables (e.g., income, unit price, and opportunity cost) and composites are indicated by Pearson product moment correlations. In the case of the Australia (N=158). Table <ref type="table">4</ref>.1 also contains numerical frequencies and percentages for categorical variables and means and standard deviations (SD) for continuous measures. Comparisons across sites for categorical measures were conducted using the chi-square test of independence and for continuous measures using variance decomposition techniques (single-factor analysis of variance, also known as one-way ANOVA).</p><p>For all three sites combined (N=640), 58% of the participants were male (N=369), and 42% were female. All three sites had more male than female participants (54% at St. Louis, 61% at Miami, and 59% at Sydney). However, there were no statistically significant differences in the proportion of male or female participants across sites.</p><p>A variable coding participant's age at study time was categorized into three age groups: "Minors," defined as being 20 years or younger, "Young Adults," included 21 to 24 years old, and "Adults," defined as being 25 years old or older. The overall mean age of the participants in the sample was  and Standard Deviation (SD) = 5.01]. A total of 214 participants (33%) were "Minors," 246 participants (38%) were "Young Adults," and 180 participants (28%) were "Adults." Although there were more individuals classified as "Young Adults" among St. Louis participants than in either Miami or Sydney, there were no significant differences in mean age or distribution of the three levels across the three sites.</p><p>else?" and if the respondent selected "YES," they were asked to further "SPECIFY:</p><p>" the source. The list included legal sources of income (such as "Paid job, salary, or business," "Welfare, public assistance, or AFDC," "Social Security, disability, or Workman's Compensation," "Student Loan," and "Selling or trading goods, or bartering") as well as illegal sources of income (such as "Dealing drugs," "Winnings from gambling or betting," and "Prostitution or trading sex"). Approximately one third (33%, N=209) of the participants reported using one or more illegal activities as additional sources of income. Cross-tabulation of the measure of income distribution and sources of income (legal vs. illegal) indicated that individuals from lower income brackets ($15,000 and under) resorted more to illegal sources of income than participants with higher income brackets,  2 (2)=10.04, p=.007.</p><p>Consumption Patterns of Ecstasy ---Table <ref type="table">4</ref>.2 includes descriptive information indicating levels of involvement with Ecstasy and other illicit drugs. The Table also provides psychiatric diagnostic information used to designate whether a participant met criteria for abuse or dependence; i.e., addicted on a particular drug.</p><p>The first column in Table <ref type="table">4</ref>.2 shows descriptive statistics for the overall sample (N=640), while the remaining columns describe the sample by gender (second and third columns) and site (fourth, fifth and sixth columns). The statistical information includes numerical frequencies and percentages for categorical variables, and means with their standard deviations (SD) for continuous variables. Statistical analysis of categorical measures relied on the chi-square ( 2 (df)) statistic, while t-tests or oneway analysis of variance (ANOVA) was used for continuous measures. To assess whether these differences were consistent across the age ranges of participants' first use of Ecstasy, the age of onset variable was categorized, using 5years date bands. Overall, nearly 80% of participants reported initiating their use of Ecstasy before the age of 21, corresponding to the minimum legal drinking age in the United States. In particular, 16 participants (2% of total sample) started using Ecstasy while they were 14 years old or younger and 491 participants (77%) used Ecstasy when they were between the ages of 15 and 20 years. In contrast, 87 participants (14% of the total sample) reported initiating their use of Ecstasy when they were engage in sexual risk than participants from St. Louis, M SL-SDY =.32, t=2.09, p=.0374, and Miami, M MI-SDY =.31, t=1.95, p=.0536. There were however no statistically significant differences in the mean levels of sexual risk-taking between the participants from St. Louis and Miami.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Age of Onset of</head><p>Tests of Multicollinearity ---A commonly used approach to check for the presence of multicollinearity relies on the strength or magnitude of bivariate associations (or inter-correlations) between each pair of variables in the data. Large magnitude of association between any given pair would indicate not only empirical overlap, but also conceptual overlap, suggesting the two variables measure the same phenomenon. It is usually suggested that an absolute value of Pearson's |r| less than .10 is "trivial," between .10 and .35 is "small" (or low), between .35 and .70 is "moderate," and greater than .70 is substantially "large" (or high). Based on this interpretation, multicollinearity should be a very serious concern when the intercorrelation between a pair of independent variables is large, |r| &gt;.70, which generally means that there is considerable redundancy between the two items <ref type="bibr">(Ferketich, 1991)</ref>.</p><p>On the other hand, construction of a well-defined and psychometrically reliable construct requires that the relations between its indicators (items, parcels or multiitem scales) be moderate to large (r = .45 to .60).</p><p>Given the type of data used in this study, both parametric (Pearson) and nonparametric (Spearman's rank-order) inter-correlations between all the measured variables and/or latent constructs developed within the five domains defined above accounts for predictive variance). This By all indications, a model positi as 'unbiased' model) did not provide an optimal fit to the data (results not shown in Tables <ref type="table">),</ref><ref type="table"> 2 (11) = 69.40,</ref><ref type="table">p  .001 ( 2 /df = 6.31</ref>), NFI = .922, CFI = .932, SRMR = .049, RMSEA = .091, and AGFI = .924. Specifically, the  2 was large and statistically significant and the  2 /df = 4 exceeded the upper bounds of acceptable upper limits for this fit index. Furthermore, although the Comparative Fit Index (CFI  .9) and the Adjusted Goodness of Fit Index (AGFI  .9) meet the criteria for adequate model fit, the RMSEA was greater than .05, indicating there was substantial Post-Hoc Specifications and Model Refinement -At this point it made sense with all of the specified predictors included in the model to run empirical specification searches to detect any additional 'nonstandard' effects (or associations in this case, given the cross-sectional nature of the data) that may help improve the overall model fit. Theoretically speaking, the full model specified very general predictive relations; however, there are other less obvious relations that exist within the data that may be sample specific, but were not hypothesized as part of the psychoeconomic model. These also help to uncover the "true" model. The specification searches include any "indicators" of a predictor construct that influence either an endogenous latent construct or the indicator corresponding to an endogenous construct. In addition, nonstandard relations can include exogenous constructs that "1" and onsumption and Dependence. Although this model showed a better fit than th those from St. Louis and Miami coded as "0"). Again these additions led to a decrement in model fit,  2 (321) = 1356.42, p  .001 ( 2 /df = 4.23), NFI = .760, CFI = .803, RMSR = .09, RMSEA = .07, and AGFI = .841. Furthermore, there was also additional evidence of "suppression" because certain parameter estimates (income index and monetary cost) reversed signs predicting both Consumption ( = .01, p &gt; .10 and  = .30, p &gt; .10, respectively) and Dependence ( = -.01, p &gt; .10 and  = -.02, p &gt; .10, respectively). Indeed, based on earlier bivariate analysis, both race and education were strongly associated with site (see Table <ref type="table">4</ref>.1). Since neither variable reached the nominal alpha level for significance, they were candidates for elimination.</p><p>A third and final conditioned model examined the effect of gender, age and site on both C e two previous models, it was only marginally acceptable (reported in Tables 4.8 and 4.9),  2 (272) = 1042.51, p  .001 ( 2 /df = 3.83), NFI = .829, CFI = .901, RMSR = .08, RMSEA = .07, and AGFI = .868. Of all three control variables added to the model, only site was a strong and significant ( = .479, p  .001) predictor of Ecstasy use or Consumption, indicating that, holding all else constant, Ecstasy users in Australia consumed more pills that their counterparts in St. Louis and Miami. On the other hand, gender ( = -.11, p  .01) and age ( = .15, p  .001) were the only significant predictors of Dependence. At this point there were no further statistical tests that could be applied to ascertain the validity of the research hypotheses.</p><p>The chapter begins with a review of the purpose of the study, continues with discussion of the study rationale, and then summarizes the findings with respect to the main research hypotheses. The chapter also revisits ways in which the current study improves upon and refines existing research on drug consumption. The chapter then discusses the strengths as well as the limitations of the data noting in particular its source, data collection methods, data manipulations, and transformations. The chapter concludes by discussing the potential implications of these findings and provides recommendations for future research.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Purpose of the Study</head><p>For centuries, philosophers have engaged considerable debate over whether man acts in a rational or irrational manner in making certain decisions. For the most part, these different views of "thought" have fueled considerable discussion with different disciplines weighing in at different times. Among the many disciplines investigating human behavior, economists take the view that humans are entirely rational and their behavior can therefore be examined through traditional marketprice mechanisms (i.e., invisible hand). The success of this approach has gained earnest respect and models have been developed to explain production and consumption of goods and services, as well as many other aspects of day-to-day economic activity. Interestingly, drug use is one of many activities engaged by</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CHAPTER V: DISCUSSION AND CONCLUSIONS</head><p>Findings from the Model including Demographics ---Data were obtained from three distinct study sites, each containing unique cultural, ethnic (racial), and social influences that may affect consumption practices. Earlier variance decomposition analyses had indicated relatively equivalent representation of gender at the different sites, ensuring that socialization practices should not play a large role in any observed differences in drug consumption practices. However, the Miami site had fewer white participants and a much greater proportion of Hispanic participants.</p><p>The St. Louis site, on the other hand had more African-American participants, all of which may presage any observed difference in the operation of economic or psychological factors. For instance, fewer participants from Sydney were in the lower income bracket and more Sydney participants were working full time and fewer were unemployed than participants from the US sites. ifferences suggest that important site differences may influence There were also some significant differences in consumption patterns across the three sites. In particular, participants from St. Louis were older when they first started using Ecstasy and were much newer to the drug in terms of the gap between when they started and last used it (or used more recently). These same individuals from St. Louis had lower mean levels of consumption than Miami or Sydney participants. Sydney participants had used Ecstasy more recently, were more "regular" users, and had higher daily intake of Ecstasy based on quantity and The conditioned models were tested in stages. This was done in order to detect any subtle relations that may be produced by the participants' gender, age, race, education, and location. The assumption here is that higher educated, older, males earn more than others. In fact, this might have masked the true effects of income and opportunity cost. The model including all control measure with the exception of site provided an inferior fit compared to the full model (the CFI went from .898 down to .849).</p><p>When site was added to the full set of demographic measures, the model slightly improved. However, by all indication it still provided a poorer fit than the full model. This perhaps underscores that race and ed words, Sydney had a disproportionate representation of higher-earning participants and white drug users, while the remaining sites had relatively more African-American and Hispanic participants earning less. Site is essentially capturing the effect of race and education and along with these demographics possibly income.</p><p>A model trimmed of race and education and only including the remaining demographic measures (gender and age) and site fit reasonably but showed a slight decrement in fit. In fact, there is evidence of confounding indicating conditioning of the relations between race, age, education, and consumption. In order to tease these apart, a trimmed model was tested with site, gender, and age. ched out and hant's tail and blurted out "truly a queer animal." He then returned and sat story of drug abuse is also a matter of perspective. That is, if the story teller is where his friends were seated and joined them. It was the second blind man's turn and he walked to the elephant with the assistance of the merchant. He rea touched the elep beside his friends.</p><p>It was the third blind man's turn and he walked to the elephant whereupon he touched its trunk, swaying back and forth from side to side. He blurted out "That's it! I've learned." Each blind man then graciously thanked the merchant and went on their merry way. They were excited to share their new knowledge about the elephant. Soon they sat under a tree at which point the second blind man blurted out, "this queer animal is like our straw fans swinging back and forth to provide a breeze." It is, he continued "rather wispy in touch and feel." The first blind man shouted in disagreement, "No, no, this queer animal is like two big trees that have no branches." Without hesitating, the third blind man stated, "this queer animal is like a snake, long, round, and very strong."</p><p>The economically minded analyst, market factors like income, unit price, and the considerable time one spends locating a drug accurately foretell consumption practices. However, when the world is viewed through a psychologist's lenses other factors like motivation or the underlying desires that foster drug use appear to matter.</p><p>Clearly, the combination of perspectives provides a better view of the "elephant" and allows each of the blind men to see the true animal. liffs, NJ: Prentice-Hall Akaike, H. <ref type="bibr">(1987)</ref>. Factor analysis and AIC. Psychometrika, 52, 317-332.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ameri</head><p>A review and recommended two-step approach. Psychological Bulletin, 103, 411-Arbuckle, J. L. <ref type="bibr">(1997)</ref>. Amos User's Guide Version 3.6. Chicago: Smallwaters integration. In D. K. Freedheim (Ed.), History of psychotherapy: A century of part of IND # 63,384. MAPS website.</p><p>Bagozzi, R. P., and Heatherton, T. F. <ref type="bibr">(1994)</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Wi</head><p>H., <ref type="bibr">Reich, T., Goate, A. M., Beirut L. J. (2004)</ref>. Evidence of common and spec genetic effects: association of (CHRM2) gene with alcohol dependence and major depressive syndrome. Human Molecular <ref type="bibr">Genetics, vol. 13:17, 1903</ref><ref type="bibr">Genetics, vol. 13:17, -1911. .</ref> </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Understanding attitudes and predicting social behavior</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ajzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fishbein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)</title>
		<meeting><address><addrLine>Washington, DC</addrLine></address></meeting>
		<imprint>
			<publisher>American Psychiatric Association</publisher>
			<date type="published" when="1980">1980. 1994</date>
			<biblScope unit="page">4</biblScope>
		</imprint>
	</monogr>
	<note>th ed.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Gerbing</surname></persName>
		</author>
		<title level="m">Structural equation modeling in practice: 423. Corporation</title>
		<imprint>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Introduction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Archer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tritter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Rational Choice Theory: Resisting Colonization</title>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Archer</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><surname>Tritter</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Arnkoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Glass</surname></persName>
		</author>
		<title level="m">Cognitive therapy and psychotherapy change</title>
		<meeting><address><addrLine>Washington, DC</addrLine></address></meeting>
		<imprint>
			<publisher>American Psychological Association</publisher>
			<date type="published" when="1992">1992</date>
			<biblScope unit="page" from="657" to="694" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">3,4-methylenedioxymethamphetamine (MDMA)-a review of the English-language scientific and medical literature</title>
		<author>
			<persName><forename type="first">M</forename><surname>Baggott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jerome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stuart</forename><forename type="middle">R</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>Submitted to FDA as ltifaceted personality constructs: Application to state self-esteem. Structural</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">On the Use of Structural Equation Models in Experimental Designs</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Bagozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Marketing Research</title>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Rivers</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="271" to="284" />
			<date type="published" when="1998">1998</date>
			<publisher>Nebraska symposium on Nebraska Press</publisher>
		</imprint>
	</monogr>
	<note>psychobiological analysis of urges</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The effects of item parceling on goodness-of-fit and parameter estimate bias in structural equation modeling</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Bandalos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structural Equation Modeling</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="78" to="102" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Social Learning Theory</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bandura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Tler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">EQS: Structural equations pro CA: BMDP Statistical Software. tler, P.M</title>
		<meeting><address><addrLine>Englewood Cliffs, NJ</addrLine></address></meeting>
		<imprint>
			<publisher>Prentice Hall</publisher>
			<date type="published" when="1977">1977. 1992. 1992</date>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="400" to="404" />
		</imprint>
	</monogr>
	<note>Bulletin</note>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Tler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J C</forename><surname>Wu</surname></persName>
		</author>
		<title level="m">EQS for Multivariate Software, Inc. tler, P. M</title>
		<meeting><address><addrLine>Encino, CA</addrLine></address></meeting>
		<imprint>
			<publisher>Multivariate Software, Inc</publisher>
			<date type="published" when="1995">1995. 1995</date>
		</imprint>
	</monogr>
	<note>EQS structural equations program manual</note>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-H</forename><surname>Yuan</surname></persName>
		</author>
		<title level="m">Structural equation modeling with sma samples: Test statistics</title>
		<imprint>
			<publisher>Multivariate Beha</publisher>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main">EQS 6 Structural Equations Program Manual</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>Multivariate Software</publisher>
			<pubPlace>Encino, CA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Berke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hyman</surname></persName>
		</author>
		<title level="m">Addiction, dopamine, and the molecular mechanisms of memory</title>
		<imprint>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Berridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Robinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brian Research Reviews</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="309" to="369" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The debate over dopamine&apos;s role in reward: the case for incentive salience</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Berridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends in Neurosciences</title>
		<editor>
			<persName><forename type="first">K</forename><forename type="middle">C</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="391" to="431" />
			<date type="published" when="2003">2003. 2003. 2006. 2007</date>
		</imprint>
	</monogr>
	<note>Psychopharmacology</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bespalov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lebedev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Panchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zvartau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="377" to="383" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Toward a behavioral econo understanding of drug dependence: Delay discounting processes</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Kel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Marsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="73" to="86" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Compulsive buying: A review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Black</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Psych</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="50" to="55" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Prophets of Psychoheresy II</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bobgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bobgan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1990">1990</date>
			<publisher>EastGate Publishers</publisher>
			<pubPlace>Santa Barbara, California</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">School-based substance abuse prevention: Political</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Bu ; Bollen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Latent variables Review of Psychology</title>
		<editor>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Len</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Long</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Wiley len, K. A</publisher>
			<date type="published" when="1972">2002. September. 1989. 1989. 2002. 1993. 1972. 1978</date>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="585" to="609" />
		</imprint>
	</monogr>
	<note>A Habit Form 19</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The ration economics for the consideration of heroin control policies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Er</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Birn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Handbook of Research Methods in Social and Personality Psycho Cambridge</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">F P</forename><surname>Dges</surname></persName>
		</editor>
		<imprint>
			<publisher>CHERE Discussio Paper</publisher>
			<date type="published" when="1983">1983. 2008. 2003. 2000. 1999</date>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="661" to="679" />
		</imprint>
		<respStmt>
			<orgName>Centre for Health Economics Research and Evaluation, Univer of Sydney</orgName>
		</respStmt>
	</monogr>
	<note>Rational Demand and Expenditures Patterns under Habit Formation</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Some contributions of the study of gambling to the study o other addictions</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I F</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Eadington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cornelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Reno. Wne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cudeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Cudeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">erimental economics</title>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Sage</surname></persName>
		</editor>
		<meeting><address><addrLine>Newbury Park, CA; Princeton, NJ</addrLine></address></meeting>
		<imprint>
			<publisher>Princeton Ca</publisher>
			<date type="published" when="1989">1993. 1989. 1993</date>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="587" to="703" />
		</imprint>
	</monogr>
	<note>Rational Addiction and the Demand for Cinema. Applied Ca 0). Nicotine addiction and cigarette consumption: A psycho-11-219</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">An ethnographic rs</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Ca Ck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Org</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="279" to="286" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Biology</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="187" to="195" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Byrne</surname></persName>
		</author>
		<title level="m">Structural Equation Modeling with EQS and EQS/Windows: Basic Concepts, Applications, and Programming</title>
		<meeting><address><addrLine>Thousand Oaks</addrLine></address></meeting>
		<imprint>
			<publisher>Sage Publications Inc</publisher>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>First ed.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Adoption study demonstrating two genetic pathways to drug abuse</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Cadoret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Yates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Troughton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="42" to="52" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Fal approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine use</title>
		<author>
			<persName><forename type="first">C</forename><surname>Camerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Siegal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Economic Behavior and Organization</title>
		<editor>
			<persName><forename type="first">J</forename><surname>Kage</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Roth</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">9</biblScope>
			<date type="published" when="0199">1995. 199</date>
			<publisher>Handbook of exp University Press. meron, S</publisher>
		</imprint>
	</monogr>
	<note>617-620. meron, S. (200 economic model</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Long effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials</title>
		<author>
			<persName><forename type="first">C</forename><surname>Casco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Forcella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Beretta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grieco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Campana</surname></persName>
		</author>
		<idno type="DOI">10.1080/13556210500123340</idno>
		<ptr target="http://www.informaworld.com/10.1080/13556210500123340" />
	</analytic>
	<monogr>
		<title level="m">last retrieved on February 9</title>
		<editor>
			<persName><forename type="first">J</forename><surname>Stillo</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Barrio</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Belza</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">L</forename><surname>De La F Ca Uente</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1999">2005. 2010. 1999</date>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1156" to="1163" />
		</imprint>
	</monogr>
	<note>Drug and alcohol Ca addiction sciences</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Ecstasy Overdoses at a New Year&apos;s Eve n the 922a consumption and sexual risk behaviour among young adults: Results from a national survey</title>
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="47" to="53" />
			<publisher>Cen ity Weekly Report</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">What economics can contribute to the Centers for Disease Control and Prevention (CDC)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Ulkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nicosia</surname></persName>
		</author>
		<ptr target="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5922a1.htm?s_cid=mm" />
	</analytic>
	<monogr>
		<title level="j">Morbidity and Mortality Weekly Reports</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="722" to="742" />
			<date type="published" when="1991">2010. 1991. 2010. June. 2010. 1991</date>
			<pubPlace>Los Angeles, California</pubPlace>
		</imprint>
	</monogr>
	<note>Journal of Political Economics</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Price, tobacco control policies and 373</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ch Wechsler</surname></persName>
		</author>
		<ptr target="com/features/20060228/clark_01.shtml" />
	</analytic>
	<monogr>
		<title level="m">Tobacco control in developing Ch oclassical to behavioral economics</title>
		<editor>
			<persName><forename type="first">J</forename><surname>Prabhart</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">F</forename><surname>Chaloupka</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>Heather N. &amp; Vuchinich land: ald Cla gamasutra</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">National Bureau of Economic Research Working Paper No. 5740 aloupka, F. J. and smoking among young adults</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Chaloupka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grossman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The economics of addictio countries</title>
		<editor>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Tauras</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Grossman</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename></persName>
		</editor>
		<meeting><address><addrLine>Oxford, UK</addrLine></address></meeting>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="1996">1996. 2000</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="107" to="129" />
		</imprint>
	</monogr>
	<note>Price, tobacco control policies and youth smoking</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Evolving models of addictive behavior: From ne</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Emery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Choice, behavioural economics and addiction</title>
		<editor>
			<persName><forename type="first">R</forename><forename type="middle">E</forename></persName>
		</editor>
		<imprint>
			<publisher>Ltd</publisher>
			<date type="published" when="2003">2003</date>
			<biblScope unit="page" from="71" to="94" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Health Consequences of Illegal Drug Use</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="287" to="292" />
			<date type="published" when="2009">2009. 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Model modification in covariance structure modeling: A comparison among likelihood ratio, Lagrange multiplier, and W tests</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Multivariate Behavioral Research</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="115" to="136" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Estimates and tests in structural equation modeling</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
		<idno type="DOI">10.1080/13556210500123340</idno>
		<ptr target="http://www..ence,nd" />
	</analytic>
	<monogr>
		<title level="m">Structural equation modeling: Concepts, issues, and applications</title>
		<editor>
			<persName><forename type="first">Rick</forename><forename type="middle">H</forename><surname>Hoyle</surname></persName>
		</editor>
		<meeting><address><addrLine>Thousand Oaks, CA</addrLine></address></meeting>
		<imprint>
			<publisher>Sage Publications. rk, N</publisher>
			<date type="published" when="1995">1995. 2006</date>
			<biblScope unit="page" from="37" to="55" />
		</imprint>
	</monogr>
	<note>Are Games Addictive? The State of the Science</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">assessment of ICD-10 substance dependence disorders: CIDI-SAM vs. SCAN</title>
		<author>
			<persName><forename type="middle">E</forename><surname>Co</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Muhleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gysin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Flanagan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Methods Psychiatric Research</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="285" to="293" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>The ol Depend</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Inheritance of Alcohol Abuse: Cross Fostering Analysis of Adopted Men</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Cloninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bohman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sigvardsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of General Psychiatry</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="861" to="868" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Neurogenetic adaptive mechanisms in alcoholism</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Cloninger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci</title>
		<imprint>
			<biblScope unit="volume">236</biblScope>
			<biblScope unit="page" from="410" to="416" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">The Love Drug: Marching to the Beat of Ecstasy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Cohen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
			<publisher>The Hayworth Medical Press, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Stress</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Macmillan Library Reference. mings, D dopamine D2 receptor gene: a genetic risk factor in substance abuse</title>
		<editor>
			<persName><forename type="first">J</forename><surname>Jaffe</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>Encyclopedia of Drugs a Alcohol</note>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Dorsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Spitznagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Mager</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Structured and semi-structured</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Biasing influences on Drug Arrest Records: Implications for Deviance Research</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Creswell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Plano</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Structural Equation Modeling: Present and Future Lincolnwood, IL. leur, L</title>
		<editor>
			<persName><forename type="first">R</forename><surname>Deck</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Du Toit</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Srbom</surname></persName>
		</editor>
		<meeting><address><addrLine>Thousand Oaks, Calif</addrLine></address></meeting>
		<imprint>
			<publisher>American Soci</publisher>
			<date type="published" when="1975">2007. 2001. 1975</date>
		</imprint>
	</monogr>
	<note>Designing and conducting mixed methods research</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<author>
			<persName><forename type="first">L</forename><surname>Degenhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Topp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Ecstasy use in Australia: Findings from a national household survey</title>
		<meeting><address><addrLine>enhardt, L., Roxburgh</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="187" to="195" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">A Complex Approach to Estimate the Shadow Economy: The Structural Equation Modelling</title>
		<author>
			<persName><forename type="first">J</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Topp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Topp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dell'anno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The Epidemiology of Ecstasy Us and Harms in Australia</title>
		<editor>
			<persName><forename type="first">Marzia</forename><surname>Faggini</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Thomas</forename><surname>Lux</surname></persName>
		</editor>
		<meeting><address><addrLine>Heidelberg</addrLine></address></meeting>
		<imprint>
			<publisher>Springer Publ. Comp</publisher>
			<date type="published" when="2009">2009. 2010. 2009</date>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="110" to="130" />
		</imprint>
	</monogr>
	<note>Di , 13-30. eses cts. from imaging studies. with the C</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Drug addiction as dopamine-dependent associative learning disorder</title>
		<author>
			<persName><forename type="first">G</forename><surname>Chiara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="page">375</biblScope>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">From rats to humans and return: testing addiction hypoth by combined PET imaging and self-reported measures of psychostimulant effe Commentary on Volkow et al. &apos;Role of dopamine in drug reinforcement and addiction in humans: results</title>
		<author>
			<persName><forename type="first">G</forename><surname>Di Chiara</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2002">2002</date>
			<biblScope unit="page" from="371" to="377" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Reward system and addiction: What dopamine does and doesn&apos;t do</title>
		<author>
			<persName><forename type="first">G</forename><surname>Di Chiara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bassareo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">A clinical plan for MDMA(Ecstasy) in the treatment o traumatic stress disorder (PTSD): Partnering with the FDA</title>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<ptr target="http://www.maps.org/news-letters/v12n3/12305dob.pdf" />
	</analytic>
	<monogr>
		<title level="m">last retrieved on Octob 28, 2010. er drug users&apos; self-report of HIV risk behaviors</title>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2002">2002</date>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="185" to="194" />
		</imprint>
	</monogr>
	<note>383-Dra cting users: a review. Drug and Alcohol Du. tin, 51, on t variables. Journal of</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Reliability and validity of 392</title>
		<author>
			<persName><forename type="first">Efr</forename><surname>Dowling-Guyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Needle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kotranski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rhodes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Weatherby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Estrada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Deren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tortu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Self-report among inje Dependence</title>
		<imprint>
			<date type="published" when="1994">1994. 1998</date>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="253" to="263" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Introduction to Structural Equation Models</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychological Bulle</title>
		<imprint>
			<biblScope unit="page" from="380" to="417" />
			<date type="published" when="1954">1975. 1954</date>
			<publisher>Academic Press</publisher>
		</imprint>
	</monogr>
	<note>The theory of decision making</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Alcohol dependence: provisional descripti of a clinical syndrome</title>
		<author>
			<persName><forename type="first">G</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British medical journal</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="1058" to="1061" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Test-retest reliability of self-reported drug treatmen</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Redpath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Substance Abuse Treatment</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="7" to="11" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">An introduction to the bootstrap</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tibshirani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">ing in Els blems in the theory of rational behavior. Acta Fer cs: Aspects of item analysis</title>
		<meeting><address><addrLine>Boca Raton, FL</addrLine></address></meeting>
		<imprint>
			<publisher>CRC Press</publisher>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>Research in</note>
</biblStruct>

<biblStruct xml:id="b53">
	<monogr>
		<title level="m" type="main">Alcohol Use Across the Life Course: A Critical Review of arch Fis edictors of single</title>
		<author>
			<persName><forename type="first">For</forename><surname>Fill</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">As others see us: A case study in path analysis</title>
		<author>
			<persName><forename type="first">Fre</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">D</forename><surname>Wightman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Fri Ga</title>
		<imprint>
			<biblScope unit="page" from="2" to="1652" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Research violence against women: Methodological and ethical considerations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ellsberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agurto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Winkvist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Focus on psychometri Nursing &amp; Health</title>
		<editor>
			<persName><forename type="first">J</forename><surname>Ter</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="165" to="168" />
			<date type="published" when="1991">2001. 1993. 1991</date>
			<publisher>Some unresolved pro Sociologica</publisher>
		</imprint>
	</monogr>
	<note>Studies Family Planning</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Places and patterns of drug use in the Scottish dance scene</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="511" to="521" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>more, K. M 70 Years of International Longitudinal Research. Toronto: Addiction Rese Foundation</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Attitudes towards objects as pr and multiple behavioural criteria</title>
		<author>
			<persName><forename type="first">H</forename><surname>Fingarette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">D. Educational Statistics</title>
		<editor>
			<persName><forename type="first">M</forename><surname>Berkeley. Hbein</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">I</forename><surname>Ajzen</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="101" to="128" />
			<date type="published" when="1974">1989. 1974</date>
			<publisher>University of California Press</publisher>
		</imprint>
	</monogr>
	<note>Psychological Review</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation</title>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">398</biblScope>
			<biblScope unit="page" from="67" to="69" />
			<date type="published" when="1956">1956. 1999</date>
			<publisher>Princeton University Press</publisher>
			<pubPlace>Princeton</pubPlace>
		</imprint>
	</monogr>
	<note>rris</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">The Economics of Addiction: the role of the economist in addictions research</title>
		<author>
			<persName><forename type="first">C</forename><surname>Godfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maynard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Addiction</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="1109" to="1112" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Structural equation models in the social sciences</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Goldberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Econometrica</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="979" to="999" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Golding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Aneshensel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Factor structure of the Center for Epidemiological Studies Depression Scale among Mexican Americans and Non-Hispanic Whites</title>
		<imprint>
			<date type="published" when="1989">1989</date>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="163" to="168" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Z</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Volkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page">164</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Gr behavior and alcohol use among young adults: Results Gr r mixed-method evaluation design. Educational Evaluation and Gr ducting therapeutic sessions with Gr evel eb at</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Golod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Schulsinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Go Op</surname></persName>
		</author>
		<ptr target="http://www.psychedelic-library.org/enhance.htm" />
	</analytic>
	<monogr>
		<title level="m">Structural Equation Modeling for Travel Behavior Research</title>
		<meeting><address><addrLine>Irvine, Ca</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1977">2001. 56t8j1n6#page-1. April 25. 2011. 1977. 2001. 1995. 1989</date>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="255" to="274" />
		</imprint>
		<respStmt>
			<orgName>UCI-ITS-WP-AS Transportation Studies. Univ. of California</orgName>
		</respStmt>
	</monogr>
	<note>Policy Analysis</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">A method of con MDMA</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tolbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychoactive Drugs</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="371" to="379" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Levels of aggregation in higher l confirmatory factor analysis: Application for academic self-concept</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Hocevar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structural Equation Modeling</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="377" to="390" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Can Drugs Be Used to Enhance the Psychotherapeutic Process?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Grinspoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Bakalar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Psychotherapy</title>
		<imprint>
			<biblScope unit="volume">XL</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="27" to="474" />
			<date type="published" when="1986">1986</date>
			<pubPlace>Cambridge MA</pubPlace>
		</imprint>
	</monogr>
	<note>Available on the w , last Gr of future panels. Gr ts</note>
</biblStruct>

<biblStruct xml:id="b67">
	<monogr>
		<author>
			<persName><forename type="first">Anderson</forename><forename type="middle">R</forename><surname>Gr</surname></persName>
		</author>
		<title level="m">A Survey of Economic Ha iate all. s 09. retrieved on February 9</title>
		<imprint>
			<date type="published" when="1998">1998. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Ossman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Chaloupka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sirtalan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>An empirical analysis alcohol addiction: results from the monitoring the National Bureau of Economic Research Working Paper 5200</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">The demand for cocaine by young adul a rational addiction approach</title>
		<author>
			<persName><forename type="first">M</forename><surname>Chaloupka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chaloupka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">ossman</title>
		<imprint>
			<date type="published" when="1998">1998</date>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="631" to="643" />
		</imprint>
	</monogr>
	<note>Journal of Drug Issues</note>
</biblStruct>

<biblStruct xml:id="b70">
	<monogr>
		<title level="m" type="main">Research methods in criminal justice and criminology</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Gan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1993">1993</date>
			<publisher>MacMillan</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>Third edition</note>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title level="m" type="main">Multivar Data Analysis with Readings, 5th Edition</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hair</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Tatham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Black</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
			<publisher>Prentice H</publisher>
			<pubPlace>Englewood Cliffs, NJ</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five specie of laboratory animals</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Hardman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">O</forename><surname>Haavik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Seevers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicology and Applied Pharmacology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="299" to="302" />
			<date type="published" when="1973-06">1973. June</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<monogr>
		<title level="m" type="main">Prepared f National Clearinghouse for Mental Health Information. ath A. C., Madden, P. A. F., and Mart cooperation bias and attrition in behavioral genetic research using data-w Behavior Genetics</title>
		<author>
			<persName><forename type="first">Education</forename><surname>Health</surname></persName>
		</author>
		<author>
			<persName><surname>Welfare</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1968">1968</date>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="415" to="427" />
		</imprint>
	</monogr>
	<note>Alcohol and Alcoholism</note>
</biblStruct>

<biblStruct xml:id="b74">
	<monogr>
		<title level="m" type="main">Environmental Factors in Alcohol Use and Its Outcomes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename></persName>
		</author>
		<editor>H.W. Goeddle and Dharam P. A Genetic Aspects</editor>
		<imprint>
			<date type="published" when="1989">1989</date>
			<publisher>Pergamon Press</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Respondent driven sampling: a new approach to the study of hidden populations</title>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Soc Probl</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="174" to="199" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">AIDS and social networks: Prevention through network mobilization</title>
		<author>
			<persName><forename type="first">D</forename><surname>Heckathorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Broadhead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Anthony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Weakliem</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sociological Focus</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="159" to="179" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Ex of Respondent-Driven Sampling: A New Approach to the Study of Injection Dru Users Aged</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ckathorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Semaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Broadhead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Hughes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS and Behavior</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="18" to="25" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Toxicity and deaths from 3,4methylenedioxymethamphetamine (&apos;ecstasy&apos;)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Jeffreys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dawling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page" from="384" to="387" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hernandez-Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Farre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Roset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Menoyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pizarro</surname></persName>
		</author>
		<author>
			<persName><surname>Ortuno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="236" to="244" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Resolving the contradictions of addiction</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Heyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behavioral a Brain Sciences</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">56</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Dissociation of wanting and lik alcohol in humans: a test of the incentive-sensitization theory</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hobbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Remington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Glautier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="293" to="499" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Reliability of substance use disorder diagnoses among African-American and Caucasians</title>
		<author>
			<persName><forename type="first">J</forename><surname>Horton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcoho Depend</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="203" to="209" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Diagnostic concordance of DSM-III-R, DSM-IV, a Disorders</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Ard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Abdallah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="223" to="228" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Fit indices in covariance structural equa modeling: Sensitivity to under parameterized model misspecification</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bentler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychological Methods</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="424" to="453" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Cutoff criteria for fit index structure analysis: Conventional criteria versus new alternatives</title>
		<author>
			<persName><forename type="first">L.-T</forename><surname>Bentler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structural Equation Modeling</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1" to="55" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Addiction and the brain: the neurobiology compulsion and its persistence</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Man</surname></persName>
			<affiliation>
				<orgName type="collaboration">Nat Rev Neuros Hyman, S. E.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Malenka</surname></persName>
			<affiliation>
				<orgName type="collaboration">Nat Rev Neuros Hyman, S. E.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename></persName>
			<affiliation>
				<orgName type="collaboration">Nat Rev Neuros Hyman, S. E.</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1414" to="1422" />
			<date type="published" when="2001">2001. 2001. 2005</date>
		</imprint>
	</monogr>
	<note>Addiction: a disease of learning and memory</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Addiction and Satiation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phases in the D Journal of Studies on Alcohol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="88" />
			<date type="published" when="1946">1986. 1946</date>
		</imprint>
	</monogr>
	<note>Econ. Letters</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Phases of alcohol addiction</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Quarterly Journal of Studies on Alcohol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="673" to="684" />
			<date type="published" when="1952">1952</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<monogr>
		<title level="m" type="main">MDMA Literature update</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jerome</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004-01">2005. March 2004-January 2005</date>
			<publisher>Ultidisciplinary Association for Psychedelic Studies</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Maturing out of substance use: The other side of etiology</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Jochman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fromme</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">rug Use, working paper. 91-815. and Social . ey blication No. 10-7583)</title>
		<editor>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Petry</surname></persName>
		</editor>
		<meeting><address><addrLine>Washington, D.C; Bethesda, MD</addrLine></address></meeting>
		<imprint>
			<publisher>American Psychology Association Press</publisher>
			<date type="published" when="2004">2009. 2004</date>
		</imprint>
		<respStmt>
			<orgName>National Institute Jofre-Bonet</orgName>
		</respStmt>
	</monogr>
	<note>Effects of Heroin and Cocaine Price Changes on Addicts&apos; Polyd</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Three perspectives on addiction</title>
		<author>
			<persName><forename type="first">B</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Psychoanalytic Association</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">7</biblScope>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Stability of psychological symptoms: Drug use consequences and intervening processes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Health Behavior</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="277" to="291" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<monogr>
		<title level="m" type="main">Monitoring the Future national results on adolescent drug use: Overview of k findings</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>O'malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Bachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Schulenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>O'malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename></persName>
		</author>
		<ptr target="http://www.monitoringthefuture.org/pubs/monographs/overview2009.pdf" />
		<imprint>
			<date type="published" when="2009">2010a. 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Joh Schulenberg</surname></persName>
		</author>
		<ptr target="http://monitoringthefuture.org/pubs/m," />
		<title level="m">last retrieved on Jr social 982), Party I, Chapter 4. . re Int. etween alcohol use and risky sexual behavior. use, heavy use, abuse, and dependence in a US 1-269. Kh f addictive disorders: Kli ion modeling</title>
		<meeting><address><addrLine>Bethesda, MD; New York</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford</publisher>
			<date type="published" when="1975">2010b. 1975-2009. February 9, 2010</date>
		</imprint>
		<respStmt>
			<orgName>National Institute on Drug Abuse</orgName>
		</respStmt>
	</monogr>
	<note>me I: onographs/vol1_2009.pdf Monitoring the Future national survey results on drug use</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">The LISREL approach to causal model-building in the sciences</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Jreskog/Wold</title>
		<imprint>
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<monogr>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Jreskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Srbom</surname></persName>
		</author>
		<title level="m">LISREL 8User&apos;s Reference Guide</title>
		<meeting><address><addrLine>Chicago</addrLine></address></meeting>
		<imprint>
			<publisher>Sci Softwa</publisher>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<monogr>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Jreskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Srbom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Du Toit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Du Toit</surname></persName>
		</author>
		<title level="m">LISREL 8: New Statistical Features</title>
		<meeting><address><addrLine>Chicago</addrLine></address></meeting>
		<imprint>
			<publisher>Scientific Software International</publisher>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">The influence of traits of disinhibition on the association b</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Justin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Finn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Steinmetz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Clin Exp Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1028" to="1035" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">On the Loss-of-Control Phenomenon in Alcoholism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Keller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Addiction</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="155" to="166" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Illicit psychoactive substance population-based sample of male twins</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Kendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Karkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Neale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Prescott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Principles and practices of structural equat nd erns. andbook of Motivational Counseling</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Ne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="1259" to="1264" />
			<date type="published" when="1985">1985. 1998</date>
			<publisher>Ku stial</publisher>
		</imprint>
	</monogr>
	<note>The self-medication hypothesis o Focus on heroin and cocaine dependence</note>
</biblStruct>

<biblStruct xml:id="b102">
	<monogr>
		<title level="m" type="main">Leg g and Les -241</title>
		<author>
			<persName><surname>Lea</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">rnal of Lin ss. el or n, Weighing the Merits. Structural Equation Lom Low tance use and HIV-related sexual behaviors among US high school</title>
		<author>
			<persName><forename type="first">America</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Studies on Alcohol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="143" to="174" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Kline</surname></persName>
		</author>
		<title level="m">Principles and Practice of Structural Equation Modeling</title>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford</publisher>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>2 ed.</note>
</biblStruct>

<biblStruct xml:id="b105">
	<monogr>
		<title level="m" type="main">Motivation and the Theory of Current Conc</title>
		<author>
			<persName><forename type="first">E</forename><surname>Klinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Cox</surname></persName>
		</author>
		<editor>W. Miles Cox and Eric Klinger</editor>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>H John Wiley &amp; Sons, Ltd</publisher>
			<biblScope unit="page" from="1" to="27" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Cele Arts Lawson DM. Canadian Chiropractic Examining Board: report to the profession</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Can Chiropr Assoc</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="201" to="205" />
			<date type="published" when="1976">1976. 2002</date>
			<pubPlace>Millbrae, CA, USA</pubPlace>
		</imprint>
	</monogr>
	<note>Chinese Folk Tales</note>
</biblStruct>

<biblStruct xml:id="b107">
	<monogr>
		<title level="m" type="main">Specification searches: Ad hoc inference with nonexperimental data</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Mer</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1978">1978</date>
			<publisher>John Wiley</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Catatonic stupor after `ecstasy&apos;</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W Y</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Medical Journal</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="372" to="374" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Focusing in reasonin decision making</title>
		<author>
			<persName><forename type="first">P</forename><surname>Renzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Girotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Johnson-Laird</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cognition</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="37" to="66" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Addiction is a Brain Disease, and It Matters</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Hner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="45" to="47" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Ecstasy and other club drugs: A review of recent epidemiological studies</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">234</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<monogr>
		<title level="m" type="main">The Discovery of Addiction: Changing Conceptions of Habitual Drunkenness i</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Levine</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Appropriateness of composites in structural equation models</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Whitelaw</surname></persName>
		</author>
		<idno>pp. S52-S59</idno>
	</analytic>
	<monogr>
		<title level="j">Jou Gerontology: Social Sciences</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<monogr>
		<title level="m" type="main">Managing Alcoholism: Matching Clients to Treatments</title>
		<author>
			<persName><forename type="first">L</forename><surname>Dstrom</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1992">1992</date>
			<pubPlace>Oxford, England</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Oxford University Pre</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Covariance structure analysis: Extensions and developments</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shahar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Widaman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">To Parc Not to Parcel: Exploring the Questio Modeling: A Multidisciplinary Journal</title>
		<editor>
			<persName><forename type="first">B</forename><surname>Thompson</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1989">2002. 1989</date>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="171" to="204" />
		</imprint>
	</monogr>
	<note>Advances in social scientific methodology</note>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Subs students: Are they related?</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Holtzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Truman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kolbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">1116-1120. e for covariance structure modeling</title>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">84</biblScope>
		</imprint>
	</monogr>
	<note>Psychological Ma he problem of capitalization on chance</note>
</biblStruct>

<biblStruct xml:id="b117">
	<monogr>
		<title level="m" type="main">Alcohol and intentions to ltural aspects</title>
		<author>
			<persName><forename type="first">T</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
			<biblScope unit="page" from="407" to="428" />
			<pubPlace>Hove, United Ma</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">on of structural Ma ndexes in al Bulletin, Ma models of factorial invariance: Ma conomic&apos; Theory of Addiction</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ma Sabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Heckathorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Consulting and Clinical Psychology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="411" to="417" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>Review of sampling holism</note>
</biblStruct>

<biblStruct xml:id="b119">
	<monogr>
		<title/>
		<author>
			<persName><surname>Ma</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<monogr>
		<title level="m" type="main">Power analysis and determination of sample siz Methods</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Maccallum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Sugawara</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1996">1996</date>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="130" to="149" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Official crime statistics Economic Journals, 112, F85-F106. gnani, R., hard-to-reach and hidden populations for HIV surveillance</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Roznowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Necowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Model modifications in covariance structure analysis: T Psychological Bulletin</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Adair</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Belanger</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1992">1992. 2002. 19</date>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="567" to="572" />
		</imprint>
	</monogr>
	<note>engage in risky health-related behaviors: Experimental evidence for a causal relationship. Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Hypothesis formulation, model interpretation, and model equivalence: Implications of a mereological causal interpretati equation models</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chassin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Sher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Markus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Balla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of the Addictions</title>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Rvel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Hartmann</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">4-5</biblScope>
			<biblScope unit="page" from="495" to="508" />
			<date type="published" when="1986">1987. 2008. 1988. 1994. 1986</date>
		</imprint>
	</monogr>
	<note>Multivariate Behavioral Research</note>
</biblStruct>

<biblStruct xml:id="b123">
	<monogr>
		<title level="m" type="main">NIDA expands its research on addictio NIDA Notes</title>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1" to="5" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Renovating the house of being: genomes, souls, and selves</title>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<ptr target="http://archives.drugabuse.gov/NIDA_Notes/NNVol14N4/Ecstasy.html" />
	</analytic>
	<monogr>
		<title level="j">Ma Annals of the New York Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="240" to="252" />
			<date type="published" when="1999">1999. 2003</date>
		</imprint>
	</monogr>
	<note>Ecstasy</note>
</biblStruct>

<biblStruct xml:id="b125">
	<monogr>
		<ptr target="/cswr/gcattc/Trends/ClubDrug-2004-" />
		<title level="m">Ma tterns of Club Drug Use in the U.S. Publication of the on the</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Hyponatreamia and catatonic stupor after taking &quot;ecstasy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Maxwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Polkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Henry</surname></persName>
		</author>
		<ptr target="http://www.utexas.edu/researchweb.pdf" />
	</analytic>
	<monogr>
		<title level="m">Pa Center for Excellence in Drug Epidemiology. The Gulf Coast Addiction Technology Transfer Center. The University of Texas at Austin</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Xwell</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1399">1993. 1399. 2004. 2010</date>
			<biblScope unit="volume">307</biblScope>
		</imprint>
	</monogr>
	<note>last retrieved on February 9</note>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Measuring interstate variations in drug problems</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Auliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Labrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lomuto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fournier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Betjemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="125" to="145" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Identifying Mc The Psychology of Addiction. London: Taylor and Francis nd 9-Mo harm minimization and interactive outreach: The of substance abuse treatment gaps in sub-state areas</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Auliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Woodworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mc Mc Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Dunn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Substance Abuse Treatment</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="199" to="208" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Principles and practice in reporting structural equation analyses</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M-H</forename><forename type="middle">R</forename><surname>Ho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychological Methods</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="64" to="82" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Murran</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Validity in Logistics Research</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mentzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Flint</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Business Logistics</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="199" to="216" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Substance use and risky sexual behavior in female adolescents</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Mezzich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tarter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Giancola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kirisci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug a Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="157" to="166" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<monogr>
		<title level="m" type="main">Motivational Interviewing: Preparing People to Change Addictive Behaviour</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rollnick</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1991">1991</date>
			<publisher>Guilford Press</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<monogr>
		<title level="m">The Addictions: Multidisciplinary Perspectives and Treatments</title>
		<editor>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Milkman</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Shaffer</surname></persName>
		</editor>
		<meeting><address><addrLine>Lexington, MA</addrLine></address></meeting>
		<imprint>
			<publisher>Lexington Books</publisher>
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Utility Analysis and the Consumption Function: An Interpretation of Cross-section Data</title>
		<author>
			<persName><forename type="first">F</forename><surname>Modigliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brumbergh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Post Keynesian Economics</title>
		<editor>
			<persName><forename type="first">K</forename><surname>Kurihara</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1955">1955. 1955</date>
			<publisher>George Allen and Unwin</publisher>
			<pubPlace>London</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Economics as a factor in models of behavioral motivation and change. Substance Use and Misuse</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Montoya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Atkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Trevino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Australian Journal Public Health</title>
		<editor>
			<persName><forename type="first">W</forename><surname>Norton</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Ore</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="58" to="67" />
			<date type="published" when="1993">2000. 1996. 1993</date>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>Social controls, public health implications of an ethnography of drug use</note>
</biblStruct>

<biblStruct xml:id="b137">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Needle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weatherby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Chitwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cesari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Watters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Braunstein</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>e Nes ic American</note>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Nu Reliability of self-reported risk behaviors of drug users</title>
	</analytic>
	<monogr>
		<title level="j">Psychology of Addictiv Behaviors</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="242" to="250" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">The addicted brain</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Tler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Malenka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientif</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="78" to="85" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<monogr>
		<title level="m" type="main">Psychometric theory</title>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<imprint>
			<date type="published" when="1978">1978</date>
			<publisher>McGraw Hill</publisher>
			<biblScope unit="page">701</biblScope>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<monogr>
		<title level="m" type="main">Psychometric theory</title>
		<author>
			<persName><forename type="first">J</forename><surname>Nunnally</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1967">1967</date>
			<publisher>McGraw Hill</publisher>
			<biblScope unit="page">640</biblScope>
			<pubPlace>New York; Chicago, IL</pubPlace>
		</imprint>
		<respStmt>
			<orgName>University of Chicago</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Executive Office of the President (Publication No. 207303). alysis of 1100-1104. ith Learning and Regret, Pac Pan ement e and negative affective states of alcohol addiction</title>
	</analytic>
	<monogr>
		<title level="j">Hum Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="557" to="578" />
			<date type="published" when="1998">2004. 1998</date>
			<publisher>Office of National Drug Policy</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
	<note>Ecstasy (MDMA) effects on mood cognition: , 261-Par of al research</note>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Annals of the New York Academy of Pee Pep nski</title>
	</analytic>
	<monogr>
		<title level="m">Informing America&apos;s y Per tamine in recreational users</title>
		<editor>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Pepper</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Petrie</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename></persName>
		</editor>
		<imprint/>
	</monogr>
	<note>Pee tion as a cultural concept</note>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Rational Addiction to Caffeine: An An Coffee Consumption</title>
		<author>
			<persName><forename type="first">Pet</forename><surname>Acht Reisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Olekalns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bardsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rational Addiction w Journal of Political Economy</title>
		<editor>
			<persName><forename type="first">A</forename><surname>Orphanides</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Zervos</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="739" to="758" />
			<date type="published" when="1995">1996. 1995</date>
		</imprint>
	</monogr>
	<note>Journal of Political Economy</note>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">The gene transcription factor cyclic AMP-responsive el binding protein: role in positiv</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Ula</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grossman</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Chaloupka</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>O'malley</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Johnston</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Farrelly</surname></persName>
			<affiliation>
				<orgName type="collaboration">Inc. dey, S. C.</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">National Bureau of Economic Research</title>
		<editor>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Lasky</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="139" to="268" />
			<date type="published" when="2000">2000. 2004. 2001</date>
			<pubPlace>rott, A. C</pubPlace>
		</imprint>
	</monogr>
	<note>Psychoparmacology. Human psychopharmacology of Ecstasy/MDMA: a review 15 years of empiric</note>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">The psychotherapeutic potential of MDMA (3,4methylenedioxymethamphetamine): an evidence-based review</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Parrott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<editor>
			<persName><forename type="first">S</forename><surname>Le</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="205" to="220" />
			<date type="published" when="1990">2007. 1990</date>
		</imprint>
	</monogr>
	<note>Addic Sciences</note>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">How do response problems affect measurement of trends in drug use?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Le</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Ma policy on illegal drugs: What we don&apos;t know keeps hurting us</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">V</forename></persName>
		</editor>
		<meeting><address><addrLine>Washington, D.C</addrLine></address></meeting>
		<imprint>
			<publisher>National Academ Press</publisher>
			<date type="published" when="2001">2003. 2001</date>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="321" to="348" />
		</imprint>
	</monogr>
	<note>Addiction--choice or disease?</note>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Targeted Sampling in Drug Abuse Res Review and Case Study Field Methods</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sch Brown</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Agar</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">H</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="273" to="277" />
			<date type="published" when="1988">1988. 2008</date>
		</imprint>
	</monogr>
	<note>Sage Journal</note>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Popper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The Logic of Scientific Discovery</title>
		<editor>
			<persName><forename type="first">N</forename><surname>Heather</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Vuchinich</surname></persName>
		</editor>
		<editor>
			<persName><surname>Ra Dence</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1959">1959. 1999</date>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="385" to="401" />
		</imprint>
	</monogr>
	<note>American Journal of Psychiatry</note>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title/>
		<author>
			<persName><forename type="middle">J</forename><surname>Ed Dopamine</surname></persName>
		</author>
		<author>
			<persName><surname>Neurosci</surname></persName>
		</author>
		<idno>sa.ca/2006%20CCSA%20Documents/ccsa-011332-</idno>
	</analytic>
	<monogr>
		<title level="j">Annals</title>
		<editor>
			<persName><forename type="first">B</forename><surname>Reh</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><surname>Gnam</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><surname>Patra</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Popova</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="5841" to="5846" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">A perspective on psychology and economics</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Economic Review</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="657" to="685" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Economic concepts in the behavioral study of addiction</title>
		<author>
			<persName><forename type="first">H</forename><surname>Rachlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behavioral and Econom Research</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="92" to="S99" />
			<date type="published" when="2003">2003. 2007</date>
			<publisher>Elsevier</publisher>
			<pubPlace>Oxford. chlin, H</pubPlace>
		</imprint>
	</monogr>
	<note>Drug Alcohol Depen</note>
</biblStruct>

<biblStruct xml:id="b153">
	<monogr>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename></persName>
		</author>
		<title level="m">The CES-D Scale: A self-report depression scale for research in the general population</title>
		<imprint>
			<publisher>App</publisher>
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<monogr>
		<title level="m" type="main">Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically releas</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ranaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wise</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">A Structural Equation Model: India&apos;s International Tourism Demand for Tourist Destination</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rangaswamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chaiboonsri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chaitip</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Romania</title>
		<imprint>
			<biblScope unit="page" from="107" to="134" />
			<date type="published" when="2008">2008</date>
		</imprint>
		<respStmt>
			<orgName>Univ. of Petrosani, Economics, University of Petrosani</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Baliunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brochu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fischer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">In collaboration with</title>
		<author>
			<persName><forename type="first">Sarnocinska-,</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>March</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><forename type="middle">E</forename><surname>Adlaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Recel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Single</surname></persName>
		</author>
		<ptr target="http://www.cc2006.pdf" />
	</analytic>
	<monogr>
		<title level="m">The Costs of Substance Abuse in Canada</title>
		<imprint>
			<date type="published" when="2002-10-28">2006. 2002. October 28, 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Edenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><surname>Van Eerdewegh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Foroud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hesselbrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schuckit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bucholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Porsjesz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T.-K</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Conneally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Nurnberger</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tischfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Crowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Cloninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shears</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">,</forename><surname>Cro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Willing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Begleiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<editor>nce. Ric Cord, B.J., McCann, U.D.</editor>
		<imprint>
			<date type="published" when="1998">1998. 2002</date>
			<pubPlace>Sept</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<monogr>
		<title/>
		<author>
			<persName><surname>Ril</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>Patterns of</note>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Genome-wide search for genes affecting the risk for alcohol depende</title>
	</analytic>
	<monogr>
		<title level="j">American Journal of Medical Genetics</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="207" to="215" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hatzidimitriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Severe Dopaminergic Neurotoxicity in Primates after a Common Recreational Dose Regimen of MDMA</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C E</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gregory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dingle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Cadger M recreational drug use at dance events in Edinburgh, Scotland. Addiction</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1035" to="1047" />
		</imprint>
	</monogr>
	<note>Science, 2260-2263</note>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Drug use by U.S. Army Enlisted Men in Vietnam: A Follow-up on Their Return Home</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Goodwin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Epidemiology</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="235" to="249" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">The sixth Thomas James Okey Memorial Lecture. Vietnam veterans&apos; rapid recovery from heroin addiction: a fluke or normal experience? Addiction, 88, 1041-1954. bins, L. N. interview faithful to the nomenclature</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Berridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol. binson</title>
		<editor>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Berridge</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">K</forename><forename type="middle">C</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="247" to="291" />
			<date type="published" when="1993">1993. 1993. 2000</date>
		</imprint>
	</monogr>
	<note>Brain Res. Rev.. The psychology and neurobiology o addiction: an incentive-sensitization view</note>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Recruiting injection drug users: A site comparison of results and experiences with respon sampling procedures</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Berridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Risser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcgoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rehman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jefferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Wolverton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Tortu</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Urban Health</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="283" to="323" />
			<date type="published" when="2003">2003. 2006. 2003</date>
			<publisher>Rationality and Society</publisher>
		</imprint>
	</monogr>
	<note>Preferences, Rationality and Welfare in Becker&apos;s Ex Utility Approach</note>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Sociological aspects of the disease concept of alcoholism</title>
		<author>
			<persName><forename type="first">R</forename><surname>Room</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Research Advances in Alcohol and Drug Problems</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="47" to="91" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">situation context, price structure and demographic characteristics</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Sa Daz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bign</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Johar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hassan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedin of the 2002 Multicultural Marketing Conference</title>
		<meeting>eedin of the 2002 Multicultural Marketing Conference<address><addrLine>Valencia, Spain</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="137" to="142" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Ecstasy: America&apos;s new &quot;reefer madness</title>
		<author>
			<persName><surname>Marder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychoactiv Drugs. Apr</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2002-06">2002. Jun</date>
			<publisher>A df Rosenbaum M</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">MD Assisted Psychotherapy for the Treatment of Posttraumatic Stress Diso Revised Teaching Manual Draft</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Ruse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jerome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mithoefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Doblin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gibson</surname></persName>
		</author>
		<ptr target="http://www.maps.org/research/MDMA_treatment_manual_10_23_2010_.p" />
	</analytic>
	<monogr>
		<title level="m">Sat in tical Sat i-square test statistic Sau gnostic and ion: Sch beh viors</title>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Heymann</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">N</forename></persName>
		</editor>
		<imprint>
			<date type="published" when="2001">2010. 2004. 2001</date>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="3" to="7" />
		</imprint>
	</monogr>
	<note>Is drug addiction a brain disease?</note>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Optimum Growth with Intertemporally Dependent Preferences</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Maps ; Der</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Heal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev. Econ. Studies</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1" to="33" />
			<date type="published" when="1973">2010. 1973</date>
		</imprint>
	</monogr>
	<note>Last retrieved on October 29</note>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">The Demand for Illicit Drugs</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chaloupka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Econo Inquiry</title>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="1999">1999</date>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="401" to="411" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Nucleus Accumbens Dopamine and the Regulation Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Correa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mingote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Weber</forename><forename type="middle">S M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Heckathorn D populations using respondent-driven sampling</title>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="193" to="240" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">A conceptual model of tru environment</title>
		<author>
			<persName><forename type="first">J</forename><surname>Karjaluoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Online Information Review</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="604" to="621" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<monogr>
		<author>
			<persName><surname>Windows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">No</forename><surname>Cary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Usa</forename><surname>Carolina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>El</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Goodwin</surname></persName>
		</author>
		<title level="m">Drug addiction and drug policy: The struggle to control dependence</title>
		<editor>
			<persName><forename type="first">C</forename><surname>El</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Brownsberger</surname></persName>
		</editor>
		<meeting><address><addrLine>Washington, D.; Cambridge, MA</addrLine></address></meeting>
		<imprint>
			<publisher>Harvard University Press</publisher>
			<date type="published" when="1998">2009. 1998</date>
			<biblScope unit="page" from="118" to="143" />
		</imprint>
	</monogr>
	<note>Is Drug Addiction a Brain Disea and Public Policy Center</note>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Scaling corrections for chi-square statistics covariance structure analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Orra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the American Statis Association</title>
		<meeting>the American Statis Association</meeting>
		<imprint>
			<date type="published" when="1988">1988</date>
			<biblScope unit="page" from="308" to="313" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">A scaled difference ch for moment structure analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Orra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bentler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychometrika</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="507" to="514" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">The development of the Dia Statistical Manual of Mental Disorders Version V substance use disorders sect establishing the research framework</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="208" to="212" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Drug use and risky sexual avior</title>
		<author>
			<persName><forename type="first">J</forename><surname>Afer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Blanchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fals-Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychology of Addictive Beha Sch i J.A., Copeland J., Cottler L.B</title>
		<imprint>
			<date type="published" when="1994">1994. 2010</date>
		</imprint>
	</monogr>
	<note>Tri-Sch Goers</note>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sch J. ctive Behav, Sch . Drug and Alcohol Abuse</title>
		<imprint>
			<publisher>Plenum Press</publisher>
			<pubPlace>Linz; New York</pubPlace>
		</imprint>
		<respStmt>
			<orgName>NIAAA ol Sch rtment of Economics, University of Linz</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<monogr>
		<title level="m">Sch ssociates. rch HIV risk reduction</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">Inciard city study of Ecstasy use problems: A latent class analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Schaler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<editor>
			<persName><forename type="first">L</forename><forename type="middle">M</forename></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ben</forename><surname>Abdallah</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="249" to="263" />
			<date type="published" when="2002">2002</date>
			<pubPlace>Chicago, IL</pubPlace>
		</imprint>
	</monogr>
	<note>Addiction is a Choice</note>
</biblStruct>

<biblStruct xml:id="b182">
	<monogr>
		<title level="m" type="main">Choice and Consequence</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename></persName>
		</author>
		<imprint>
			<date type="published" when="1984">1984</date>
			<publisher>Harvard University Press</publisher>
			<pubPlace>Cambridge MA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Patterns of Ecstasy Use Amongst Clubon the U.K. &apos;Dance Scene&apos;</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sherlock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Conner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Drug Policy</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="117" to="118" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a www study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Weisner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Neider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Parrott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Buchanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heffernan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rodgers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Shadow economy and corruption all over the world: what do we know? Discussion Paper, Depa Austria. oley</title>
		<editor>
			<persName><forename type="first">R</forename><surname>Wilson</surname></persName>
		</editor>
		<editor>
			<persName><surname>Dufour</surname></persName>
		</editor>
		<meeting><address><addrLine>Bethesda, MD</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1984">2000. 2007. 2004. 1984</date>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="743" to="752" />
		</imprint>
		<respStmt>
			<orgName>National Institute on Alcoh Abuse and Alcoholism</orgName>
		</respStmt>
	</monogr>
	<note>Estimating alcohol problems in small areas: Contrasting data sources, definitions, and measures</note>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">A neural substrate of prediction and reward</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schultz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Montague</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="1593" to="1599" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Predictive reward signal of dopamine neurons</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schultz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurophysiol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1" to="27" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Getting formal with dopamine and reward</title>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="241" to="263" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<monogr>
		<title level="m" type="main">A beginner&apos;s guide to structural equation modeling</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Schumacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Lomax</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>Lawrence Erlbaum A</publisher>
			<pubPlace>Mahwah, NJ</pubPlace>
		</imprint>
	</monogr>
	<note>Second edition</note>
</biblStruct>

<biblStruct xml:id="b189">
	<monogr>
		<title level="m" type="main">Behaviorism, science, and human nature</title>
		<author>
			<persName><forename type="first">B</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lacey</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1982">1982</date>
			<publisher>Norton</publisher>
			<biblScope unit="page" from="20" to="24" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">Resea notes and commentaries: An assessment of the use of structural equation modeling in strategic management research</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Shook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ketchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T M</forename><surname>Hult</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Kacmar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Strategic Management Journal</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="397" to="404" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Semaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Des Jarlais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sogalow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sweat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Norman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Needle</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Meta-analysis of the impact of t the 12th</note>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">Internet Gratifications and of r presented at the annual meeting of the Psychometric Stig interventions on safer sex behaviors of drug users</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Lum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">MDMA, politics and medical research: Have we trown the baby out with the 787-791. cham, E. and Cot Prevalence and reliability</title>
		<editor>
			<persName><forename type="first">Kenneth</forename><forename type="middle">L</forename><surname>Davis</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Dennis</forename><surname>Charney</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Joseph</forename><forename type="middle">T</forename><surname>Coyle</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Charles</forename><surname>Nemeroff</surname></persName>
		</editor>
		<meeting><address><addrLine>Geneva, Switzerland</addrLine></address></meeting>
		<imprint>
			<publisher>American College of Neuropsychopharmacology</publisher>
			<date type="published" when="1988">2009. 1988. 1999. 1992. 2004. 2007. 2002</date>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="297" to="326" />
		</imprint>
	</monogr>
	<note>Multivariate Behavioral Research</note>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">Psychological expectancy as mediator of vulnerability alcoholism</title>
		<author>
			<persName><forename type="first">O.-J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Addiction: Entries and Exits</title>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Sage</publisher>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">708</biblScope>
			<biblScope unit="page" from="1161" to="1161" />
		</imprint>
	</monogr>
	<note>Br J Addict</note>
</biblStruct>

<biblStruct xml:id="b194">
	<monogr>
		<title level="m" type="main">Copolymerization behavior of vinylimidazolium salts Chemistry Edition</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Salamone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Israel</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1975">1975</date>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="161" to="170" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">LaRo Internet Addiction: On the Uses and Abuses of New Media</title>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CyberPsychology &amp; Behavior</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="384" to="394" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">Expectancy models of alcohol use</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Stacy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Widaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Marlatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Personality and Social Psychology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="918" to="928" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">Statistically based tests for the number common factors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Steiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Economic Review</title>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Ler</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Becker</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="76" to="90" />
			<date type="published" when="1977">1980. June. 1977</date>
			<publisher>Pape Society</publisher>
			<pubPlace>Iowa City, IA</pubPlace>
		</imprint>
	</monogr>
	<note>De gustibus non est disputandum</note>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">Alcohol, drugs, and adolescent sexual behavior</title>
		<author>
			<persName><forename type="first">L</forename><surname>Strunin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hingson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of the Addictions</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="129" to="146" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<monogr>
		<title level="m">CJ 2000: Innovations in Measurement and Analysis</title>
		<editor>
			<persName><forename type="first">Tom</forename><surname>Strengths</surname></persName>
		</editor>
		<editor>
			<persName><surname>Tsu 67-Uhl</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Uhl</surname></persName>
		</editor>
		<editor>
			<persName><surname>Va</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">B</forename><surname>Porjesz</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Edenberg</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">V</forename><surname>Hesselbrock</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">R</forename><surname>Crowe</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Schuckit</surname></persName>
		</editor>
		<editor>
			<persName><surname>Begleiter</surname></persName>
		</editor>
		<meeting><address><addrLine>Washington, DC; Waller, N. G.</addrLine></address></meeting>
		<imprint>
			<date>20</date>
		</imprint>
		<respStmt>
			<orgName>National Institute of Justice. arken</orgName>
		</respStmt>
	</monogr>
	<note>Structural Equation Modeling</note>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence</title>
		<author>
			<persName><surname>Limitations</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Misconceptions ; Kins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Sellers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Clinical Psychology</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="817" to="821" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>CMAJ</note>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Molecular genetic underpinnings of human substance abuse vulnerability: a current approach</title>
		<author>
			<persName><forename type="first">L</forename><surname>Topp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Solowij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Bar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Harley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Uhl</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3" to="9" />
			<date type="published" when="1999">1999. 2001. 1999</date>
		</imprint>
	</monogr>
	<note>Drug Alcohol Depend.</note>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">The burden of complex genetics in brain disorders</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Grow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Gen. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="223" to="229" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">Structural equation modeling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Ullman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Using Multivariate Statistics</title>
		<title level="s">Een maat voor het kwaad. Leuven. Universitaire Pers Leuven</title>
		<editor>
			<persName><forename type="first">Allyn</forename><forename type="middle">&amp;</forename><surname>Bacon N Kerckvoorde</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename></persName>
		</editor>
		<meeting><address><addrLine>Needham Heights, MA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1995">2001. 2001. 1995</date>
		</imprint>
	</monogr>
	<note>th ed; pp 653-771</note>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">The addicted human brain: insigh from imaging studies</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Volkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Fowler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1444" to="1451" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">Overview of behavioral economic perspectives on substance use and addiction</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vuchinich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Heather</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Choice, behavioral economics and addiction</title>
		<editor>
			<persName><forename type="first">R</forename><surname>Vuchinich</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">N</forename><surname>Heather</surname></persName>
		</editor>
		<meeting><address><addrLine>Oxford UK</addrLine></address></meeting>
		<imprint>
			<publisher>Pergamon Press</publisher>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<monogr>
		<title level="m" type="main">What is the size of the Pie? Measuring the Informal Economy in Latin American and the Caribbean</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vuletin</surname></persName>
		</author>
		<idno>WP/08/102</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
			<publisher>International Monetary Fund</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">IMF Working Paper</note>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Hinrichs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Budde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bertelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Dick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Nurberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tischfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Sloan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Applied Economics</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="727" to="736" />
			<date type="published" when="1995">1995</date>
			<publisher>W addiction model</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Biernacki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<title level="m">Targeted sampling: Options for the study hidden po</title>
		<imprint>
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Validity of self reported drug use among injection drug users and crack cocaine users recruited throug</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Weatherby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Needle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cesari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Booth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Evaluation and Program Planning</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="347" to="355" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">Intraclass reliability estimates: Testin 25-33</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Linn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Jreskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>St</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>O'neal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Theory of Addiction</title>
		<editor>
			<persName><forename type="first">R</forename><surname>St</surname></persName>
		</editor>
		<meeting><address><addrLine>Oxford, UK. ite</addrLine></address></meeting>
		<imprint>
			<publisher>Blackwell Publishing</publisher>
			<date type="published" when="1974">1974. 2004. June. 2006. 2001</date>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="48" to="52" />
		</imprint>
	</monogr>
	<note>Addiction Disease C Magazine. February. ite, W. L. (2001b). A Disease Concept for the 2 April</note>
</biblStruct>

<biblStruct xml:id="b212">
	<analytic>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Addiction Treatment in the United States: Early pioneers institutions</title>
		<imprint>
			<date type="published" when="2002">2002</date>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page">108</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b213">
	<analytic>
		<title level="a" type="main">Measurement and Classification of Psychiatr Program</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Wing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sartorius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Economic Behavior and Organization</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">243</biblScope>
			<date type="published" when="1974">1974. 1980. 1996</date>
			<publisher>Cambridge University Press</publisher>
			<pubPlace>Cambridge. nston, G. C</pubPlace>
		</imprint>
	</monogr>
	<note>Current Opinion in Neurobiology</note>
</biblStruct>

<biblStruct xml:id="b214">
	<analytic>
		<title level="a" type="main">Brain reward circuitry: insights from unsensed incentives</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wise</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="229" to="240" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<monogr>
		<title level="m" type="main">Cross-cultural feasibility, reliability and sources of variance of the Wo artment of Mental Health and orld Health Organization. on of Wu Mannelli</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Cottler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sartorius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Regier</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1991">1991</date>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="654" to="661" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">Composite International Diagnostic Interview (CIDI)</title>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="645" to="653" />
		</imprint>
	</monogr>
	<note>The Multicentre WHO/ADAMHA Field Trials</note>
</biblStruct>

<biblStruct xml:id="b217">
	<monogr>
		<title level="m" type="main">International Guide For Monitoring Alcohol Consumption and Related Harm Dep Substance Dependence Non communicable Diseases and Mental Health Cluster</title>
		<imprint>
			<date type="published" when="1987">1987</date>
			<publisher>rld Health Organization (WHO)</publisher>
			<pubPlace>Geneva</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">The high prevalence of substance use disorders among recent MDM users compared with other drug users: implications for intervention</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Parrott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Ringwalt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Patkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<date type="published" when="1990">1990. 2004. 2009</date>
			<publisher>World Health Organization</publisher>
			<pubPlace>Geneva, Switzerland; Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
	<note>International Statistical Classificati Diseases and related Health Problems (ICD-10)</note>
</biblStruct>

<biblStruct xml:id="b219">
	<analytic>
		<title level="a" type="main">The Rational Choice Approach to Human Studies: A Reexamination</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zafirovski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Human Studies</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="41" to="66" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
